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Prof. Dr. Urs Frey, Dissertationsleiter
Prof. Dr. Matthias Egger, Korreferent
Basel, den 10.11.15
Dekan Prof. Dr. Jörg Schibler
2
”No man burdens his mind with small matters unless
he has some very good reason for doing so.”




1.1 Development of human lungs before and after birth . . . . . . . . . . . 17
1.1.1 Lung development in term-born children . . . . . . . . . . . . . 17
1.1.2 Prematurity disturbs alveolar growth . . . . . . . . . . . . . . . 18
1.1.3 Respiratory health in the context of Public Health . . . . . . . . 20
1.2 What do classic lung function tests tell us? . . . . . . . . . . . . . . . . 22
1.3 Options for measurements during normal breathing . . . . . . . . . . . . 23
1.3.1 Multiple-breath washout . . . . . . . . . . . . . . . . . . . . . . 23
1.3.2 Tidal breathing parameters . . . . . . . . . . . . . . . . . . . . 25
1.3.3 Plethysmography . . . . . . . . . . . . . . . . . . . . . . . . . . 26
1.4 BILD study - Basel & Bern Infant Lung Development . . . . . . . . . . 26
1.5 Aims of this work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2 Validation of MBW equipment 32
2.1 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.3 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
2.6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
2.7 Online Supplement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3 Lung growth in term-born children 56
3.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.3 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
3.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
3.6 Online Supplement 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.7 Online Supplement 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
4
4 Infant lung function in preterm children 98
4.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
4.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
4.3 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
4.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
4.6 Online Supplement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
5 Ventilation in school-aged preterm children 120
5.1 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
5.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
5.3 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
5.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
5.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
6 Excessive lung growth after prematurity 143
6.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
6.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
6.3 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
6.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
6.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
6.6 Online Supplement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
7 General discussion 180
7.1 General strengths and limitations . . . . . . . . . . . . . . . . . . . . . 181
7.2 Comparison with previous findings and interpretation . . . . . . . . . . . 183
7.3 Clinical and public health relevance . . . . . . . . . . . . . . . . . . . . 186
7.4 Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187





6q12 and 11p14 variants are associated with postnatal exhaled nitric oxide
and respiratory symptoms . . . . . . . . . . . . . . . . . . . . . . . . . 213
9.2 Additional manuscript
False normal Lung Clearance Index in infants with cystic
fibrosis due to software algorithms . . . . . . . . . . . . . . . . . . . . . 250
9.3 Additional manuscript
Ventilatory response to nitrogen multiple-breath washout
in infants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 260
9.4 Abstract of additional manuscript
Preterm birth, infant weight gain, and childhood asthma risk: a meta-
analysis of 147,000 European children . . . . . . . . . . . . . . . . . . . 267
9.5 Abstract of additional manuscript
Early growth characteristics and the risk of reduced lung function and
asthma: a meta-analysis of 25,000 children . . . . . . . . . . . . . . . . 269
10 Curriculum vitae 272
6
List of Abbreviations and Definitions
Abbreviation Full term
95%CI 95% confidence interval
ATS American Thoracic Society
AUC Area under the curve
BILD Bern and Basel infant lung development study
BTPS Body temperature, ambient pressure, saturated (with water vapour)
BPD Bronchopulmonary dysplasia
CEV Cumulative expired volume
CF Cystic fibrosis
CO2 Carbon dioxide
CRIB Clinical risk index for babies
CV Coefficient of variation
DSR Dead space reducer
DZL Deutsches Lungenzentrum
ELBW Extremely low birth weight (<1.0 kg)
ELGAN Extremely low gestational age neonates (<28 weeks of gestation)
FeNO Fraction of exhaled nitric oxide
ERS European Respiratory Society
FEV1 Forced expiratory volume in 1 second
FRC Functional residual capacity
FRCMBW Functional residual capacity measured by multiple-breath washout
FRCMBW V 1 Functional residual capacity measured by multiple-breath washout at visit 1
FRCMBW V 2 Functional residual capacity measured by multiple-breath washout at visit 2
FRCpleth Functional residual capacity measured by plethysmography




HeMBW Helium multiple-breath washout
ISPM Institut für Sozial- und Präventivmedizin
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Pädiatrische Pneumologie, Swiss School of Public Health.
The people who trained me and worked with me in Berlin deserve recognition for helping
me to be prepared and motivated for this new section: Doris Staab, Ulrich Wahn, Klaus
Magdorf, Anne Mehl, Anne Detjen, Maike Pincus, Horst von Bernuth, Carsten Schwarz,
Susanne Lau, Bodo Niggemann, Nico Derichs, Michael Barker, Christoph Grüber, Kai
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Understanding early lung growth is a prerequisite for strategies to ensure ideal lung devel-
opment in childhood and to minimise lifelong respiratory morbidity. Reduced respiratory
health is a major burden for many individuals across all ages and for health care systems
worldwide. Chronic lung diseases in adults originate early in life, and our knowledge
of the underlying mechanisms is limited. The aim of this work was to describe early
lung growth from infancy to early childhood in term-born and preterm children, and to
compare pulmonary outcomes and their determinants cross-sectionally and longitudinally
between these populations.
Non-invasive lung function tests like multiple-breath washout (MBW) enabled us to mea-
sure lung volumes and ventilation homogeneity in relatively large populations in infancy
and early childhood during normal breathing.
As a first step, we challenged our equipment. We performed an in-vitro study using
a lung model with quasi-physiologic conditions, testing one setup for MBW in infants
and one setup for MBW in young children. Both were based on ultrasonic flow meter
technology. Tracers were sulfur hexafluoride and helium respectively. We investigated the
agreement of the functional residual capacity (FRC) that was measured by the equipment
to the generated FRC in the model by calculating the absolute and relative differences
between the two. In the infant setup, mean (95%CI) absolute difference between model
and measured FRC was 1.9 (0.3-3.5) ml, corresponding to a relative difference of 0.7
(-0.6 – 2.0) %, 96% of runs met the criteria of measuring FRC within 10% accuracy.
In the young child setup, for FRCs between 600 and 1,400 ml, absolute difference was
-17 (-25 – -8.3) ml corresponding to a relative difference of -2.0 (-3.0 – -0.9) %. We
observed results within 10% accuracy for 98% of these trials. In conclusion, we observed
a measurement error for FRC within an acceptable range for the lung volumes expected
in our target age groups.
Using this reliable and valid equipment, we measured FRC and lung clearance index (LCI),
an early marker of small airway pathologies, repeatedly in term-born and preterm children
from an ongoing observational study in Switzerland, the so-called BILD study (Bern &
Basel Infant Lung Development). In addition, we performed MBW using nitrogen as a
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tracer, and routine lung function tests like spirometry and plethysmography. We collected
information on pre- and postnatal exposures, as well as on respiratory symptoms during
infancy and young childhood.
In a population of 124 term-born children, we tested the potential association of FRC
measured by MBW at the age of 5 weeks (visit 1), and other potential predictors, with
FRC measured by plethysmography (FRCpleth) at 6 years (visit 2) by linear regression
analysis, primary outcome of which was FRCpleth. We observed only a weak association
of FRC over time, the univariable model explained only 4.1% of the variance of FRCpleth
(coefficient 2.7 ml; 95%CI 0.6 – 4.8). In the multivariable model including height and
age at visit 2, male gender, and maternal smoking during infancy, the variance explained
was higher (coefficient 2.0 ml; 95%CI 0.02 – 3.97, R2 22%, p<0.001). We found no as-
sociation of lung volume with function of larger airways, which indicated disproportionate
growth of lung parenchyma and large airways.
In a group of 166 preterm infants, we investigated whether lung function at the cor-
rected age of 44 weeks of gestation predicts respiratory morbidity in the first year of life.
No improved prediction was found compared to standard clinical tools, but we observed
an altered breathing pattern in the subgroup that developed wheeze in the first year of
life. Tidal volume was positively associated with wheeze (adjusted odds ratio (aOR)
1.40 (95%CI 1.04-1.90) per 5 ml increase), respiratory rate was negatively associated
with wheeze (aOR 0.69 (95%CI 0.50-0.96) per 10 breath per min increase). This might
reflect an adaptive change in breathing pattern as a consequence of the underlying struc-
tural pathology.
Later in childhood, at the age of approximately 9 years, we compared ventilation homo-
geneity in 77 preterm children with 49 term-born children of the same age. We measured
LCI and slopes of nitrogen expirogram reflecting ventilation in the acinar regions (Sacin),
and conducting airways (Scond). We found no differences on the overall and acinar
level, but Scond was significantly elevated in preterm compared to term-born partici-
pants (mean difference 1.74 z-scores, 95%CI 1.17 - 2.30, p <0.001). Scond was elevated
in 54% of the preterm children. Younger gestational age was the strongest predictor of
having an elevated Scond (R2 37%).
When we analysed FRC in 80 preterm children over time, i.e. from infancy to early school
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age, we found an even weaker association of lung volume over time than in our study in
term-born children. After adjustment for height and age at visit 2, and for immaturity of
the lungs, we found a very weak association between FRC at visit 1 and FRC measured by
MBW at visit 2 (beta = 2.6 ml per ml, 95%CI 0.02 to 5.22, R2 55.7%), with the highest
proportion of variance explained by the variables for which we had adjusted. Younger
gestational age was associated with stronger relative lung volume increase, i.e. increase
in FRC standard deviation score from visit 1 to visit 2 (beta = -0.18 after adjustment,
95%CI -0.27 to -0.08, p <0.001). Compared to the term-born children, preterm children
at visit 2 showed significantly higher values for FRCpleth standard deviation score, and for
trapped gas calculated as the difference between FRCpleth and FRC measured by MBW
at the same visit. We interpret these findings as excessive catch-up growth after prema-
turity.
In the overall view, respiratory health in infancy and lung growth seemed to be deter-
mined by prematurity per se, and not by potentially harmful or beneficial therapeutic
interventions, but the latter were not randomly assigned in these observational studies.
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1 Introduction
1.1 Development of human lungs before and after birth
For better respiratory health in children and adults now and in the future it is crucial
to improve our understanding of early lung development. Respiratory morbidity across
all ages is a major public health concern, as incidence and prevalence of chronic lung
diseases are increasing [World Health Organization, 2015]. Existing preventive and ther-
apeutic strategies need further improvement, and new approaches need to be developed.
Researchers worldwide are contributing to that.
There is epidemiological evidence that lung development before and after birth has an
impact on pulmonary outcome in adulthood, and that environmental influences and gene-
environment interactions predispose for chronic disease [Barker et al., 1991, von Mutius,
2001, Silverman and Kuehni, 2007, Bush, 2008, Frey and Suki, 2008, Postma et al.,
2014]. The term asthma, despite its use as a diagnosis, is an overall term for more than
one disease [Silverman, 1995], and this explains why some therapies are only beneficial
for subgroups of patients. A deeper understanding of the different disease entities would
allow us to identify subjects at risk and to improve therapies.
1.1.1 Lung development in term-born children
Human lungs undergo very complex physiological changes before and after birth. The
most important window is during the first few years of life [Stocks et al., 2013], but lung
growth has been shown even beyond [Narayanan et al., 2012].
Fetal lung development starts during week 4 of gestation, when a single airway starts
to grow from the foregut. During the pseudoglandular stage, from week 5 to 17, the
conducting airways branch, forming a respiratory tree. The next stage is the canalicular
stage, from week 16 to 27. Here, the respiratory tree expands in length and diameter,
accompanied by blood vessels. The respiratory airways form and surfactant appears. Dur-
ing the saccular stage, from week 28 onwards, the interstitium becomes thinner, saccules
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and alveoli appear. The alveolar stage is reached around week 38. By birth, a term-born
infant has 100 million alveoli approximately, and the number increases during childhood
[Baraldi and Filippone, 2007, Stocks et al., 2013].
Multiple intrinsic and extrinsic factors have an impact on early lung development. Healthy
infants, for example, show alterations in lung function and longer duration of infec-
tious episodes after exposure to outdoor air pollution [Latzin et al., 2011, Stern et al.,
2013].
Figure available in print version
Figure 1.1.
Lung development before and after birth
[Baraldi and Filippone, 2007]
1.1.2 Prematurity disturbs alveolar growth
Premature birth, i.e. birth <37 weeks of gestation, has immediate and long-term con-
sequences on respiratory health, as normal intrauterine maturation of the lungs is in-
terrupted. By the end of a normal pregnancy, the final key features of a healthy lung
begin to emerge: millions of alveoli grow, allowing gas exchange, and surfactant reduces
18
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surface tension thereby allowing the alveoli to expand. The timing of birth is relevant
for adaptation to extra-uterine life. The earlier a child is born, the more likely it is to
develop respiratory distress (see figure 1.1.) [Baraldi and Filippone, 2007].
Worldwide, the number of preterm births was estimated at 12.9 million for the year
2005. The highest rates were observed in Africa (11.9%) and North America (10.6%). In
Switzerland, numbers comparable to the rest of Europe were observed. The percentage
of preterm births in 2013 was 6.2% for a gestational age from 32 to 36 weeks and 1%
for a gestational age <32 weeks [Beck et al., 2010, Schweizer Bundesamt für Statistik,
2015].
A well known immediate consequence after preterm birth is bronchopulmonary dysplasia
(BPD). The disease was initially described by Northway et al. in 1967 [Northway et al.,
1967]. It occurs in approximately 30% of preterm infants with a birth weight of less than
1000 g. Characteristics of BPD at the time of its first description included structural
damage like patchy bronchoalveolar scarring, overexpansion and atelectases. With the
introduction of new strategies such as prenatal corticosteroids, lung protective ventilation
and artificial surfactant, the clinical characteristics of lung disease following prematurity
changed. The so called new BPD is mainly characterised by fewer and larger alveoli
[Kinsella et al., 2006]. However, the incidence of BPD is not expected to decrease [Baker
and Alvira, 2014], as continuous improvement in reproductive medicine and of survival
in neonatology contribute to keep numbers of affected children high.
It was shown that prematurity does not only have short-term consequences on respira-
tory health, i.e. requirement of ventilation and oxygen supplementation, to name just
a few. Long-term sequelae can occur in children with and without BPD [Hoo et al.,
2002a, Stocks et al., 2013]. Common observations include a higher incidence of hospital-
isation due to respiratory symptoms during infancy, partially reversible airflow obstruction
and abnormal thoracic imaging at school age and reduced spirometric lung function re-
sults in adulthood [Greenough, 2013]. The risk of chronic obstructive pulmonary disease
(COPD) is elevated after prematurity [Stocks et al., 2013, Tai et al., 2014, Bolton et al.,
2015]. Phenotypes of respiratory diseases might differ between term-born and preterm
individuals [Martin and Fanaroff, 2013].
19
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Figure available in print version
Figure 1.2.
The life course of lung function
Black line indicates term individuals, grey solid line indicates preterm-born individuals
and grey dashed line indicates possible rates of decline in lung function in preterm-born
individuals [Bolton et al., 2015]
1.1.3 Respiratory health in the context of Public Health
Respiratory morbidity is a burden for health care systems worldwide. In the US, for
example, 10.000 premature infants are affected annually by BPD and its impact on overall
and pulmonary health [McEvoy et al., 2014]. Especially in very young children, acute
20
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respiratory infections are likely to cause symptoms that require hospitalisation [Pramana
et al., 2011], and one of the parents is often admitted with the child. Compared with
adults, children have higher minute ventilation in relation to their body size, so inhaled
agents are likely to harm them even more, especially because of the limited ability to
leave areas with exposures. There is a potential window of increased vulnerability. At
the same time, this might be a window of opportunity where protection from disturbing
factors might be very beneficial for long-term respiratory health.
Thus, improved respiratory health in childhood has the potential not only to reduce short-
term costs, as has been observed after introducing smoke-free legislation [Been et al.,
2014]; it can additionally be expected that long-term costs for health care systems will
also be reduced.
21
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Figure available in print version
Figure 1.3.
Risk Factors for Chronic Obstructive Pulmonary Disease (COPD)
[Postma et al., 2014]
1.2 What do classic lung function tests tell us?
Classic lung function tests like spirometry measure expiratory flow in the larger airways.
A forced exhalation is often performed for that purpose. Some of the advantages of
spirometry are high reproducibility, low variability and availability of reference values for
different ages throughout childhood and for different ethnic groups [Quanjer et al., 2012].
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Valuable information on airway growth has been collected over many years [Kotecha et al.,
2013]. One limitation of the method is the necessity of sedating uncooperative children,
i.e. infants. It is worth noting that information on flow in the central airways is not the
same as information on small airway function or volume of the lung parenchyma. Lungs
and airways might grow disproportionately, a concept known as dysanapsis [Green et al.,
1974, Martin et al., 1988]. Recently, new tidal-breathing lung function tests became
available which do not require sedation, and which deliver additional information.
1.3 Options for measurements during normal breathing
A paediatric setting needs tailored lung function tests [Rosenfeld et al., 2013]. Here
in particular, lung function measurements that can be performed during quiet, normal
breathing are of great interest. For infants, these are only available in research settings, as
they require specific equipment and experienced operators [Frey et al., 2000a, Frey et al.,
2000b]. For older children, these tests are becoming more widely available, although
experience is still essential [Robinson et al., 2013].
1.3.1 Multiple-breath washout measures lung volume
and small airway function
Multiple-breath washout (MBW) is a tidal breathing lung function test of increasing im-
portance and popularity, especially in paediatric respiratory medicine. The principle was
described as far back as 1940 [Darling et al., 1940]. MBW allows detection of early lung
disease, for example in cystic fibrosis, long before pathologies in the larger airways are
detectable by spirometry [Gustafsson et al., 2008]. A tracer is added to the inhaled air
and, breath by breath, washed into the lungs. Once it is equally distributed, the washout
to 1/40th of the initial concentration can begin. Functional residual capacity (FRC) is
calculated as cumulative expired volume (CEV) of tracer gas divided by the difference be-
tween end-tidal tracer concentrations at the start and end of washout. The lung clearance
index (LCI), calculated as the number of turnovers of FRC needed to reach the end of
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washout, is an established parameter of overall ventilation homogeneity. An international
consensus on how to perform and analyse MBW was published recently [Robinson et al.,
2013]. In infants, sulfur hexafluoride (SF6) is the age-appropriate tracer. In children
beyond infancy, helium (He) or nitrogen (N2) can be used. N2MBW allows analysis of
the slopes of alveolar phase III (SIII) of the N2 expirogram. The first SIII reflects the
diffusion-convection-dependent acinar airways (Sacin), and SIII values from lung turnover
1.5 to 6.0 reflect ventilation homogeneity within convection-dependent conducting air-
ways (Scond).
Initially, a mass spectrometer was required for direct determination of the tracer gas
concentration. Nowadays, tracer concentration can be determined indirectly using an ul-
trasonic flow meter (USFM), which allows widespread application in specialised research
laboratories.
At our paediatric lung function laboratory, we specialised in MBW in children of all age
groups. While older children usually cooperate, measurements in infants require sleep
phases without dreaming in order to ensure quiet breathing. We regularly perform mea-
surements in infants as young as 5 weeks in natural sleep, i.e. without sedation. Analyses
were optimised [Latzin et al., 2007b, Anagnostopoulou et al., 2015], and normative values
for FRC and LCI were published [Fuchs et al., 2011a]. A typical MBW measurement in
an infant at our paediatric lung function laboratory is shown in figure 1.4.
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Figure 1.4.
Multiple-breath washout in an infant sleeping naturally
1.3.2 Tidal breathing parameters
In infants, tidal breathing flow volume loops (TBFVL) and the fraction of exhaled nitric
oxide (FeNO) can be measured in unsedated sleep using a USFM. Normative values for
tidal volume, respiratory rate, minute ventilation and time to peak tidal expiratory flow
from our paediatric lung function laboratory are available [Fuchs et al., 2011a].
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1.3.3 Plethysmography
Plethysmography is an established technique which allows measurements of intra-thoracic
lung volume. It is based on the law of Boyle-Mariotte [Criée et al., 2011]. Most young
children are able to cooperate and perform the procedure successfully. In an air-tight
chamber, intra-thoracic gas volume is calculated from relative changes in pressure. The
child breathes through a mouthpiece which is the only opening of the chamber. A very
short occlusion of this opening is induced, and the child attempts to continue breath-
ing. During the attempted breathing motion, the intra-thoracic air is compressed and
expanded, which leads to changes of pressure in the chamber. The latter can be mea-
sured, and allows calculation of lung volume at the end of expiration. The measurement
is performed in triplicates. For adults, variability of single trials should be within 5%.
This seems a reasonable approach for older children as well, but for younger children, a
greater variability certainly needs to be accepted.
1.4 BILD study - Basel & Bern Infant Lung Development
As early lung development is only poorly understood, an observational study was initiated
in Switzerland to investigate predisposing and modifying factors of respiratory morbidity
in early childhood. The so-called Basel & Bern Infant Lung Development (BILD) study
began at the Children’s University Hospital at Inselspital Bern in 1999, and recruitment
has been ongoing ever since. Recently, the study expanded to a second site, the Chil-
dren’s University Hospital Basel (UKBB). The study was described in details by Fuchs et
al. [Fuchs et al., 2012a].
In this population-based study, it was essential to use non-invasive lung function tests,
where variability can be higher than in tests using sedation and forced manoeuvres.
Term-born and preterm children were recruited and information on family history, expo-
sures, and respiratory symptoms was collected using standardised interviews and question-
naires. Whenever possible, we obtained DNA samples from cord blood or buccal swabs.
Many results were previously published, including new recommendations for non-invasive
lung function testing [Frey, 2001, Latzin et al., 2007b], and interesting comparisons of
26
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respiratory morbidity between term-born and preterm infants [Roiha et al., 2007, Latzin
et al., 2009b, Pramana et al., 2011].
The aim of this cohort study was to improve our understanding of early lung development
and to create new strategies to improve the respiratory health of individuals at risk and
the general population.
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1.5 Aims of this work
The accuracy of the relatively new setups for MBW using SF6 in infants and using
helium in young children was not tested previously. However, using an improved lung
model with quasi-physiologic conditions, this was now possible. Such validation studies
were requested by the current consensus on inert gas washout [Robinson et al., 2013],
they ensure that measurements are performed with high quality. We hypothesised that
both setups measure FRC reliably and accurately.
Using these newly validated and other established lung function tests in a prospective
cohort study, we were able to investigate early lung volume increase in unselected term-
born children. A big advantage for application in a population-based study is that MBW
is non-invasive. Information on lung volume increase early in childhood was lacking, and
this new knowledge would allow a better understanding of early lung development. We
hypothesised to find tracking of lung volume.
In preterm infants, early biomarkers for later respiratory morbidity are needed to identify
infants at risk and to improve clinical care. We hypothesised that prediction might be
more accurate when infant lung function results were added to established clinical tools,
and that infant lung function parameters were altered in individuals with respiratory
symptoms like wheeze during the first year of life.
School-age children after premature birth show higher respiratory morbidity and altered
spirometric lung function results compared to their peers, but until now, small airway
function was not described in detail in a larger population with heterogeneous neonatal
characteristics. Nitrogen MBW enabled us to measure small airway function in a relatively
large population, including ventilation on the overall, conductive and acinar level. We
hypothesised to find inhomogeneous ventilation in preterm children.
Whether or not physiological lung volume increase is altered in preterm children was
previously unknown. Data on spirometry showed tracking over time, but data on FRC
was not available. As MBW can be performed without sedation in individuals of all
ages, we were able to assess FRC over time in a population of preterm children. We
hypothesised to find different lung growth characteristics in preterm children compared
to term-born controls, and to find catch-up growth.
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The following specific aims will be addressed in this work:
1. Investigate the accuracy of multiple-breath washout equipment using the tracers
SF6 and helium for measuring lung volumes in infants and young children
2. Test for tracking of lung volume from infancy to early childhood in term-born
children, i.e. for an association of lung volumes in infancy with lung volumes in
early childhood; test which factors were associated with lung volume and whether
or not airways and lung tissue grow disproportionately
3. Test whether lung function at the corrected gestational age of 44 weeks in preterm
infants, using physiological breathing tests, helps to predict respiratory symptoms,
and whether altered infant lung function was associated with respiratory symptoms
during 1st year of life
4. Test for abnormal ventilation distribution at school age in preterm children, espe-
cially in the peripheral lung regions
5. Test for tracking and catch-up growth of lung volumes from infancy to early child-
hood in preterm children, and investigate which factors have an impact on early
lung growth in preterm children
30
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2.1 SUMMARY
Introduction: The new ATS/ERS consensus report recommends in vitro validation of
multiple-breath inert gas washout (MBW) equipment based on a lung model with simu-
lated physiologic conditions. We aimed to assess accuracy of two MBW setups for infants
and young children using this model, and to compare functional residual capacity (FRC)
from helium MBW (FRCMBW ) with FRC from plethysmography (FRCpleth) in vivo.
Methods: The MBW setups were based on ultrasonic flow meter technology. Sulphur
hexafluoride and helium were used as tracer gases.We measured FRC in vitro for specific
model settings with and without carbon dioxide and calculated differences of measured
to generated FRC. For in vivo evaluation, difference between FRCMBW and FRCpleth was
calculated in 20 healthy children, median age 6.1 years. Coefficient of variation (CV) was
calculated per FRC.
Results: In the infant model (51 runs, FRC 80 – 300 ml), mean (SD) relative differ-
ence between generated and measured FRCs was 0.7 (4.7) %, median CV was 4.4% for
measured FRCs. In the young child model, one setting (8 runs, FRC 400 ml) showed a
relative difference of up to 13%. For the remaining FRCs (42 runs, FRC 600 – 1,400
ml), mean (SD) relative difference was -2.0 (3.4) %; median CV was 1.4% for measured
FRCs. In vivo FRCpleth exceeded FRCMBW values by 37% on average.
Conclusions: Both setups measure lung volumes in the intended age group reliably and
reproducibly. Characteristics of different techniques should be considered when measur-
ing lung volumes in vivo.
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2.2 INTRODUCTION
Multiple-breath inert gas washout (MBW) is of special interest in infants and children.
This tidal breathing pulmonary function test allows measurement of lung clearance index
(LCI), a marker of ventilation heterogeneity that is of growing relevance for researchers
and clinicians working with children with conditions such as cystic fibrosis (CF) and pri-
mary ciliary dyskinesia. Originally, this method required a mass spectrometer [Robinson
et al., 2009, Gustafsson, 2005, Aurora et al., 2005a]. Nowadays, devices based on ul-
trasonic flow meters (USFM) that measure the molar mass (MM) in order to derive the
respired tracer gas concentration are commercially available, and allow widespread ap-
plication. Several investigators have found the technique to be reliable and feasible in
healthy and diseased children with a regular breathing pattern [Schibler et al., 2002, Pil-
low et al., 2004, Fuchs et al., 2012b]. LCI measurement, calculated as cumulative expired
volume (CEV) over functional residual capacity (FRC), directly relies on correctly mea-
sured lung volumes. Therefore the current ATS/ERS consensus for MBW recommends
in vitro validation of MBW derived lung volumes [Robinson et al., 2013]. Most previous
attempts for validation of sulfur hexafluoride (SF6) and helium MBW equipment were
based on in vivo data or on in vitro data without simulated physiologic conditions regard-
ing temperature, humidity, or carbon dioxide (CO2) [Schibler et al., 2002, Fuchs et al.,
2012b, Wauer et al., 2003, Scalfaro et al., 2000, Proquitte et al., 2006, Fuchs et al.,
2009]. However a new rigid lung model was developed recently, simulating physiologic
conditions encountered during clinical testing, such as body temperature, pressure, and
humidity (BTPS) over the breath cycle. This model has been successfully used to vali-
date a nitrogen MBW setup [Singer et al., 2012a]. The aims of this study were twofold:
first, to use this lung model to test accuracy of two available MBW setups using age-
appropriate tracer substances: one setup using SF6 as a tracer gas for MBW in infants
(MBWSF6), and one setup using helium for MBW in young children (MBWHe); and
second, to gain more physiological insight by comparing FRC from MBWHe (FRCMBW )
in vivo with FRC derived by plethysmography (FRCpleth) in young children. We hypothe-
sized that the difference between generated FRC and measured FRC would be within 10%.
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2.3 MATERIALS AND METHODS
Study Design
First, MBW setups for both infants and young children were tested in vitro for accu-
racy of FRC determination using a realistic lung model [Singer et al., 2012a]. Second,
FRCMBW was compared with FRCpleth in 20 young children. The children’s age ranged
from 5.9 to 6.9 years; further characteristics are shown in Table 1. Inclusion criteria were
Caucasian ethnicity and term delivery. General exclusion criteria were severe maternal
health problems or drug abuse other than nicotine, major birth defects, or perinatal dis-
ease, previously abnormal spirometry, respiratory tract infection within 2 weeks prior to
the study, and any other known conditions likely to affect lung function. This study was
approved by the Ethics Committee of the Canton of Bern, Switzerland. The children’s
assent was obtained and parents or caregivers provided written informed consent for this
study. Primary outcome was the difference between measured FRC and the known nom-
inal FRC generated with the model. Secondary outcomes were intra-test repeatability of
FRC measurements, and the difference between FRCMBW and FRCpleth.
Table 2.1.
Characteristics of Children for Helium MBW and Plethysmography In Vivo
Studies
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Hardware and Software
A commercially available apparatus containing USFM sensors (Exhalyzer D, Eco Medics
AG, Duernten, Switzerland) was used. We used established tracer gases for MBW in
infants and children that is, for the infant setup 4% SF6, and for the young child setup
20% helium. Both are medical gases produced by Carbagas, Bern, Switzerland (details
in Supplemental online figures). Availability of inert test gases may vary between coun-
tries. Approval for testing with SF6 depends on national regulations [Robinson et al.,
2013]. Apparatus and procedure for infants have been described previously [Schibler
et al., 2002, Latzin et al., 2007b, Fuchs et al., 2011a]. For young children, the same ap-
paratus was used in a slightly different setup as provided by the manufacturer. Schematic
layout of both setups can be found in the online supplement (Supplementary Figs. 1 and
2). In both setups, tracer concentration was derived by measuring MM of in- and ex-
haled gases. Mainstream MM was the primary signal used in infants and side stream
MM in young children. Flow and volume were measured by the mainstream USFM in
both setups. In the young child setup, CO2 concentration was measured in addition to
other signals via side stream. Stable end-tidal CO2 concentrations were used as a quality
control proxy for sustained regular tidal breathing.
Daily calibration of volumes, two-point calibration of CO2 sensor, and verification of ad-
equate MM change and flow when adding tracers were performed. All MBW tests were
recorded and analyzed using commercially available software (WBreath, ndd Medical
Technologies, Zurich, Switzerland). Corrections for BTPS conditions and signal align-
ment were conducted as previously described [Latzin et al., 2007b]. FRC was calculated
as CEV of tracer gas divided by the difference between end-tidal tracer gas concentrations
at the start and end of MBW.
Lung Model
The lung model established by Singer et al. [Singer et al., 2012a], an improvement on
an existing model without BTPS conditions [Brunner et al., 1985], is built of two water
tanks. The inner tank contains two compartments: one lung compartment, that is open
and can be set to different specific lung volumes and another communicating compart-
ment that enables mechanical ventilation.We used two different inner tanks (Soloplex,
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Tidaholm, Sweden), a smaller infant and a larger young child tank. The outer tank
serves to heat the inner chamber to 37◦C using a thermostat in order to generate BTPS
conditions. The inner chamber was filled with water until the desired FRC was achieved,
measured as the end-expiratory water level using a vertical tape measure. Each FRC was
determined geometrically: 1mm change of water level corresponds to 4.8 ml in the infant
lung model and 18.2 ml in the young child lung model. A continuous flow, pressure-
controlled infant ventilator (Acutronic, Medical Systems AG, Hirzel, Switzerland) was
used to ventilate the lung compartment and thus generate specific FRCs with physiologi-
cal ranges for tidal volumes, and respiratory rates (see Table 2). All in vitro measurements
were performed by A.S. and supervised by T.R. and F.S. In vitro assessment of the infant
MBWSF6 system was undertaken across six different nominal FRCs ranging from 80 to
300 ml (n=51, minute ventilation 900 – 3,600 ml). The young child MBWHe system was
evaluated across six different FRC settings, ranging from 400 to 1,400 ml (n=50, minute
ventilation 3,250 – 6,000 ml). FRC settings were measured with and without CO2 in the
model. For runs with CO2, pure CO2 from cylinders (Carbagas) was bubbled at a flow of
0.7 – 2.7 ml/s in order to establish stable and quasi-physiological end-tidal CO2 fractions
ranging from 2.4% to 4.4%. Added CO2 volume in the infant model was corrected by
applying standard flow baseline correction. In the larger model, added CO2 volume was
estimated by the product of test duration and CO2 flow and subtracted from measured
FRC.
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Table 2.2.
In Vitro Settings of the Infant and Young Child Setup
Generated FRC (ml) is the functional residual capacity that was determined from the
known dimensions of the lung compartment within the inner tank. Respiratory rate
(min−1) and tidal volume (ml) were regulated using a ventilator.
a Age estimates of FRC values were based on published reference values [Fuchs et al.,
2011a, Lum et al., 2011].
Comparison of Lung Volume Measurements In Vivo
To gain more physiological insight in vivo, we compared lung volumes measured using
different pulmonary function tests in healthy children aged 5 – 6 years participating in an
ongoing study at the University Children’s Hospital Bern [Fuchs et al., 2012a]. All children
performed MBW in triplicate using the helium setup described earlier in this manuscript,
MBWHe was conducted according to recent consensus [Robinson et al., 2013]. After
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MBWHe measurements, children performed plethysmography using JAEGER R© Master-
Screen R© Body (CareFusion, Wuerzburg, Germany) according to standards, applied by a
trained operator [Wanger et al., 2005]. MBWHe and plethysmography were both per-
formed with the child sitting upright. Means of FRCMBW and FRCpleth were calculated
from two to three technically acceptable tests.
Statistical Methods
We assessed accuracy of FRC measurements in vitro by calculating absolute (ml) dif-
ference (measured FRC generated FRC), relative (%) difference (absolute difference *
100/generated FRC), and limits of agreement (mean difference ±1.96 SD of differences).
Differences were assessed according to Bland and Altman [Bland and Altman, 1986].
Intra-test variability of both generated and measured FRCs was calculated as intra-test
coefficient of variation (CV = SD/ mean *100) per specified lung volume. Median val-
ues and interquartile range (IQR), that is, the range from percentile 25 to 75, of CV
are reported. In vitro parallax error, that is, the possible error of reading water levels,
was assumed to be one mm corresponding to 4.8 ml for the smaller and 18.2 ml for the
larger model. For the in vivo part, the difference between FRC measurement techniques
was assessed as absolute and relative difference between FRCpleth and FRCMBW . CV of
FRCMBW and FRCpleth were calculated per individual. As currently no consensus exists
regarding acceptable differences in pediatric MBW, we arbitrarily defined error cut-offs of
10% in vitro and expected difference of 20% in vivo. All analyses were performed using
StataTM (Stata Statistical Software: Release 11. College Station, TX: StataCorp LP).
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2.4 RESULTS
Infant Lung Model
Accuracy of FRC measurement of the MBWSF6 setup with six generated FRCs between
80 and 300 ml is displayed in Figure 1A and B. We found high accuracy in the infant
setup with a mean (95%CI) absolute difference between model and measured FRC of 1.9
(0.3 – 3.5) ml, corresponding to a relative difference of 0.7 (-0.6 to 2.0) %. Median CV
was 2.2 (IQR 1.9 – 2.8) % for generated FRCs and 4.4 (IQR 3.1 – 6.8) % for measured
FRCs. CV for runs with and without CO2 is displayed in Table 3.
Young Child Lung Model
Accuracy of FRC measurement of the MBWHe setup with generated FRCs between 400
and 1,400 ml is displayed in Figure 2A and B. For the lowest FRC setting in the model
(n=8, FRC 400 ml), accuracy was beyond predefined error cut-off (±10%) in most runs.
Relative difference was between -12% and +13%. For all other settings of the model
(n=42, FRC 600 – 1,400 ml), mean (95%CI) absolute difference was -17 (-25 to -8.3)
ml corresponding to a relative difference of -2.0 (-3.0 to -0.9) %. For runs without CO2,
absolute difference was -8.1 (-15 to -1.6) ml and relative difference was -1.3 (-2.3 to -0.3)
%. In runs with CO2, absolute difference was -26 (-41 to -10) ml; relative difference was
-2.7 (-4.6 to -0.8) %. Median CV was 0.2 (IQR 0–0.6) % for generated FRCs and 1.4
(IQR 0.6– 2.1) % for measured FRCs. CV for runs with and without CO2 is displayed in
Table 3.
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Figure 2.1. A and B
Accuracy of in vitro functional residual capacity (FRC) measurement for the
infant setup using sulfur hexafluoride (n=51)
Bland Altman plot [Bland and Altman, 1986] of measured FRC minus generated FRC
plotted versus mean of measured and generated FRC. Closed circles represent runs with-
out CO2; open circles represent runs with CO2. The thick line shows mean difference,
thin lines show upper and lower limits of agreement. A: Mean (95%CI) absolute differ-
ence was 1.9 (0.3 – 3.5) ml, upper and lower limits of agreement were 13 and -9.2 ml.
B: Mean (95%CI) relative difference was 0.7 (-0.6 to 2.0) %, upper and lower limits of
agreement were 9.9% and -8.4%. The dotted line represents possible nominal volume
bias due to reading parallax error (1mm, i.e., ±4.8 ml).
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Figure 2.2. A and B
Accuracy of in vitro functional residual capacity (FRC) measurement for the
young child setup using helium (n=50)
Bland Altman plot [Bland and Altman, 1986] of measured FRC minus generated FRC
plotted versus mean of measured and generated FRC. Closed circles represent runs with-
out CO2, open circles represent runs with CO2. The thick line shows mean difference for
FRCs between 600 and 1,400 ml, thin lines show upper and lower limits of agreement.
A: Mean (95%CI) absolute difference for FRCs from 600 to 1,400 ml was -8.1 (-15 to
-1.6) ml in runs without CO2, and -26 (-41 to -10) ml in runs with CO2. Upper and
lower limit of agreement for runs with and without CO2 were +37 and -70 ml. B: Mean
(95%CI) relative difference for FRCs from 600 to 1,400 ml was -1.3 (-2.3 to -0.3) %
for runs without CO2, and -2.7 (-4.6 to -0.8) % for runs with CO2. Upper and lower
limit of agreement for runs with and without CO2 were 4.6% and -8.6%. The dotted
line represents possible nominal volume bias due to reading parallax error (1mm, i.e.,
±18.2ml).
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Lung Volume Measurements In Vivo
FRCpleth exceeded FRCMBW in all children. Mean (SD) FRCpleth and FRCMBW were
1,075 (141) and 676 (119) ml, respectively. The relation of FRCpleth and FRCMBW is
displayed in Figure 3. Difference was beyond the expected range (±20%). Mean absolute
(relative) difference was 399 ml (37%), upper limit of agreement was 596 ml (52%), and
lower limit of agreement was 201 ml (22%).
In vivo intra-test variability of FRC measured by MBWHe and plethysmography was higher
compared to in vitro intra-test variability of FRC measured by MBW. In vivo median CV
for FRCMBW and FRCpleth was 7.4 (IQR 4.4–11.4) %and 6.5 (IQR 3.8–13.4) %, respec-
tively. No adverse events occurred in our studies.
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Figure 2.3.
Comparison of functional residual capacity (FRC) measured by helium multiple-
breath washout (FRCMBW ) and by plethysmography (FRCpleth) in 20 healthy
young children
Bland Altman plot [Bland and Altman, 1986] of FRCpleth minus FRCMBW plotted versus
mean of both measurements. FRCpleth values exceeded FRCMBW values in all children.
The thick line represents the mean absolute difference of 399 ml (corresponding to a
mean relative difference of 37%), the thin lines show upper limit of agreement (596 ml
resp. 52%), and lower limit of agreement (201 ml resp. 22%).
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2.5 DISCUSSION
This is the first in vitro study assessing accuracy of USFM setups for MBWSF6 and
MBWHe according to the current consensus on inert gas washout testing [Robinson
et al., 2013]. We found that FRC can be measured within 10% accuracy over FRC
volumes between 80 and 300 ml with the infant setup and between 600 and 1,400 ml
with the young child setup. Intra-test repeatability of measured FRC in vitro is 4.4% in
the infant setup and 1.4% in the young child setup. We confirm that lung volumes and
realistic breathing patterns can be simulated in this lung model and that it is suitable for
bench-testing USFM setups, as recommended by the consensus statement. As expected,
FRC measured by MBWHe and plethysmography in young children differ systematically,
but to an unexpected extent, suggesting considerable influence from physiological FRC
variability, trapped gas and different measurement techniques [Pillow et al., 2004, Miller
et al., 1995, Jensen et al., 2013].
Accuracy of MBW for FRC Measurements and Comparison With Other Setups
Our in vitro results show good agreement for generated and measured infant lung vol-
umes. Forty-nine out of 51 runs (96%) met the criteria of measuring FRC within 10%
relative difference from generated FRC; mean relative difference between generated and
measured volumes was not statistically significant, although the mean absolute differ-
ence was significant. Accuracy of FRC measurement for FRCs between 600 and 1,400
ml using the helium setup was also good with 41 out of 42 runs (98%) meeting the
criteria of measuring within predefined error cut-off. In the helium trials, runs without
CO2 show a linear trend from discrete under-estimation of FRC in lower lung volumes
towards almost no measurement error in higher lung volumes. Ventilator settings are a
likely cause, especially the ratio of dead space and tidal volume. For detailed analysis
of the single factors contributing to this slight linear trend, a new study with varying
ventilator settings would be required. Both absolute and relative differences were small
but significant for the helium setup. We assume that none of the significant differences
are clinically relevant: Bland Altman plots show that in both setups, measurement error
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included over- and under-estimation of the true FRC values; and the mean offset for
absolute values was less than ml per kg body weight in the intended age groups. Alto-
gether, the measurement error was within acceptable range for lung volumes between 80
and 300 ml, and between 600 and 1,400 ml.
We can only speculate on possible reasons for the higher relative error observed in the
smallest nominal FRCs of 400 ml in the young child model. In all in vitro trials, error
might be caused by inaccurate determination of dead space and water level; the impact
on relative error is higher in smaller lung volumes. Non-linear flow dependent temper-
ature and humidity fluctuations, and volume drift due to CO2 administration are likely
to contribute as well. The error introduced by fixed (and not flow-dependent) delay
corrections for side stream MM is higher in smaller lung volumes. Bland Altman plots
show that relative error decreases with increasing FRC in both setups. It has been shown
previously that accuracy of FRC measurements is lower in smaller lung volumes [Singer
et al., 2012a].
Many prior studies validating MBWSF6 and MBWHe equipment were based on in vivo
studies or on in vitro models with neither BTPS conditions nor CO2 [Schibler et al.,
2002, Fuchs et al., 2012b, Wauer et al., 2003, Scalfaro et al., 2000, Proquitte et al.,
2006, Fuchs et al., 2009]; our study evaluates in vitro FRC data derived in simulated
physiologic conditions using SF6 and helium. Comparable but preliminary in vitro FRC
data using a similar model come from other USFM setups (EasyOne Pro, ndd Medical
Technologies) and customized photo-acoustic sensors (Innocor, Innovision, Odense, Den-
mark) as well as mass spectrometers (AMIS 2000, Innovision) [Fuchs et al., 2011b, Gonem
et al., 2012, Singer et al., 2012b]. The technical error from the current USFM setup is,
however, higher than that published for an available nitrogen MBW setup (Exhalyzer D,
Eco Medics AG) where error was within 5% for 98% of the runs in the large lung model
and within 7% for the small model. Comparable to our study, tidal flow was measured
using a mainstream USFM. Nitrogen concentration was measured indirectly via oxygen
and CO2 sensors [Singer et al., 2012a]. A limitation of our study is that results from the
USFM were not compared to results derived via mass spectrometry. Other investigators
compared in vivo MBW results derived by mass spectrometry to those derived using an
USFM in infants [Pillow et al., 2004] and adults [Fuchs et al., 2006] and found signifi-
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cant differences. Possible Limitations of the Current Setup The conditions of the in vitro
model are quasi physiologic and may have some limitations. Even though we monitored
the temperature within the model in order to assure stable BTPS conditions we cannot
rule out, for example, different temperature dynamics compared to in vivo conditions.
The low variability of FRC measurements without CO2 indicates stable model conditions
regarding generated lung volumes, temperature, and humidity. Intra-test variability of
FRC measurements is slightly higher when CO2 is added in the model, and it is known
that regard should be paid to CO2 levels in MBW [Fuchs et al., 2006]. The impact of CO2
bubbled into the model was higher in the larger helium setup which is why we subtracted
additional CO2 volume. We assume that the additional gas in the model limits complete
washin of the tracer and thus influences measurement of FRC. This phenomenon might
be caused by varying CO2 volumes added, different diffusivity of the tracer gases, and
a consecutively uneven gas distribution within the helium model. In vivo, irregular CO2
levels, for example, hyperventilation, may also influence FRC and LCI measurements, as
it is the expired CO2 fraction that mainly determines the MM of expired air. This is
unlikely to happen in sleeping infants, but more likely in older children due to limited
cooperation. BTPS correction algorithms might also need refinement (Singer F 2012).
Some of the breathing parameters we chose to bench test the MBW setups were less
physiological with rather low tidal volumes and high respiratory rates. Extreme breathing
patterns, for example, high respiratory rate, can impact on FRC measurements in most
MBW setups as delay and BTPS correction factors are fixed. Such extreme breathing
patterns combined with fixed corrections would cause an under-estimation of the true
accuracy encountered during quiet tidal breathing. Bench-testing MBW setups with
these extreme settings enabled us to observe technical limitations and posit that flexi-
ble corrections would be desirable. The small but significant mean absolute differences
between generated and measured FRC are clinically irrelevant for both setups. Software
alignments for parameters influencing the MM signal are crucial for correct calculation of
FRC. We conducted data analysis with appropriate care, but had only restricted insight
to details of internal calculations of the software.
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Comparison of Lung Volume Measurements In Young Children
We applied plethysmography and MBWHe to explore physiological and technical factors
influencing FRC measurements. FRC values from plethysmography are within expected
normal range (Hibbert ME 1989, Rosenthal M 1993). FRCpleth shows consistently higher
results than FRCMBW . Intra-individual discrepancy of FRC measurements of 20% and
more using different techniques has been described earlier for infants and older children
[Pillow et al., 2004, Jensen et al., 2013, Owens et al., 2011]. Our findings confirm pre-
vious data in children: mean differences between FRCMBW using SF6 and FRCpleth were
28% in healthy children and 39% in children with CF aged – years 20; and 13% in healthy
children and 40% in children with CF aged 6-10 years [Owens et al., 2011]. In healthy
school-aged children, mean FRC difference was 8.5 ml/kg body weight [Lum et al., 2011].
There are only few published studies evaluating in vivo tests of MBWHe and unfortunately
FRC values were not reported [Wang et al., 2013, Vermeulen et al., 2013]. One group of
investigators used a different setup with quartz tuning forks to detect density of the air,
the main outcome was accuracy of measuring gas concentrations [Wang et al., 2013].
Another group compared LCI results from washin and washout in 130 children [Ver-
meulen et al., 2013]. LCI showed rather poor agreement, possibly due to technical and
physiological factors. It is noteworthy that mainstream instead of side stream MM was
analyzed, the latter being more appropriate in children beyond infancy [Robinson et al.,
2013]. Helium dilution technique is frequently used for FRC measurements in infants
and young children. Due to technical differences, values cannot be directly compared
to values from MBWHe. However, it is worth mentioning that published FRC values
derived by helium dilution were lower than those derived by plethysmography [Stocks and
Quanjer, 1995]. It is likely that the high mean difference observed in our study group
is explained by a combination of physiologic intra-subject variability of FRC as well as
differences in measurement techniques and trapped gas detected. The relative difference
is slightly higher than previously observed in healthy children [Jensen et al., 2013, Owens
et al., 2011, Lum et al., 2011]. This might be explained by the different age ranges
assessed, the use of different tracer gases and customized setups. Whether MBWHe or
plethysmography technique is more accurately measuring the true range of physiologically
variable FRC is unknown and cannot be disentangled based on the current data.
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Relevance and Implications
Accuracy of FRC determination needs to be assessed prior to measurement and inter-
pretation of, for example, LCI, an increasingly acknowledged measure of lung function.
Knowledge of technical reliability of lung function techniques is fundamental for conduct-
ing early intervention studies, for example, in children with CF, and longitudinal studies
on lung development in healthy and diseased children.
We tested the setups with age-appropriate tracer substances. This is relevant because
tracer gas characteristics differ [Robinson et al., 2013], and the preferred substance de-
pends on the age of the child. For infants, SF6 is currently preferred as nitrogen MBW
may change breathing patterns and MBWHe is susceptible to gas leaks [Robinson et al.,
2013, Singer et al., 2014a]. In older children, helium compares preferably to SF6, as it
is non-polluting and air-tight setups are available. For routine clinical use in children be-
yond infancy in the future, nitrogen MBW currently seems very promising [Singer et al.,
2014a, Singer et al., 2013, Yammine et al., 2013, Schulzke and Frey, 2013]. However,
different rheological characteristics of the tracers might lead to systematic differences in
MBW results [Jensen et al., 2013]. Values derived from MBWHe might elucidate differ-
ent aspects of lung physiology than those derived by other tracers, which may hamper
interpretation of serial MBW measurements at different time points during childhood.
As differences across age-groups will remain in the near future, age- and setup-specific
z-scores should be used to overcome this issue, at least partially.
The current software algorithm may need further improvement to better account for vari-
able conditions during MBW, for example, CO2 level and flow.
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2.6 CONCLUSION
The two tested MBW systems allow accurate and reproducible measurement of FRC in
the intended age group: the SF6 setup is appropriate for FRCs between 80 and 300 ml;
the helium setup is appropriate for FRC between 600 and 1,400 ml.Accuracy of both
systems may be further improved by more adaptive software algorithms. As expected,
FRC values measured in young children by MBWHe and plethysmography differ, suggest-
ing considerable influence from physiological FRC variability and different measurement
techniques. The two systems are appropriate for MBW in infants and in young children
of 5 years and more, and serve as valuable tools for clinical and research applications.
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2.7 Validation of multiple-breath washout equipment
for infants and young children
ONLINE SUPPLEMENT
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Supplemental online figure 1
Multiple breath washout setup for infants
In the setup for infants, flow and molar mass are measured via the main stream ultrasonic
flow meter (USFM). The apparatus (Exhalyzer D, Eco Medics AG, Duernten, Switzerland)
and software (WBreath, ndd medical technologies, Zurich, Switzerland) are available.
The flow head with dead space reducer (DSR) is applied using a face mask. Sulfur
hexafluoride (SF6) is used as tracer gas produced by Carbagas, Bern, Switzerland (SF6
4%, oxygen (O2) 21%, balance nitrogen (N2). All signals are processed using a personal
computer (PC). The figure was provided by the manufacturer.
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Supplemental online figure 2
Multiple breath washout setup for young children
In the setup for young children, flow is measured via the main stream ultrasonic flow
meter (USFM). In addition, a side stream USFM and infrared carbon dioxide (CO2)
sensor measure molar mass and CO2, respectively. Temperature and humidity of exhaled
air for side stream USFM are equilibrated with room air due to characteristics of the tube
(Nafion, Perma Pure LLC, Toms River, USA). The apparatus (Exhalyzer D, Eco Medics
AG, Duernten, Switzerland) and software (WBreath, ndd medical technologies, Zurich,
Switzerland) are available. The flow head with dead space reducer (DSR) is applied
using a bacterial filter and snorkel mouth piece. Helium is used as tracer gas produced by
Carbagas, Bern, Switzerland: A mixture of 22% oxygen (O2) and 78% helium is blended
with medical air containing balance nitrogen (N2) to achieve a helium concentration of
20%. All signals are processed using a personal computer (PC). The figure was provided
by the manufacturer.
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3.1 ABSTRACT
Background
Chronic lung disease may originate in early childhood. Understanding physiological lung
growth and its influencing factors facilitates the development of preventive strategies for
respiratory health in children and adults. We investigated whether functional residual
capacity (FRC) tracks throughout childhood, and which factors have an effect on lung
growth.
Methods
We performed longitudinal measurements of FRC without sedation at the ages of 5 weeks
and 6 years in term-born children from a prospective birth cohort. We used multiple-
breath washout (MBW) at the first visit, and plethysmography at the second visit. Main
outcome was plethysmographic FRC (FRCpleth) at 6 years. We tested tracking of lung
volumes, i.e. association of FRC at both visits, and factors potentially influencing lung
growth, by regression analysis.
Results
In 124 children, we observed weak tracking of FRC values. The univariable model ex-
plained only 4.1% of the variance of FRCpleth (coefficient 2.7 ml FRC at visit 2 per 1 ml
FRC at visit 1; 95%CI 0.6 – 4.8). The explained variance was higher (22%, p<0.001) in
the multivariable model including height and age at visit 2, male gender, and maternal
smoking during infancy (coefficient 2.0; 95%CI 0.02 – 3.97).
Conclusions
As previous studies reported lung function data from forced manoeuvres, this investiga-
tion based on more physiological manoeuvres adds new information to the field of early
lung development. Our study showed weak tracking of FRC in term-born children from
infancy to early childhood.
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3.2 INTRODUCTION
Understanding physiological lung growth during childhood and its influencing factors
holds the potential for preventive strategies: Lung morbidity is a major health issue
[World Health Organization, 2015]; and obstructive lung diseases in adults originate
partly in childhood [Postma et al., 2014, Henderson, 2014, Silverman and Kuehni, 2007].
The pathogenesis of respiratory disease is complex and multi-factorial [Frey and Suki,
2008, Barker et al., 1991], and, especially in early childhood, is only poorly understood.
Lung growth was observed even beyond childhood [Narayanan et al., 2012]. The most
important window for the complex physiological lung development were the first few years
of life [Stocks et al., 2013].
Data on early lung development were published from different types of studies, mostly
reporting airway function. Studies reporting lung function data throughout childhood in
term-born children focused on forced manoeuvres [Hopper et al., 1991, Turner et al.,
2014], where results were mostly determined by fixed mechanical properties, providing
valuable information on growth of the larger airways. Children with severe asthma were
at risk of having chronic obstructive pulmonary disease in adulthood [Tai et al., 2014].
Within an organ, physiologically normal growth can be disproportionate, a concept known
as dysanapsis [Green et al., 1974]. Dysanapsis of airways and lung tissue seems to
originate early in childhood [Martin et al., 1988]. Thus, data on lung volume is necessary
to fill in the gap of knowledge regarding growth of the entire organ. This study is
the first to provide longitudinal data on increasing lung volume, i.e. functional residual
capacity (FRC), in unselected children between the ages of 5 weeks and 6 years. In
addition to what was known from previous publications using forced manoeuvres, our
study focused on measurements of intrapulmonary gas volume using techniques without
sedation, and with more natural breathing. We used multiple-breath washout (MBW) for
FRC determination in infancy [Fuchs et al., 2011a], and plethysmography [Criée et al.,
2011] at the age of 6 years.
The main aim of this study was to investigate how strongly FRC tracks from infancy to
early childhood, and to investigate the effect of different factors on lung growth in an
unselected population. The secondary aim was to test disproportionate growth of airways
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and lung tissue. Main outcome was lung volume at the age of 6 years, we hypothesised
to find an association of lung volumes over time.
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3.3 METHODS
Participants
Term-born, unselected Caucasian children from a prospective birth cohort were recruited
antenatally for longitudinal lung function measurements using MBW and plethysmogra-
phy. The entire study protocol was previously described,[Fuchs et al., 2012a] and relevant
details for this publication are provided in the Online Supplement (OLS). The study was
approved by the Ethics Committee of the Canton of Bern, Switzerland. Parents or care-
givers provided written informed consent for this study. At the second visit, the child’s
assent was obtained.
Lung function measurements
End-expiratory lung volume was measured at the age of 5 weeks (visit 1) using MBW
(FRCMBW ) during quiet natural sleep in the supine position with the Exhalyzer D (Eco
Medics AG, Duernten, Switzerland) and 4% sulfur hexafluoride (SF6). At 6 years (visit 2),
FRC was measured by plethysmography (FRCpleth) with the awake child sitting upright
using the JAEGER Master-Screen Body (CareFusion, Wuerzburg, Germany). At visit 2,
spirometry was performed before plethysmography measuring maximum mid-expiratory
flow (MMEF). All measurements were performed according to current standards and
consensus [Frey et al., 2000a, Robinson et al., 2013, Wanger et al., 2005, Miller et al.,
2005] by experienced operators (for details see OLS).
For longitudinal analysis, participants with high quality FRC measurements at both study
visits were included.
At visit 2, children performed helium MBW in addition, for details see OLS.
Assessment of exposures and health
We assessed the family history and potentially harmful exposures. We defined binary vari-
ables for any exposure to parental smoking (no vs. yes for mother and/or father/other
person in the household during year one and year six, and any of those). Severe res-
piratory symptoms during the first year of life were assessed during weekly phone calls
[Latzin et al., 2006]. At visit 2, symptoms from 5 to 6 years of age were assessed in
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a standardised interview. [Kuehni et al., 2001] A skin prick test was performed on the
mothers at visit 1, and on the participants at visit 2. More information on the definition
of exposures is provided in the OLS.
Statistical Methods
In order to analyse tracking of lung volumes, linear regression and Pearson correlation
coefficient were used, with FRCpleth in ml at visit 2 being the outcome, and FRCMBW
in ml at visit 1 being the exposure. Variables with potential association with FRCpleth
were tested using univariable linear regression (see OLS for details), including gender and
height at visit 2, as their impact on lung volume is well known. We selected predictors
for the multivariable model according to physiological plausibility and p-value <0.10 in
the univariable analysis. We ranked those by R2 and performed a forward stepwise se-
lection where co-linearity was tested. Variables that improved R2 by at least 10% were
included in the multivariable model. We tested non-linear correlation of exposures with
FRCpleth by adding quadratic transformation of predictors to the model. Regression mod-
els with and without quadratic terms were compared using the likelihood ratio test. If
the latter showed no improvement of the model using the quadratic term, we used the
non-quadratic term only. We calculated gender-specific z-scores for FRC and spirometric
values. Details and results of regression analysis using FRC z-scores instead of absolute
values are provided in the OLS. Coefficient of variation (CV) of FRC measurements was
calculated as the ratio of SD and mean FRC value per child and technique.
In order to test for dysanapsis, i.e. whether airway function and lung volume were associ-
ated per individual at visit 2, the association of MMEF and FRC was tested using visual
data analysis and linear regression.
Power calculation was limited due to lack of comparable investigations. The size of the
population was, however, equal to a population where the association of forced expiratory
flow over time was assessed [Stern et al., 2007]. Power was 80% to detect a correlation
coefficient of 0.25 with a significance level of 0.05 (two-sided).
Statistical analyses were performed in STATA 11 (STATA Corporation, Texas, USA) and
R 3.1.2 (http://www.r-project.org/).
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3.4 RESULTS
Study participants and lung volume
We evaluated FRC measurements at study visits 1 and 2. After strict quality control, we
included 124 children with a successful FRC measurement at both visits in the longitu-
dinal analysis (figure 1). All but four of these performed spirometry successfully.
Characteristics of the study population are shown in table 1 (see OLS for comparison
with non-included children). Mean (SD) gestational age at birth was 40 (1.2) weeks.
At visit 1, mean (SD) FRCMBW was 103 (17) ml. Median (inter-quartile range, IQR)
intra-subject CV for FRCMBW (n=105) was 4.2 (2.6 6.1) %. At visit 2, mean (SD)
FRCpleth was 1088 (206) ml. Median (IQR) intra-subject CV for FRCpleth (n=123) was
5.0 (3.4 8.7) %.
In addition, we performed helium MBW at visit 2. Despite the experience in our group,
success rate was poor, as leaks and other technical problems were frequent. MBW results
at visit 2 are reported in the OLS. In this ongoing study, we switched to nitrogen MBW
at visit 2.
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Figure 3.1.
Participants
Longitudinal measurements of functional residual capacity (FRC) in children participating
in the cohort study (BILD study, Bern and Basel Infant Lung Development).[Fuchs et al.,
2012a] The study is ongoing. Only children who already reached the age of 6 years were
eligible for visit 2. High quality measurements of FRC from multiple breath-washout
(FRCMBW ) at visit 1 (age 5 weeks), and from plethysmography (FRCpleth) at visit 2
(age 6 years) were available in n=124 children. In the online supplement, characteristics
of the entire BILD cohort, compared to the subgroup included in this study, are provided.
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Table 3.1.
Population characteristics (n=124)
# Values are displayed in mean (SD) of n=124 if not otherwise stated
* Some information missing in n=3
** Available in n=99
Tracking of functional residual capacity
Table 2 shows the association of FRCpleth with different predictors. FRCMBW at visit 1
significantly predicts FRCpleth at visit 2, but only weakly: Univariable regression showed
that per ml FRC at visit 1, FRC at visit 2 was 2.7 ml larger (95%CI 0.6 to 4.8), and
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FRC at visit 1 explains only 4.1% of the variance of FRC at visit 2. The adjusted coeffi-
cient was 2.0 (95%CI 0.02 to 4.0), the multivariable model explains 22% of the variance.
Pearson correlation coefficient for FRCMBW at visit 1 with FRCpleth at visit 2 was 0.22
(p=0.014).
Statistical analyses using FRC z-scores instead of absolute values showed comparable
results (see OLS). Figure 2 shows trajectories of FRC z-scores from visit 1 to visit 2 for
all children.
Factors associated with lung volume
As expected, larger FRCpleth values at visit 2 were associated with greater height and
weight, male gender, and with being older at visit 2. We found larger FRCpleth in children
exposed to maternal smoking during the first year of life, and to any parental smoking
at the age of 6 years. No association of severe respiratory symptoms during infancy or
early childhood, maternal atopy or parental asthma with FRCpleth at visit 2 was found
(variables without association are listed in the OLS). In a post-hoc-analysis, we found
a trend towards stronger FRC increase over time in individuals with longer duration of
respiratory symptoms during infancy, this trend was explained by an association of larger
FRC at visit 1 with longer duration of respiratory symptoms in infancy (data not shown).
Stepwise generation of the multivariable regression model showed co-linearity of anthro-
pometric data at visits 1 and 2, and of height and weight at visit 2, with height at visit
2 being the strongest predictors of FRCpleth.
The association of FRCMBW at visit 1 with FRCpleth at visit 2 was confirmed in the mul-
tivariable analysis after adjustment for height and age at visit 2, gender, and exposure to
maternal smoking.
At visit 2, no relationship between airway function and lung volume, i.e. between MMEF
in ml and FRCpleth in ml was found in the study population (figure 3) (n=120; coefficient
0.04, 95%CI -0.06 to 0.15 in the univariable model; coefficient 0.02, 95%CI -0.8 to 1.1
after adjustment for height and age at visit 2, male gender, and exposure to maternal
smoking in the first year of life). MMEF z-scores were not associated with FRCpleth
z-scores, nor with FVC z-scores (data not shown).
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Figure 3.2:
Weak tracking of functional residual capacity (n=124)
Functional residual capacity (FRC) tracks from the age of 5 weeks to the age of 6 years.
Z-scores were derived separately for males and females for FRC measured by multiple-
breath washout at visit 1 and FRC measured by plethysmography at visit 2. Z-scores for
FRCpleth were based on published reference values [Rosenthal et al., 1993]. Regression
analysis showed an association of absolute FRC values and of FRC z scores over time.
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Figure 3.3
Dysanapsis - FRCpleth and MMEF at age 6 years (n=120)
Maximum mid-expiratory flow (MMEF) in spirometry plotted versus functional residual
capacity measured by plethysmography (FRCpleth) at the age of 6 years in children with
successful plethysmography and spirometry (n=120). Z-scores were derived separately
for males and females, and based on published reference values [Rosenthal et al., 1993,
Quanjer et al., 2012]. Lines represent z-scores of 0. Regression analysis showed no
association of absolute values or z-scores.
70
Early lung development 3 LUNG GROWTH IN TERM-BORN CHILDREN
3.5 DISCUSSION
This study was the first to examine tracking of FRC in term-born, unselected children
from infancy to early childhood. Tracking of this physiological lung function parameter
was weak. Male gender, height and age at visit 2, and exposure to maternal smoking
during the first year of life, were associated with larger plethysmographic lung volumes at
visit 2. At visit 2, MMEF and FRCpleth were not associated, which was consistent with
dysanapsis, and underlines the relevance of analysing longitudinal data on end-expiratory
lung volume, as presented in this article.
Strengths and limitations
Strengths of this study were the prospective design with longitudinal assessment of lung
volume data and potential influencing variables in an unselected population, and the use
of established and validated methods for lung volume determination not requiring seda-
tion in infants.
We applied strict quality criteria for inclusion of FRC measurements in the longitudinal
analyses, which increased the quality of the data, but limited the sample size.
Limitations of this study were methodological differences between FRC techniques at
different visits. We took measurements during natural sleep and in supine position at
visit 1, and awake in an upright position at visit 2. At visit 2, some children’s cooper-
ation was limited. MBW and plethysmography used different principles. The first was
based on dilution of a tracer gas in the lungs during tidal breathing, while the latter re-
lied on the relationship of intra-thoracic gas volume and pressure when normal breathing
was interrupted. Thus, MBW measured the gas volume that participated in ventilation;
plethysmography measured trapped gas in addition.
Both techniques showed variability between the single tests, especially as we performed
infant measurements without sedation. As in all comparable studies, a remaining mea-
surement error of both techniques had to be assumed. For FRCMBW at visit 1, error
was quantified in an in-vitro study; it was within approximately ± 10% [Schmidt et al.,
2015b]. For FRCpleth, the measurement error was unknown.
A selection bias cannot be excluded for either participation or exposures. It is possible
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but not given that a stronger effect of exposures would have been found indeed in a
population with more and randomly - exposed children.
Interpretation and comparison with literature
Tracking of lung volumes in our study population was weak; only 4.1% of variance of
FRCpleth values at visit 2 was explained by FRCMBW values at visit 1 in the univariable
regression. The multivariable regression model, including height and age at visit 2, male
gender, FRCMBW and exposure to maternal smoking in the first year of life, explained
22% of the variance of FRCpleth.
The remaining variance might be explained by several physiological and methodological
factors. Certainly, the physiological variability of the end-expiratory level was high at
both visits. Infants in particular change their FRC frequently and within a short period of
time. Some measurement error was likely to contribute to the remaining non-explained
variance as well. Some exposures were not included in our analysis, such as outdoor air
pollution, individual susceptibility to harmful substances, or individual capacity for tissue
regeneration after injury.
Comparability with previous studies was limited because, so far, investigations of track-
ing were based on parameters from forced manoeuvres. Results from studies in selected
children of comparable ages are summarised in table 3a. The same outcome, FRC, was
available from a longitudinal study in preterm children with and without bronchopul-
monary dysplasia during the first 2 years of life, but not beyond, the outcome of interest
was a group comparison over time [Schmalisch et al., 2012]. Hoo and colleagues showed
tracking of maximal flow at FRC (VmaxFRC) early in life in term-born and preterm chil-
dren [Hoo et al., 2002a, Hoo et al., 2002b]. Filippone et al. described tracking of airway
function from 2 years to 9 years of age [Filippone et al., 2003]. In a longitudinal study of
older children and young adults, tracking of airway function was found in full-term and
preterm children [Vollsæ ter et al., 2013]. Studies in children with cystic fibrosis showed
that LCI tracks from infancy to childhood [Kieninger et al., 2011] and from age 4 years
to 8 years [Aurora et al., 2011] in those individuals with elevated values. Several studies
of term-born children reported data from school age on only [Twisk et al., 1998, Hibbert
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et al., 1990]. Recent studies with a comparable study protocol, i.e. unselected birth
cohorts with longitudinal lung function measurements starting very early in childhood,
are listed in table 3b. Outcomes were spirometry [Turner et al., 2014, Stern et al., 2007],
and specific resistance [Belgrave et al., 2014]. The explained variance was reported by
Stern and colleagues [Stern et al., 2007] it was 9 to 14%, so tracking was weak here as
well. Spirometric measurements in infants were performed with sedation, and physiolog-
ical variability might be lower than in our measurements without sedation.
Respiratory symptoms in infancy or early childhood showed no association with lung vol-
ume at visit 2 in the multivariable model. Despite the low number of children in this
subgroup, we found larger FRCpleth values in those children exposed to maternal smoking
even after adjustment. As potential explanations cannot be differentiated, i.e. hyperin-
flation and increased lung growth, this result needs to be interpreted with caution. It
would be interesting to compare lung function and respiratory health in these children in
adolescence.
With the data currently available, the question as to which lung function method is most
informative for understanding lung development, i.e. expiratory flow from forced manoeu-
vres or lung volume data from more physiological manoeuvres, cannot be answered. We
found no association between MMEF and FRC at visit 2, a previous study showed a very
weak association of VC and expiratory flow in healthy children and adolescents [Hopper
et al., 1991]. Most likely, different techniques provide different, albeit complementary
information. Studies reporting data from physiological manoeuvres, like FRC, will allow
us to understand lung growth better in the future.
In order to increase the comparability of future longitudinal studies, we would like to
recommend a somewhat clearer definition and use of the term tracking. We observed
that it is currently used for a broad spectrum of findings, and in our opinion, this is not
always appropriate. We would like to suggest avoiding the term when reporting group
comparisons over time, e.g. stratified by symptoms, or other factors. Group compar-
isons help us indeed to understand lung development, and they are an important part of
the epidemiological puzzle. The term tracking, however, should only be used when the
association of longitudinal measurements in the same individuals is reported, which was
done indeed by most of the authors we are citing. Interestingly, the variance explained
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by tracking was only reported by some investigators.
Medical relevance and conclusions To the best of our knowledge, this was the first
study reporting tracking of FRC, a parameter with high physiological variability, in un-
selected term-born children from infancy to early childhood. Tracking was weak which
shows that by measuring lung volume after birth, lung volume in early childhood can only
be predicted to a small extent. Certainly, the high physiological variability of FRC at both
visits hampers detection of tracking. It is likely that many factors modify lung growth
in this early period. The size of the population included in this analysis was relatively
high considering the complexity of measuring FRC throughout childhood. However, ob-
servations of children exposed to potentially disturbing factors were few. This increases
the challenge of interpreting our findings with regards to clinical relevance. We found
no evidence for hyperinflation in children exposed to parental smoking, but it is possible
that, later in life, hyperinflation will be measurable in these individuals.
Our study adds relevant information to current knowledge, as previous studies in unse-
lected populations early in childhood focused on data from forced exhalation techniques;
which reflects airway growth rather than overall lung growth.
In the future, a standardised approach for investigating lung function tracking is desirable,
as this would help us to compare findings from different studies. In our opinion, studies
on tracking should report associations of the individuals’ parameters over time.
In conclusion, tracking of lung volume during early childhood was weak in term-born chil-
dren. We hypothesise that this was due to a combination of high physiological variability
and multiple influencing factors early in life.
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3.6 Early lung growth in term-born children:
Weak tracking of end-expiratory lung volume from infancy
to early childhood
ONLINE SUPPLEMENT #1
Additional details on methods and results
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ADDITIONAL DETAILS ON METHODS
Detailed criteria for inclusion and exclusion
Inclusion criteria were Caucasian ethnicity, term delivery (at least 37 weeks), and ability
of parents to speak one of the major Swiss languages (German or French). Exclusion
criteria for study participation were severe maternal health problems, maternal drug abuse
other than nicotine, known major birth defects or perinatal disease of the newborn, such
as respiratory distress, airway malformation or other major respiratory diseases diagnosed
after birth; while exclusion criteria for lung function analysis were respiratory tract in-
fection within two weeks prior to lung function measurements or poor technical quality
of FRC measurements. The entire study protocol was previously described.[Fuchs et al.,
2012a]
Lung function measurements
For MBW, we used a commercially available apparatus (Exhalyzer D, Eco Medics AG,
Duernten, Switzerland) with an age appropriate tracer gas, i.e. 4% sulfur hexafluo-
ride (SF6).[Robinson et al., 2013] We performed daily calibration of flow, volume and
tracer concentration. Apparatus and procedure were described previously,[Fuchs et al.,
2011a, Latzin et al., 2007b] and the setup was validated as requested by current con-
sensus.[Schmidt et al., 2015b] Spirometry and plethysmography were performed at visit
2 only, using the JAEGER Master-Screen Body (CareFusion, Wuerzburg, Germany).
Plethysmographic FRC determination was based on the law of Boyle-Mariotte.[Criée
et al., 2011]
Criteria for exclusion of a single test were poor cooperation of the child, irregular breath-
ing pattern during MBW, incomplete wash-in or washout of the tracer, deviations in
molar mass, or relevant volume drift. The latter was defined as >3 ml*s-1 at visit 1.
Maximal tracer concentration during MBW was determined from end-inspiratory molar
mass [Anagnostopoulou et al., 2015]. At least 3 tests were performed for each FRC
measurement. Mean FRCMBW and mean FRCpleth were calculated from the maximum
of technically acceptable tests. Single FRC measurements beyond 25% deviation from
the median of trials per child and technique were excluded [Robinson et al., 2013].
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Assessment of exposures and respiratory health
Exposure to parental smoking was assessed several times and for each parent using stan-
dardised questionnaires and interviews: during pregnancy, during the first year of life, and
at age 6 years. Exposure during pregnancy was verified based on children’s urine coti-
nine levels. We defined binary variables for any exposure (no vs. yes for mother and/or
father/other person in the household during year one and year six, and any of those).
Severe respiratory symptoms during the first year of life were assessed during weekly
phone calls, and were defined as previously reported.[Latzin et al., 2006] At visit 2, symp-
toms from 5 to 6 years of age were assessed in a standardised interview, based on the
ISAAC questionnaire.[Kuehni et al., 2001]
Maternal atopic disease was defined as the mother having atopic dermatitis, atopic rhini-
tis or asthma. Parental asthma was defined as either parent reporting doctor-diagnosed
asthma.
Skin Prick Test
We performed a skin prick test (Allergomed, Switzerland) in mothers at visit 1, and in chil-
dren at visit 2. We tested for dog dander, cat dander, Dermatophagoides pteronyssinus,
mixed tree pollens, mixed grass pollens, Alternaria tenuis, positive control: histamine,
negative control: NaCl. Tests were positive in case of hives bigger than positive control
in any of the tested allergens.
Statistical Methods
Z-scores were calculated for functional residual capacity (FRC) at visit 1 based on gender
specific mean and standard deviation (SD) within the study population:
z-score = (gender-specific mean within group individual value) / gender-specific SD
within group Z-scores for FRCpleth were calculated based on gender specific reference
values. [Rosenthal et al., 1993]
Z-scores for spirometry were calculated based on gender specific reference data published
by the Global Lung Initiative. [Quanjer et al., 2012]
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ADDITIONAL DETAILS ON RESULTS
Participants
Of the 324 children in this ongoing study who had reached the age of eligibility for visit
2 (6 years of age), 247 participated (76%), and 184 performed plethysmography. On-
line Supplement Table 3.6.1 shows characteristics of all participants of this nested study
(n=124), compared to children present at follow up but lacking high quality FRC mea-
surements at visit 1 and / or visit 2 (n=123), and with children who participated but
were below the age of 6 years or not present at visit 2 (n=265).
Univariable regression analysis
Online Supplement Table 3.6.2 shows variables without association with FRCpleth at visit
2, and how these variables were defined.
Multivariable regression analysis using highest or lowest FRC measurement per
child and visit
Online Supplement Table 3.6.3a (outcome FRCpleth) shows results of multivariable re-
gression analysis if, instead of using mean values of FRC per child and visit, only the
highest or lowest FRC measurement was used.
Online Supplement Table 3.6.3b shows results when FRC from helium MBW at visit 2
was used as the outcome in 75 children, using variables for adjustment from the multi-
variable model regarding FRCpleth.
Multivariable regression analysis if FRC z-scores were used instead of abso-
lute values
Online Supplement Table 3.6.4 shows results of multivariable regression analysis when,
instead of absolute FRC values, z-scores were used.
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Online Supplement Table 3.6.4:
Multivariable regression using z scores of FRCpleth
Results of multivariable regression analysis when, instead of absolute FRC values, z-scores
were used. Z-scores were calculated for functional residual capacity (FRC) measured
by multiple-breath washout (FRCMBW ) at visit 1 based on gender specific mean and
standard deviation (SD) within the study population. Z-scores for FRC measured by
plethysmography (FRCpleth) at visit 2 were calculated based on gender and height specific
published reference values.[Rosenthal et al., 1993]
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3.7 Early lung growth in term-born children: Weak tracking of
end-expiratory lung volume from infancy to early childhood
ONLINE SUPPLEMENT # 2
Details on helium multiple-breath washout at visit 2 –
Successful measurements, exclusion criteria,
and implications for MBW using helium
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Helium multiple-breath washout performed insufficiently in young children
At the second visit of the longitudinal study, in addition to plethysmography, we measured
functional residual capacity (FRC) using multiple-breath washout (MBW, FRCMBW ). We
used helium which is an appropriate tracer for young children [Robinson et al., 2013]; and
when follow-up was initiated helium MBW was a promising approach. The setup was
based on an ultrasonic flow meter (USFM); its validity was described in detail previously
[Schmidt et al., 2015b]. Operators in our lung function laboratory were experienced with
MBW in infants and children of all ages. Surprisingly, many of the results were not
within the expected range for healthy children at the age of six years. Thus, we tested
the credibility of the FRCMBW values in order to ensure their suitability as an outcome
for longitudinal analysis. In the process, many measurements had to be excluded. From
our experience, helium is not suitable for MBW in young children, at least when tracer
concentration is measured indirectly using molar mass signal. Details about the problems
we encountered, and a discussion of those, are presented in this online supplement.
Equipment for helium MBW and daily calibration
We used a commercially available apparatus (Exhalyzer D, Eco Medics AG, Duernten,
Switzerland) and software (WBreath, ndd medical technologies, Zurich, Switzerland). A
main stream USFM measured flow, a side stream USFM sensor measured molar mass
(MM). For the side-stream MM signal, temperature and humidity of exhaled air were
equilibrated with the surrounding air via a nafion tube (Nafion, Perma Pure LLC, Toms
River, USA). A side-stream infrared carbon dioxide (CO2) sensor measured CO2. Helium
was produced by Carbagas, Bern, Switzerland: A mixture of 22% oxygen (O2) and 78%
helium was blended with medical air containing balance nitrogen (N2) to achieve a helium
concentration of 20%. Tracer concentration was measured indirectly via MM of in- and
exhaled air. We performed daily calibration of volumes, CO2 signal, and controlled ap-
propriate MM change when adding the tracer. Stable CO2 levels were used as a quality
control for regular tidal breathing. FRC was calculated as cumulative expired volume
(CEV) of tracer gas divided by the difference between end-tidal tracer gas concentrations
at the start and end of MBW. Lung Clearance Index (LCI) as a measure of ventilation
homogeneity was calculated as CEV over FRC.
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Initial inclusion of n=99 helium MBW measurements for longitudinal analy-
sis
For inclusion of helium MBW measurements in the longitudinal analysis, we performed
visual control for quiet breathing, appropriate wash-in; and for absence of leak, sensor
issues, or hyperventilation. The latter is problematic in helium MBW using an USFM:
tracer concentration is indirectly measured via molar mass of inhaled and exhaled air, and
CO2 is one of the most important determinants of molar mass of exhaled air. A change
in CO2 levels during MBW can interfere with correct calculation of tracer concentration.
After a first visual control, 66% of the 209 helium MBW measurements we performed
showed acceptable quality. In 99 out of the 137 children, a high quality FRC measure-
ment at birth was available, so these children were included in the detailed analysis.
After analysis of the initially included 99 measurements according to standards [Robinson
et al., 2009], LCI results were not within the range we expected in a group of unselected
children at the age of six years [Lum et al., 2013]. (Online Supplement Table 3.7.1)
Thus, we performed several post-hoc analyses to test credibility of the helium MBW
results.
Online Supplement Table 3.7.1:
Results from helium MBW (n=99) at visit 2
Statistical methods to test quality of helium MBW measurements
Comparison with normative data was not possible, because reference values for FRC
measured by helium MBW were not available. Most children (n=79) had a success-
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ful measurement of FRCpleth at the same visit, so we calculated the absolute (FRCpleth
FRCMBW ) and relative differences (absolute difference * 100 / FRCpleth) between the
two measurements and displayed the agreement of the two techniques according to Bland
and Altman [Bland and Altman, 1986].
FRCpleth values were compared to normative values published by Hibbert and by Rosen-
thal [Hibbert et al., 1989, Rosenthal et al., 1993]. Coefficient of variation (CV) was
calculated for children with 2 or 3 successful measurements for each FRC technique. We
tested a potential association of FRCMBW values with LCI values in the same individuals
by graphical and linear regression analysis. Statistical analyses were performed in STATA
11 (STATA Corporation, Texas, USA) and R 3.1.2 (http://www.r-project.org/).
Results of the credibility analyses
We found larger values in FRCpleth compared to FRCMBW with a mean (SD) relative
difference of 39 (13) % (see Online Supplement Table 3.7.2). Plethysmography showed
FRC results within expected range (Online Supplement Table 3.7.3). Intra-subject CV
was slightly higher for FRCMBW than for FRCpleth (Online Supplement Table 3.7.4).
Bland-Altman plots show agreement of both techniques (Online Supplement Figure
3.7.1). LCI values plotted versus FRC values from helium MBW (Online Supplement
Figure 3.7.2) showed an association of both, especially in FRC values below 800 ml.
Linear regression analysis showed that both parameters were associated, an increase of 1
ml FRC reduced LCI by 0.004 (95%CI -0.006 to -0.002; p<0.001; R2 19%).
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Online Supplement Table 3.7.2:
Difference of functional residual capacity (FRC) from helium MBW at visit 2 (FRCMBW )
to FRC from plethysmography at visit 2 (FRCpleth) (n=79)
Online Supplement Table 3.7.3
Functional residual capacity from plethysmography (FRCpleth) in % of predicted values
from published reference data (n=101)[Hibbert et al., 1989, Rosenthal et al., 1993]
Online Supplement Table 3.7.4
Intra-subject coefficient of variation (CV) of functional residual capacity (FRC) from
helium MBW at visit 2 (FRCMBW , n=77) and FRC from plethysmography at visit 2
(FRCpleth, n=100)
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Online Supplement Figure 3.7.1:
Agreement of FRCpleth & FRCMBW
Bland Altman Plot [Bland and Altman, 1986] showing the absolute (upper figure) and rel-
ative (lower figure) difference of functional residual capacity (FRC) measured by plethys-
mography (FRCpleth) and by helium multiple-breath washout (FRCMBW ) at the age of 6
years, versus the mean of both. Dashed lines represent upper and lower limit of agree-
ment, dotted lines represent confidence interval of mean difference.
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Online Supplement Figure 3.7.2.:
Association of FRCMBW and LCI
Functional residual capacity from helium multiple-breath washout (FRCMBW ) plotted vs.
lung clearance index (LCI) of the same individuals (n=99)
Discussion of physiological and technical explanations for the findings
We expected a relative difference between FRC from helium MBW and plethysmography
at visit 2 of up to 20%, as described in previous studies [Pillow et al., 2004, Owens
et al., 2011, Jensen et al., 2013]. Surprisingly, the observed difference was even higher.
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To the best of our knowledge, paediatric reference values for helium MBW were not
available. A previous study in children from 4 to 17 years of age reports LCI values from
helium MBW; these were higher compared to published reference values using different
tracers. FRC values were not reported in this study and main stream molar mass signal
was used instead of side stream signal [Vermeulen et al., 2013]. A study in intubated
rabbits showed lung volumes measured by helium MBW and chest computer tomography
to be in the same range, but volumes were very small and cannot be compared to this
paediatric population. Exact values were not given for LCI or FRC; figures indicated that
LCI decreased with increasing lung volumes [Albu et al., 2014].
Published FRC values derived from helium dilution technique were lower than FRC values
measured by plethysmography [Stocks and Quanjer, 1995]. As FRCpleth measurements
were within the expected range [Hibbert et al., 1989, Rosenthal et al., 1993] for children
of this age group, the large relative difference was unlikely to be caused by an incorrect
overestimation of FRCpleth. Several reasons were likely to contribute to the large dif-
ference between the two techniques: Plethysmography detected trapped gas in addition
to the lung volume that participated in ventilation. Physiologic variability of FRC and
differences in measurement techniques were likely to contribute as well.
Intra-subject-variability, i.e. CV, was slightly higher in MBW compared to plethysmogra-
phy, but this does not explain the large relative difference between the techniques either.
Measurement error was evaluated for the MBW setup, it was within ±10% approximately
for FRC values of 600 ml and more [Schmidt et al., 2015b]. For plethysmography, mea-
surement error was unknown. Bland-Altman plot showed a systematic underestimation of
FRC in helium MBW. It is possible that specific normative values are needed for different
techniques.
LCI was not independent of FRC (see Online Supplement Figure 3.7.2); and this indi-
cated that our results were not reliable. In a cross-sectional paediatric study, upper limit
of normal for LCI was constant beyond 6 years of age [Lum et al., 2013] and we expected
LCI to be independent of FRC.
Only MBW files without apparent leak were included. From our experience, a flow base-
line correction below 1 ml/kg body weight per MBW file is acceptable [Fuchs et al.,
2011a]. We cannot exclude that identification of leakage by the software was always
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accurate as we had no insights in the details of the software. Leaks can occur at several
locations within the setup, and the magnitude can vary within the breath cycle. It was
challenging to identify leaks, especially as the software only allowed visual control. The
changing tracer concentration was not displayed during measurements. A list of limita-
tions of the helium MBW setup can be found in Online Supplement Table 3.7.5.
Online Supplement Table 3.7.5
Limitations of helium multiple-breath washout
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Implications
Unfortunately, most of the measurements we performed had to be excluded, and the
remaining successful measurements were too few for a reliable statistical analysis (see
Online Supplement Figure 3.7.3). In conclusion, helium MBW performed insufficiently in
this population of young children. Helium is very volatile and thus prone to leaks; these
leaks were often invisible during measurement, even for an experienced operator. The
combination of limited cooperation in young children and suboptimal operator control
caused poor quality in many of the measurements. From our experience, nitrogen MBW
is easier to perform, especially by young children, as it is less prone to leaks and test
duration is shorter.
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Online Supplement Figure 2.3.:
Remaining participants for longitudinal analysis with outcome FRCMBW
Longitudinal measurements of functional residual capacity (FRC) in children participating
in the BILD study[Fuchs et al., 2012a] high quality measurements of FRC from multiple
breath-washout (FRCMBW ) at visit 1 and visit 2 were available in n=99 children. Mean
relative difference between FRCMBW and FRC from plethysmography (FRCpleth) at the
same visit was 39Mean lung clearance index (LCI) at visit 2 was 9.0. After exclusion of
problematic helium MBW measurements, the number of children included was too low
for a sound statistical analysis.
96
Early lung development 3 LUNG GROWTH IN TERM-BORN CHILDREN
97
Early lung development 4 INFANT LUNG FUNCTION IN PRETERM CHILDREN
4 Can infant lung function predict respiratory
morbidity during the 1rst year of life in preterm
infants?
Elena Proietti1,2,7, Thomas Riedel3,7, Oliver Fuchs1,4, Isabelle Pramana2, Florian Singer1,5,
Anne Schmidt1,2, Claudia Kuehni6, Philipp Latzin1,2 and Urs Frey2
Affiliations:
1 Paediatric Pulmonology, Inselspital and University of Bern, Bern, Switzerland.
2 University Childrens Hospital (UKBB), Basel, Switzerland.
3 Paediatric Intensive Care, Inselspital and University of Bern, Switzerland.
4 University Childrens Hospital, Munich, Germany.
5 University Childrens Hospital, Zurich, Switzerland.
6 Institute for Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
7 These authors contributed equally to this work.
Eur Respir J, 2014. 43(6): p. 1642-51
98
Early lung development 4 INFANT LUNG FUNCTION IN PRETERM CHILDREN
4.1 ABSTRACT
Compared with term-born infants, preterm infants have increased respiratory morbidity
in the first year of life. We investigated whether lung function tests performed near term
predict subsequent respiratory morbidity during the first year of life and compared this to
standard clinical parameters in preterms.
The prospective birth cohort included randomly selected preterm infants with and with-
out bronchopulmonary dysplasia. Lung function (tidal breathing and multiple-breath
washout) was measure at 44 weeks post-menstrual age during natural sleep. We assessed
respiratory morbidity (wheeze, hospitalisation, inhalation and home oxygen therapy) after
1 year using a standardised questionnaire. We first assessed the association between lung
function and subsequent respiratory morbidity. Secondly, we compared the predictive
power of standard clinical predictors with and without lung function data.
In 166 preterm infants, tidal volume, time to peak tidal expiratory flow/expiratory time
ratio and respiratory rate were significantly associated with subsequent wheeze. In com-
parison with standard clinical predictors, lung function did not improve the prediction of
later respiratory morbidity in an individual child.
Although associated with later wheeze, noninvasive infant lung function shows large phys-
iological variability and does not add to clinically relevant risk prediction for subsequent
respiratory morbidity in an individual preterm.
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4.2 INTRODUCTION
Respiratory morbidity is a common consequence of prematurity. Compared with term-
born infants, preterm infants are more likely to have lung function alterations, and to
develop respiratory symptoms in early infancy, childhood and adulthood [Baraldi et al.,
1997, Latzin et al., 2009a, Vrijlandt et al., 2013, Narang et al., 2008, Doyle et al., 2006].
Several studies identified various perinatal factors leading to impaired lung function (e.g.
post menstrual age (PMA) at birth or days on supplemental oxygen) and/or respiratory
symptoms in later life (e.g. perinatal adaptation or ventilator support) [Latzin et al.,
2009a, Doyle et al., 2006, Schmalisch et al., 2005, Pramana et al., 2011]. Although
infants with bronchopulmonary dysplasia (BPD) [Ehrenkranz et al., 2005] are at higher
risk of pulmonary morbidity, neither standard perinatal clinical risk predictors nor BPD
severity classification can reliably predict subsequent respiratory disease burden in the
first year of life for an individual child [Pramana et al., 2011, Lamarche-Vadel et al.,
2004].
For clinical management, we need early functional biomarkers to identify infants with par-
ticular risks of subsequent respiratory morbidity. Infant lung function has been proposed
as such a biomarker predicting respiratory morbidity in early life [Vrijlandt and Duiverman,
2010]. So far, few studies have investigated the association between early lung function
and clinical outcome in the first years of life. Most of these studies included babies born
at or near term [Gabriele et al., 2012, Giffin et al., 1994, Greenough et al., 1998, Latzin
et al., 2006, van Putte-Katier et al., 2012]. For use in daily clinical routine, lung function
measurements should not require sedation, and be minimally invasive and easily appli-
cable at bedside, and normative values should be available. We developed such a lung
function test compatible with the latest European Respiratory Society (ERS)/American
Thoracic Society (ATS) consensus statement in our cohort of healthy infants [Frey et al.,
2000a, Fuchs et al., 2012a, Fuchs et al., 2011a].
The aims of the present study were to investigate in infants born prematurely: first, to
determine whether noninvasive lung function measured near term (44 weeks PMA) is
associated with subsequent respiratory morbidity during the first year of life (pathophys-
iological association); and second, to assess the usefulness of early lung function tests to
100
Early lung development 4 INFANT LUNG FUNCTION IN PRETERM CHILDREN
predict later respiratory morbidity in the individual (clinical usefulness). In particular, we
investigated whether postnatal lung function adds to the predictive power for subsequent
symptoms in addition to standard perinatal predictors and risk scores.
4.3 METHODS
Study design
We prospectively recruited preterm infants during postnatal hospitalisation and performed
lung function measurements at the age of 44 weeks PMA [Latzin et al., 2009b]. After
1 year of age, we sent standardised questionnaires to the parents to record respiratory
symptoms during the first year of life [Pramana et al., 2011]. The Ethics Committee of
the Canton of Bern (Bern, Switzerland) approved the study protocol and parents agreed,
with written consent, to participate in the study.
Subjects
Infants born prematurely (<37 weeks PMA) were recruited at the University Childrens
Hospital of Bern (Bern, Switzerland) between 1999 and 2010, excluding infants with
congenital diaphragmatic hernia. Data on perinatal course were recorded using the
neonatology database (NEODAT 4.10, Tubingen, Germany). We additionally assessed
commonly used clinical scores such as the clinical risk index for babies (CRIB) [The inter-
national neonatal network, 1993] and the ATS JobeBancalari BPD severity classification
[Ehrenkranz et al., 2005].
Lung function measurement
At the age of 44 weeks PMA, we performed lung function tests in unsedated infants
during non-rapid eye movement sleep (by monitoring behaviour and online flowvolume
curves). First, we measured tidal breathing for 10 min, assessing tidal volume (Vt),
respiratory rate, minute ventilation (V’E), tidal expiratory flows at 25% (TEF25) and
50% (TEF50) of the remaining Vt, peak flow, and the time to peak tidal expiratory flow
(tPTEF)/expiratory time (tE) ratio, the latter describing the shape of the tidal breathing
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flowvolume loop. Second, we applied triplicate multiple-breath washout (MBW) mea-
surements (each lasting 3–4 min) using 4% sulfur hexafluoride to estimate functional
residual capacity (FRC) and ventilation heterogeneity, assessing lung clearance index
(LCI), and first and second moment ratios. LCI is defined as the number of lung volume
turnovers (in terms of FRC) required to reduce the sulfur hexafluoride to 1/40th of the
starting concentration. It is calculated as cumulative expired volume/FRC. During the
measurements, we aimed for a transcutaneous oxygen saturation >92%. When infants
required supplemental oxygen, we started the analysis from the first constant breaths.
Measurements were not undertaken in children whose oxygen saturation fell below 92%
while breathing room air. We performed the measurements and the analysis according to
the ERS/ATS consensus, using an ultrasonic flow meter device (Exhalyzer D; Eco Medics
AG, Duernten, Switzerland), as previously reported [Frey et al., 2000a]. The equipment’s
dynamic dead space is estimated to be far below the recommended 2 ml/kg-1.
Outcomes and questionnaire
This preterm cohort (recruitment period 1999-2007) has been described in detail in two
previous papers [Latzin et al., 2009b, Pramana et al., 2011]. Since then, recruitment has
been ongoing. The present study included infants recruited from January 1999 to De-
cember 31 2010. Follow-up questionnaires for the additional participants were distributed
in 2011.
The questionnaire contained questions modified from that of the International Study
on Asthma and Allergies in Childhood (http://isaac.auckland.ac.nz) (online supplement
material). We defined four binary outcomes (yes/no): wheeze, inhalation therapy with
β-agonists for >4 weeks, re-hospitalisation due to respiratory disease (excluding admis-
sions for diagnostic purposes), and home oxygen therapy after hospital discharge. These
outcomes can be reproducibly assessed, as previously reported in a subpopulation of
this cohort and in other studies [Pramana et al., 2011, Peacock et al., 2013, Strippoli
et al., 2007]. The returned questionnaires underwent quality control performed by study
nurses and medical doctors. We further validated the answers for re-hospitalisation and
home oxygen therapy using medical histories from hospital records. As four out of 45
re-hospitalisations were related to check-ups rather than symptoms, these were recoded.
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Statistical analysis
Pathophysiological association
We investigated the association between lung function parameters and subsequent res-
piratory morbidity separately for each of the four outcomes, using multivariable logistic
regression. Adverse perinatal course and pre-existing risk factors may cause respiratory
morbidity through an independent pathway not involving lung function. Therefore, to
avoid confounding in the association between lung function and respiratory symptoms,
we adjusted the models for: maternal atopy (defined as history of hay fever, asthma
or eczema); sex; mode of delivery; PMA at birth; Apgar score at 5 min; duration of
mechanical ventilation (days of invasive ventilation (intubation) plus days of noninvasive
ventilation (continuous positive airway pressure)); weight gain as a standard deviation
score (SDS) using the 1990 British Growth Reference from birth until the lung func-
tion test date; and PMA, weight in SDS and length in centimetres at the lung function
test date. To reduce the risk of collinearity and Type I error, we chose the previously
mentioned clinical parameters prior to statistical analysis, guided by clinical evidence
[Lamarche-Vadel et al., 2004] and experience from our prospective healthy term cohort
from the same region [Pramana et al., 2011, Latzin et al., 2007a]. We describe sensitivity
analyses in the online supplementary material.
Clinical relevance
We investigated whether the performed lung function test improved the prediction of
respiratory symptoms compared to the standard clinical predictors or scores alone. We
carried out logistic regressions using common clinical scores (CRIB and BPD classifica-
tion), and standard predictors (maternal atopy, sex, PMA at birth, mechanical ventilation
and weight gain). We then included lung function parameters in each of the models and
compared the area under the receiver operator characteristic curve (AUC) to assess dis-
crimination and the Brier score to assess the overall predictive performance of the models.
The Brier score [Pescatore et al., 2014] is the averaged squared difference between the
predicted and observed outcomes: the lower the score, the more accurate the prediction,
so that a perfect predictor would have a score of 0, a perfect mispredictor a score of 1 and
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a predictor acting as a fence-sitter a score of 0.25. In addition, we calculated the p-values
of likelihood ratio tests (LRTs) comparing models with and without lung function data
included.
We performed the analysis using Stata version 11.2 for Windows (Stata Corporation,
College Station, TX, USA).
4.4 RESULTS
Study population
We performed lung function measurements in 236 preterm born infants between 1999 and
2010. 166 (70%) caregivers returned the follow-up questionnaires (online supplementary
fig. S1). In the analysis, we used data of 163 subjects with valid tidal measurement and
142 subjects with valid MBW according to ERS/ATS quality criteria [Robinson et al.,
2013] (tables 1 and 2, and online supplementary tables S1 and S2).
The 70 caregivers who did not complete questionnaires had infants with a more severe
perinatal course: they had lower PMA at birth (mean 27.9 versus 29.2 weeks), lower
Apgar score at 5 min (mean 7 versus 7.6), longer mechanical ventilation (mean 39 versus
25 days) and more severe BPD. There were no significant differences in weight (in SDS),
length, CRIB score, delivery mode and most lung function parameters (table S3). The
cohort differed from the total population of preterms hospitalised at the Childrens Hospital
of Bern in that the clinical conditions of the preterms without BPD are somewhat poorer
(table S4).
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Table 4.1.
Demographics, clinical, anamnestic and lung function data of the cohort infants
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Table 4.2.
Outcomes: respiratory symptoms
Data are presented as n (%) unless otherwise stated. Symptoms during the first year of
life assessed through questionnaire.
Pathophysiological association
Infant lung function was weakly associated with subsequent wheeze and inhalation ther-
apy (table 3). For example, Vt was positively associated with wheeze (adjusted OR (aOR)
1.40 (95%CI 1.04–1.90) per 5 ml increase in Vt) and respiratory rate was negatively as-
sociated with wheeze (aOR 0.69 (95%CI 0.50-0.96) per 10 breath per min increase) (figs
1 and 2). A higher tPTEF/tE ratio was negatively associated with several outcomes,
most strongly with inhalation therapy (aOR 0.56 (95%CI 0.35-0.89) per 10% increase)
and oxygen therapy (aOR 0.27 (95%CI 0.07-1.07) per 10% increase). V’E, FRC, LCI,
moment ratios and tidal flows (TEF50, TEF25 and peak flow) were not associated with
subsequent symptoms (see table 3 for results for all lung function variables except flows).
All approaches of the sensitivity analyses confirmed the main results (online supplemen-
tary table S5). For instance, the aOR per 10% increase in tPTEF/tE for inhalation
therapy was 0.65 (95%CI 0.43-0.97) in the unadjusted model, 0.56 (95%CI 0.35–0.89)
in the main model and 0.54 (95%CI 0.29-1.03) when further adjusted. Six infants re-
quired oxygen therapy at the time of lung function measurements; none was ventilated.
The sensitivity analysis adjusted for additional oxygen showed comparable results. The
stratification based on oxygen therapy (yes/no) at 36 weeks PMA (i.e. no or mild BPD
versus moderate or severe BPD) also confirmed the main results (data not shown).
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FIGURE 4.2:
Association between the lung function parameters assessed at 44 weeks of post-menstrual
age (PMA) and subsequent wheeze during infancy. The models were adjusted for ma-
ternal atopy, sex, mode of delivery, PMA at birth, Apgar score at 5 min, duration of
mechanical ventilation, weight gain as a standard deviation score (SDS) from birth until
the lung function test date, and PMA, weight as SDS and length in centimetres at the
lung function test date. Adjusted odds ratio and 95% confidence intervals for developing
subsequent wheeze are shown, per increment of the lung function parameter. tPTEF:
time to peak tidal expiratory flow; tE: expiratory time; FRC: functional residual capacity;
LCI: lung clearance index.
Clinical relevance
The prediction model including common clinical scores only (BPD severity and CRIB
score) had the lowest performance, with an AUC of 0.54 and a Brier score of 0.25. The
model with the combination of standard clinical predictors had a better performance,
with an AUC of 0.67 and a Brier score of 0.23. Adding lung function parameters to
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each of these three models did not improve the performance (table 4 and fig. 3). For
example, adding Vt, respiratory rate and tPTEF/tE to a combination of standard clinical
predictors (sex, PMA, mechanical ventilation, weight gain and maternal atopy), the AUC
increased from 0.68 to 0.71 and the Brier score improved from 0.23 to 0.22. The p-value
of the LRT was 0.12.
FIGURE 4.3:
Receiver operating characteristic curves comparing bronchopulmonary dysplasia (BPD)
classification, clinical risk index for babies (CRIB) score, clinical standard predictors alone
and with the lung function parameters (minute ventilation, respiratory rate, time to peak
tidal expiratory flow/expiratory time ratio) for prediction of subsequent wheeze during
the first year of life. Clinical predictors: sex, post-menstrual age, maternal atopy, weight
gain from birth until the time of lung function test and days of mechanical ventilation.
LFT: lung function test.
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4.5 DISCUSSION
Summary
With the present study, we demonstrate weak correlations of tidal breathing parameters
with subsequent respiratory symptoms. These findings give interesting insight into adap-
tive mechanisms in preterm infants but do not help to predict respiratory outcomes in
these children.
Pathophysiological association
From a physiological point of view, we observed an interesting breathing pattern among
the infants developing subsequent wheeze. This group has a lower respiratory rate and
a higher Vt. We hypothesise that this might be caused by adaptive mechanisms only
seen in unsedated infants. Greater dynamic dead space and airways more susceptible
to collapse may be compensated by higher Vt (lung volume recruitment), leading to
lower respiratory rates, in order to maintain constant V’E. An increase in dynamically
controlled dead space could lead to increased ventilation heterogeneity, i.e. increased
LCI, as reported previously [Latzin et al., 2009b, Hülskamp et al., 2009]. Additional
data suggest an immature hypercapnic ventilatory response in the first weeks of life with
limited change in respiratory rate but substantial increase of Vt [Putnam et al., 2005].
Whether this immature response still influences the breathing pattern at 44 weeks PMA
in premature infants remains unclear, as it has only been studied in the first few weeks of
life. Another explanation for higher Vt and lower respiratory rates could be a higher time
constant in these infants that is already present near term. This hypothesis is supported
by the work of van Putte-Katier et al. [van Putte-Katier et al., 2012], who demonstrated
an increased risk of wheeze in the first year of life in term-born infants with higher time
constant at the age of 2 months, and by a recent publication by Drysdale et al. [Drysdale
et al., 2011], who reported that prematurely born infants admitted to hospital for lower
respiratory tract infection in the first year of life had higher resistance of the respiratory
system at 36 weeks PMA. To further elucidate the mechanical changes in this group of
premature infants, future studies need to explore airway mechanics, flow limitation and
adaptive mechanisms in more detail using additional lung function techniques.
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An as yet unexplored but potentially highly relevant explanation is that preterm infants
have a ventilation perfusion mismatch and a rarefication of the acinar structure. Modelling
studies of pulmonary carbon dioxide washout have shown that a potential simplification
of acinar structure may affect carbon dioxide clearance mostly at low Vt independently of
the respiratory rate [Neufeld et al., 1992]. Thus, in order to maintain V’E and effective
carbon dioxide elimination, preterms may predominantly increase Vt and even decrease
respiratory rate.
Clinical relevance
Lung function measured at 44 weeks PMA in premature infants is weakly related to res-
piratory symptoms in the first year of life. The differences in Vt, respiratory rate and
tPTEF/tE we found at the group level (between those infants who subsequently devel-
oped wheeze or needed inhalation therapy versus those who did not) had poor predictive
value for later respiratory symptoms at the individual level. From a clinical point of view,
the lung function parameters measured near term in our study do not yet help in predict-
ing later respiratory symptoms in the first year of life.
Predicting respiratory outcome in preterms: comparison with previous liter-
ature
Multiple studies aimed to predict respiratory outcome after preterm birth using differ-
ent clinical factors, such as chorioamnionitis or BPD. Even prematurity without BPD
is associated with a higher prevalence of respiratory symptoms in preschool children
and schoolchildren [Vrijlandt et al., 2013, Narang et al., 2008, Lamarche-Vadel et al.,
2004, Palta et al., 2001, Vrijlandt et al., 2007]. Additionally, preterms can exhibit im-
paired lung function from preschool age to adulthood [Baraldi et al., 1997, Doyle et al.,
2006]. In contrast to our study, these studies used lung function as an outcome but not
as a predictor.
Other studies included term-born infants and assessed whether infant lung function pre-
dicts short-term outcomes [Greenough et al., 1998, van Putte-Katier et al., 2012, Kav-
vadia et al., 2000]. Greenough et al. [Greenough et al., 1998] investigated whether lung
function testing in term-born infants shortly after birth was predictive of respiratory out-
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come in the first year of life. They found that higher airway resistance and higher FRC
after birth related to symptoms in the first year of life, but the positive predictive value
was weak. Drysdale et al. [Drysdale et al., 2011] studied whether preterm infants devel-
oping viral lower respiratory tract infection in the first year of life had poorer lung function
at 36 weeks PMA than infants without infection. They found no difference in respiratory
system resistance, compliance or FRC, except in children who were hospitalised, whose
resistance was significantly higher. It is important to note that measurements of lung
function at 36 weeks PMA are technically demanding, show high variability and represent
different aspects of lung mechanics to measurements performed in later phases of lung
development after term. In contrast to our study, Drysdale et al. [Drysdale et al., 2011]
used a combined outcome of cough, wheeze and/or shortness of breath, and they used
different lung function techniques, which makes comparison with our data difficult. Con-
sistent with our data, van Putte-Katier et al. [van Putte-Katier et al., 2012] showed in
termborn infants that a higher respiratory system compliance before the age of 2 months
was associated with a decreased risk of cough and wheeze during the first year of life,
whereas higher resistance and time constant were associated with an increased risk of
cough and wheeze. Kavvadia et al. [Kavvadia et al., 2000] investigated the predictive
value of very early (day 2 of life) lung function measurements and found that FRC <19
ml/kg-1 body weight was independently predictive of oxygen dependency beyond day 28
or 36 weeks PMA in very preterm infants. In summary, there is little evidence to support
regular clinical use of current lung function techniques to estimate respiratory disease
outcomes in premature infants.
Strengths and limitations
We investigated the clinical value of early lung function measurements to predict res-
piratory morbidity during the first year of life in preterm infants. To our knowledge,
together with the study by Drysdale et al. [Drysdale et al., 2011], this is the only large
study in preterm infants. Ideal for prediction would be a lung function parameter with
low variability, such as maximal flow at FRC; however, these techniques are more in-
vasive as they require sedation for squeeze manoeuvres and are less applicable in sick
infants, as a bedside application or for widespread clinical use. We used a noninvasive
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technique not interfering with potential physiological adaptations of underlying structural
and/or functional alterations, being aware of the potentially larger intersubject variability.
At 44 weeks PMA, high-quality, standardised lung function measurements are easier to
perform, compared with measurements at 36 weeks PMA [Fuchs et al., 2011a]. Never-
theless, normal physiological variability is still rather high, making infant lung function in
an individual difficult to interpret.
Retrospective questionnaires always carry the risk of reporting bias. The dropout rate of
30% in the first year of life is comparable to that reported in other studies [Vrijlandt et al.,
2013]. However, it entails the risk of selection bias. In fact, the final cohort contained
fewer subjects with severe BPD. As the aim of this study was to investigate an association
between lung function and symptoms, and not to obtain precise estimates of prevalence
or incidence of symptoms, this should not have greatly affected our findings. This is
further supported by the fact that results in the subgroup of children with more severe
BPD were comparable to those from the whole group. Moreover, the preterms with BPD
had a comparable clinical condition to those in the whole population of preterms. We
did not include more specific lung function measures that would require tidal phase III
slope analyses (e.g. double-tracer gas phase III slope, and ventilation inhomogeneity of
conducting and acinar airways).
Conclusion
Alterations in tidal breathing pattern measured at 44 weeks were associated with res-
piratory outcomes in the first year of life in premature infants. For instance, higher Vt
and lower respiratory rate were associated with wheeze later in life. This combination
potentially reflects an adaptive change in breathing pattern due to underlying structural
pathology. However, the clinical value of postnatal lung function testing for the pre-
diction of respiratory morbidity is limited for the individual child: lung function data
(tidal breathing and MBW measurement) did not improve prediction of morbidity over
and above standard clinical parameters, which are easier to assess. This could partly be
due to the high variability of parameters measured during natural sleep. Whether this is
different for more invasive lung function tests, such as raised volume rapid thoracic com-
pression, needs to be examined; however, their invasive nature and the need for sedation
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preclude clinical application in routine settings.
In summary, we do not recommend routine tidal lung function testing as a clinical tool
to predict subsequent symptoms in the first year of life, but we strongly recommend its
use in future studies as an important means for understanding respiratory pathophysiology.
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4.6 Can infant lung function predict respiratory morbidity during
the 1rst year of life in preterm infants?
SUPPLEMENTAL ONLINE FIGURE
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5.1 SUMMARY
Prematurity is the most common disruptor of lung development. The aim of our study
was to examine the function of the more vulnerable peripheral airways in former preterm
children by multiple-breath washout (MBW) measurements. Eighty-six school-aged chil-
dren, born between 24 and 35 weeks of gestation and 49 term-born children performed
nitrogen MBW. Lung clearance index (LCI), and slope III derived Scond and Sacin were
assessed as markers for global, convection-dependent and diffusion-convection dependent
ventilation inhomogeneity, respectively. We analyzed data of 77 former preterm (mean
age 9.5 years; range 7.2 – 12.8) and 46 term-born children (mean age 9.9 years; range
6.0 - 15.9). LCI and Sacin did not differ between preterm and term-born children. Scond
was significantly elevated in preterm compared to term-born participants (mean differ-
ence 1.74 z-scores, 95%CI 1.17 - 2.30, p <0.001), with 54% of former preterm children
showing elevated Scond. In multivariable regression analysis Scond was significantly re-
lated only to gestational age (R2 0.37). Normal Sacin provides evidence for functionally
normal alveolar compartment, while elevated Scond indicates impaired function of more
proximal conducting airways. Together, our findings support the concept of continued
alveolarization albeit with dysanaptic lung growth in former preterm children.
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5.2 INTRODUCTION
On a global scale, the proportion of preterm births has steadily increased over the last
decades [Blencowe et al., 2012]. Despite remarkable advances in neonatal and perinatal
care [Field et al., 2008], the incidence of bronchopulmonary dysplasia (BPD) remains
high affecting up to 40% of the extremely premature infants who survive [Stoll et al.,
2010, Jobe, 2012]. Since its first description almost fifty years ago [Northway et al.,
1967] advances in the management of respiratory distress syndrome (prenatal steroids,
administration of surfactant, minimising of oxygen toxicity and barotrauma) have led
to changes in the underlying pathological features of BPD. Thus, the contemporary
form of the disease is characterized by impaired alveolar and vascular development which
results in abnormal septation, fewer and larger alveoli, and smaller vascular bed, but with
only minimal peribronchial fibrosis and airway-muscle hypertrophy [Baraldi and Filippone,
2007, Jobe and Bancalari, 2001, Berkelhamer et al., 2013]. Despite the apparently less
severe lung pathology in infants born extremely premature in the post-surfactant era, long-
term respiratory impairment still exists. Several studies have shown evidence of airway
obstruction [Fawke et al., 2010, Lum et al., 2011, Hacking et al., 2013, Kaplan et al.,
2012, Joshi et al., 2013] and air trapping [Lum et al., 2011, Kaplan et al., 2012, Joshi
et al., 2013] at school age in such populations. However, only few studies have specifically
examined ventilation inhomogeneity (VI) as biomarker of peripheral lung function, and
this with inconclusive results. Two studies in preterm infants showed contradictory results,
one with elevated VI [Hülskamp et al., 2009] and the other with no sign for VI [Latzin
et al., 2009b]. At school age only one study examined VI in former preterm children
showing mildly elevated VI in 58% of them [Lum et al., 2011]. Currently, BPD affects
mainly premature infants born during the early saccular period of lung development.
Thus, because the subsequent alveolar period of lung development is disrupted [Weibel,
2013, Burri, 2006], long-term adverse effects on lung function are not unexpected. The
aim of our study was therefore, to examine the function of the most vulnerable peripheral
lung regions in former preterm children at school age using multiple-breath washout
(MBW) measurements - a well-established technique for the assessment of small airway
function [Verbanck et al., 2003, Horsley et al., 2008b, Thompson et al., 2014, Stanojevic
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et al., 2015]. In addition to the lung clearance index (LCI) and moment ratios which were
used as measures of global VI, we particularly focused on specific parameters of regional
VI, namely Sacin for the alveolar lung regions and Scond for the conducting airways. We
hypothesized that due to the premature disruption of normal lung development, former
preterm children may present an abnormal ventilation distribution particularly in alveolar
lung regions.
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5.3 METHODS
Study Population
Between February 2012 and June 2014, we prospectively recruited former preterm and
term-born children aged 6 to 16 years at the University Childrens Hospital of Bern.
Preterm-born participants (<37 weeks of gestation) were recruited from a previously
described study [Pramana et al., 2011] and the outpatient clinics. Preterm children
with congenital bronchopulmonary malformations, or thoracic-abdominal surgery were
excluded. According to their gestational age, preterm children were classified into ex-
tremely low gestational age neonates (ELGAN) <28 weeks of gestation) or no-ELGAN
(≥28 weeks of gestation). Term-born controls with birth weight appropriate for gesta-
tional age (i.e. >2500 g in all cases) were recruited from local schools and playgroups.
Term-born children with asthma, or other chronic respiratory diseases were excluded.
Exclusion criteria for both preterm and term-born participants were respiratory infections
within the last 3 weeks. The study was approved by the Ethics Committee of the Canton
Bern, Switzerland. The children’s assent was obtained and parents or caregivers provided
written informed consent.
Assessment of respiratory symptoms and atopic sensitization in former preterm
participants
In preterm children symptoms related to asthma and allergy were assessed by an adapted
International Study on Asthma and Allergies in Childhood (ISAAC) questionnaire filled
out by the parents [Asher et al., 1995]. For later subgroup analysis, we focused on four bi-
nary outcomes (yes/no): Wheeze over the past 12 months, cough without cold, shortness
of breath due to cough or asthma, and doctor diagnosed asthma. Current asthma was
defined as wheeze or use of asthma medication in the past 12 months or doctor-diagnosed
asthma. Atopic sensitization was assessed by positive skin prick testing on at least one
common inhalant allergen (mixed trees, mixed grasses, cat, dog, house dust mite and
Aspergillus fumigatus). We further measured the fraction of exhaled nitric (FeNO) oxide
by the single-breath method using a commercially available analyser (CLD 77 AM; Eco
Medics AG). After inhaling NO-free air to TLC, children were exhaling against an expira-
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tory resistance with a constant flow of 50ml*s−1 for at least 6 seconds. To prove validity
of our findings irrespective of other possible changes in lung development, we performed
sensitivity analysis comparing three subgroups of preterm children to term-born controls:
(i) Absence of respiratory symptoms (absent if all four above mentioned survey questions
were negative), (ii) no current asthma, and (iii) absence of atopic sensitization (negative
prick testing and FeNO <20 ppb; [Dweik et al., 2011]).
Nitrogen multiple-breath washout
All children performed nitrogen MBW (N2MBW) according to current consensus [Robin-
son et al., 2013] using a described setup [Singer et al., 2012a, Singer et al., 2013]
(Exhalyzer D, Eco Medics AG, Duernten, Switzerland). The application of 100% O2
washes out the lung resident N2. The N2 signal is measured indirectly from O2, CO2
and the estimated Argon fraction. Children performed N2MBW while sitting upright,
wearing a nose clip and tidally breathing through a snorkel mouth piece. At least two
successful N2MBW runs were obtained. N2MBW runs were accepted if functional resid-
ual capacity (FRC) varied <10% for 2 and <25% for 3 trials [Robinson et al., 2013].
Measurements with leaks were excluded. All data were recorded and analyzed using
Spiroware 3.1.6 (Eco Medics AG). Outcomes were calculated as currently recommended
[Robinson et al., 2013], LCI from cumulative expired volume divided by FRC, resulting in
lung turn over units. We used LCI and moment ratios (M1/M0, M2/M0) as a measure
of global VI. As specific markers for peripheral lung ventilation we analyzed slopes of
alveolar phase III (SIII) of the N2 expirogram. The first SIII value is thought to reflect
VI within diffusion-convection-dependent acinar airways (Sacin), while the subsequent
evolution of SIII values from lung turn over 1.5 to 6.0 is thought to reflect VI within
convection-dependent conducting airways (Scond) [Robinson et al., 2013]. Scond was
calculated according to a validated automated algorithm with SIII determination between
65 to 95% of expired volume and exclusion of breaths deviating >25% from median tidal
volume with additional visual control of breath quality [Bigler et al., 2015]. Breaths
without a clear linear phase III portion of the expirogram, or irregular expiration and os-
cillation were excluded. SIII values were normalised for mean gas concentration over their
calculation interval and corrected for tidal volume [Aurora et al., 2005b]. If insufficient
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SIII values were left, i.e. if more than 33% of all SIII values were de-selected, Scond was
excluded [Robinson et al., 2013]. We additionally assessed minute ventilation, and airway
dead space (VD) using the Fowler’s method on the CO2 expirogram of washout breaths
[Fowler, 1948].
Spirometry
Spirometry was performed only in former preterm children after washout measurements
using the MasterLab setup (Jaeger, Wurzburg, Germany) and according to standard
guidelines [Miller et al., 2005]. Forced expiratory volume in 1 second (FEV1) and forced
expiratory flow between 25-75% of maximal expired volume (FEF25−75) were expressed
as z-scores [Stanojevic et al., 2009]. Spirometry was considered to be normal if both
FEV1 and FEF25−75 were >-1.64 z-scores [Quanjer et al., 2012].
Data analyses
Sample size calculation was based on a baseline mean Scond of 0.01 (SD ±0.01) from
20 healthy school-aged children measured with the same setup [Bigler et al., 2015]. A
sample size of 22 children in each group would provide 90% power to detect differences
in washout parameter of one population SD between index and healthy control group, at
a two sided 5% significance level. Continuous variables were compared with Student’s t
test after verification for normal distribution. Categorical variables were compared with
chi-square test. Upper limit of normal (ULN) for lung function parameters was defined as
mean + 1.64*SD [Quanjer et al., 2012] of a healthy reference population for spirometry
[Stanojevic et al., 2009] and from our term-born controls for washout parameters. We
assessed the relationships between washout parameters and perinatal factors and other
lung function parameters in univariable and multivariable regression analysis. The mul-
tivariable model was adjusted for body length, sex and gestational age. All analyses
were done using StataTM (Stata Statistical Software: Release 11. College Station, TX:
StataCorp LP).
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5.4 RESULTS
Study population
A total of 86 former preterm and 49 term-born children were enrolled. At least 2 valid
N2MBW measurements were obtained in 77 (90%) preterm and 46 (94%) term-born
participants. Reasons for exclusion were leaks, irregular breathing pattern and FRC vari-
ability exceeding 10% for 2 valid trials or 25% for 3 valid trials, respectively. The mean
age of the 77 (42 boys) former preterm was 9.5 years (range 7.2 – 12.8) and of the 46
(21 boys) term-born children 9.9 years (range 6.0 – 15.9). Excluded children did not
differ from those included in terms of age, sex, weight, length or gestational age (data
not shown). Preterm and term-born children showed similar characteristics at inclusion
(table 1). Preterm participants had a mean gestational age of 28.7 weeks (range 23.9
– 34.7), and mean birth weight of 1139 g (range 420 – 2980). 75% of them developed
BPD, and 21% fulfilled the criteria for current asthma at school age. The characteristics
of the preterm participants in relation to their gestational age (ELGAN no-ELGAN) are
presented in table 2.
Table 5.1.
Population characteristics at inclusion
Data are mean ± SD.
*Student’s t test or chi-square test, as appropriate.
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Table 5.2.
Characteristics of former preterm children,
according to extremely low gestational age
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Data are given as mean ± SD or median [interquartile range].
∗: Student’s t test, non-parametric Wilcoxon ranksum test (#), or chi-square test as
appropriate comparing extremely low gestational age neonates (ELGAN, <28 weeks of
gestation) to neonates ≥ 28 weeks of gestation (no-ELGAN).
ELBW: Extremely low birth weight (<1.0 kg), Respiratory support: Days of invasive and
non-invasive ventilation, BPD: Bronchopulmonary dysplasia, Positive skin prick testing:
Positive on at least one of the tested common inhalant allergens. Missing data in the EL-
GAN subgroup for prick test (n = 1) and for chorioamnionitis (n = 1), in the no-ELGAN
subgroup for chorioamnionitis (n = 1).
Nitrogen multiple-breath washout
Fourteen preterm and 8 term-born children were additionally excluded from Scond analy-
sis, and 7 preterm and 9 term-born from Sacin analysis due to insufficient SIII values left
after breath quality control as per current consensus [Robinson et al., 2013]. Excluded
children for invalid Scond and Sacin did not differ from those included in terms of age,
sex, weight, length or gestational age (data not shown). LCI and M2/M0 showed no
significant difference between preterm and term-born children (table 3, figure 1). The
moment ratio M1/M0 was significantly higher in preterm children (mean difference 0.49
z-scores, 95%CI 0.05 - 0.92, p = 0.028) (table 3), with 11 (14%) out of 77 preterm
children showing M1/M0 values above the ULN. While Sacin did not differ between
preterm and term-born participants (figure 2), Scond was significantly higher in former
preterm compared to term-born children (mean difference 1.74 z-scores, 95%CI 1.17 -
2.30, p <0.001) (figure 3). Thirty-four out of 63 (54%) preterm children had Scond
values >ULN. Scond remained significantly elevated (p <0.001) in subgroups of preterm
children without (i) respiratory symptoms, (ii) current asthma, (iii) atopic sensitization,
or without any of those three criteria (data not shown). Also in preterm with normal
spirometry, Scond was significantly elevated. Results remained similar for raw Scond and
Sacin values without tidal volume correction (data not shown). Within preterm children,
Scond showed no significant difference between ELGAN and no-ELGAN (table 3), while
it was slightly elevated in preterm children with BPD compared to preterm without BPD
(mean difference 0.008, 95%CI 0.001 - 0.015, p = 0.026). However after adjustment
for gestational age, the difference between BPD and no-BPD disappeared. FRC, minute
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ventilation and VD, all corrected for body weight, showed neither a difference between
preterm and term-born children, nor between ELGAN and no-ELGAN (table 3).
Spirometry
We found some evidence for airway obstruction: FEV1 was mean -0.60 z-score (SD
±1.11) in former preterm children (table 3), thereof 18% (14/77) had decreased values
(<-1.64 z-score) [Stanojevic et al., 2009]. FEF25−75 was mean -0.97 z-score (SD ±1.20)
(table 3), thereof 30% (23/77) with decreased values. There was no significant difference
in FEV1 and FEF25−75 between ELGAN and no-ELGAN (table 3), nor between preterm
with and without BPD.
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Figure 5.1.
Lung clearance index in former preterm and term-born children.
Lung clearance index (LCI) of nitrogen multiple-breath washout measurement in 46 term-
born children, in 39 preterm children born ≥ 28 weeks of gestation and in 38 born <28
weeks of gestation. Black circles represent preterm children with bronchopulmonary
dysplasia (BPD), grey circles without BPD. The dashed line represents the upper limit
of normal (ULN). Of the 5 preterm children with LCI >ULN, 4 had current asthma,
respiratory symptoms, and/or abnormal spirometry.
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Figure 5.2.
Sacin in former preterm and term-born children.
Sacin of nitrogen multiple-breath washout measurement in 37 term-born children, in 34
preterm children born ≥ 28 weeks of gestation and in 36 born <28 weeks of gestation.
Black circles represent preterm children with bronchopulmonary dysplasia (BPD), grey
circles without BPD. The dashed line represents the upper limit of normal.
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Figure 5.3.
Scond in former preterm and term-born children.
Scond of nitrogen multiple-breath washout measurement in 38 term-born children, in 32
preterm children born ≥ 28 weeks of gestation and in 31 born <28 weeks of gestation
with mean Scond values per group. Black circles represent preterm children with bron-
chopulmonary dysplasia (BPD), grey circles without BPD. The dashed line represents the
upper limit of normal.
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Factors associated with elevated Scond
Regression analysis in the whole study population showed that from all significantly asso-
ciated perinatal factors with Scond in the univariable model (gestational age, BPD, days
of supplementary O2, respiratory support, intubation, surfactant, antenatal steroids) only
gestational age remained significantly associated in the multivariable model after adjust-
ment for gestational age, body length and sex (r2 37%) (table 4). When stratifying for
ELGAN within preterm children, the relationship between Scond and gestational age re-
mained significant within the ELGAN group (-0.004, 95%CI -0.008 - -0.001, p = 0.010),
while it was not significant in the no-ELGAN group. For Sacin and spirometry (FEV1
and FEF25−75) no perinatal factor was significantly associated (data not shown). Includ-
ing lung function parameters as exposure variables (Sacin, LCI, VD/kg, FRC/kg, minute
ventilation/kg, FEV1, FEF25−75), only minute ventilation per body weight showed a sig-
nificant positive association with elevated Scond in the uni- and multivariable model (data
not shown).
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5.5 DISCUSSION
This study is the first to specifically examine lung function of peripheral airways in former
preterm children at school age using the MBW technique. Lung clearance index reflecting
global VI did not differ between term-born and former preterm participants, including
ELGAN and those with BPD. In contrast to our hypothesis, we found no evidence of
diffusion dependent VI at the acinar level, reflected by similar Sacin values between our
study groups. However, Scond was elevated in more than half of preterm participants,
indicating VI in the more proximal convection-dependent airways. Gestational age was
the strongest predictor of Scond in our cohort, independent of other confounders, but in a
rather weak association These findings provide evidence for functionally normal alveolar
compartment in former preterm children at school age, albeit with disturbed airway
function at a more proximal level, in the small convection-dependent airways.
Previous reports on lung function of former preterm children have provided evidence of
airway obstruction [Fawke et al., 2010, Lum et al., 2011, Hacking et al., 2013, Kaplan
et al., 2012, Joshi et al., 2013], air trapping [Lum et al., 2011, Kaplan et al., 2012, Joshi
et al., 2013], and reduced diffusing capacity for carbon monoxide [Lum et al., 2011,
Kaplan et al., 2012, Joshi et al., 2013]. However, only one study has assessed global
ventilation distribution in school-aged children born extremely preterm [Lum et al., 2011].
Although the investigators reported that 58% of those children had mildly elevated LCI,
spirometry performed better in discriminating prematurity or BPD. More specific markers
of peripheral VI, such as Sacin and Scond were not assessed. In contrast to Lum et al.
[Lum et al., 2011], we found no relevant difference in LCI between former preterm and
term-born children, while only 6% of our prematurely-born participants had elevated LCI.
This difference may be attributed to the inclusion of children born solely <26 weeks of
gestation in their study with a high asthma prevalence of 55% [Lum et al., 2011].
As specific regional ventilation parameters, Scond and Sacin have shown to reflect dif-
ferent disease-characteristic pathogenetic mechanisms, such as in cystic fibrosis [Horsley
et al., 2008b], asthma [Verbanck et al., 2003], and bronchiolitis obliterans [Thompson
et al., 2014]. Our results showed a distinguished pattern of regional VI in former preterm
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children: We found normal Sacin values indicating normal ventilation distribution at the
acinar level. Thus, our study provides evidence for a functionally normal alveolar compart-
ment in former preterm children. On the other hand, Scond was consistently elevated in
more than half of preterm participants without asthma symptoms or other lung function
abnormalities, indicating impaired ventilation distribution in the more proximal conduct-
ing airways. Multivariable regression analysis confirmed the association between Scond
and prematurity, showing that gestational age could explain 37% of the variability in
Scond independent of other confounders. Lack of association in the multivariable model
between other perinatal factors such as BPD, days of supplementary O2 and intubation
with Scond or spirometry after adjusting for gestational age underlines the pathophys-
iology of new BPD [Proietti et al., 2014]: functional changes are not primarily caused
by the therapy (barotrauma, O2 toxicity) but rather by prematurity per se. However it
remains difficult to disentangle the exact influence of the different interrelating factors,
mostly because gestational age and BPD showed strongly collinear effects within our
observational study. There was no clear difference for Scond between ELGAN and no-
ELGAN within preterm children. Further the association between Scond and gestational
age in weeks was strongest within the ELGAN group. Thus, the pathophysiology of the
premature lung is complex with many factors contributing and interacting. Whether the
association of minute ventilation with Scond indicates an adaptive mechanism upon in-
creased Scond, or a primary regulatory response cannot be answered by our data [Latzin
et al., 2009b]. The mechanism for this pattern of ventilation inhomogeneity, could be
explained by the fact that these children were born during the late canalicular – early
saccular period of lung development, when the peripheral conducting airways are already
developed and, thus vulnerable while the alveolar regions develop later and continue to
grow after birth [Herring et al., 2014]. Thus, our findings indicate a mismatch in the
growth of peripheral conducting airways and lung parenchyma in children born preterm,
supporting the concept of a dysanaptic lung growth [Green et al., 1974, Merkus et al.,
1993], related to prematurity. Overall there was no evidence for increased global VI in
preterm children. While LCI and M2/M0 showed no difference between preterm and
term-born children, M1/M0 was elevated in 11 children. Since the weight given to the
latter part of the washout increases from M1/M0 to M2/M0 one could postulate a more
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proximal involvement of peripheral airways.
Recent advances in imaging techniques [Narayanan et al., 2012] and stereological counting
methods [Herring et al., 2014] have provided new evidence for continued alveolarization
beyond infancy up to young adulthood in the healthy lung. Of particular interest, a recent
study using helium magnetic resonance showed evidence of continued alveolarization
at school age both in healthy adolescent [Narayanan et al., 2012] and former preterm
children [Narayanan et al., 2013], half of the latter were diagnosed with BPD. Given that
the main pathophysiological feature of the new BPD was described as arrest of alveolar
development [Baraldi and Filippone, 2007], these findings suggest that the time-window in
which alveolarization and potential lung repair occur may be much wider than previously
thought. It is unclear whether the morphological term of continued alveolarization can be
used in an equivalent and sensible way to describe lung function. Nevertheless, our study
provides evidence for a functionally intact continued alveolarization in former preterm,
and is thus in line with the structural findings. However our cross-sectional data cannot
answer the question of the exact underlying mechanism or structural correlate of this
complex process.
The main limitation of our study is the model based interpretation of Sacin and Scond
and thus the lack of proof for its association with specific lung morphology. There-
fore, the interpretation of our results strongly depends on the assumption that Scond
and Sacin are a valid proxy for the regional ventilation distribution in convection- and
diffusion-convection-dependent lung zones, respectively [Verbanck et al., 2003, Horsley
et al., 2008a, Thompson et al., 2014]. A further limitation is the lack of spirometry in
term-born controls and thus the limited comparison to reference values only [Stanojevic
et al., 2009]. The lack of precise birth weight records in term-born controls hampered
adjustment for birth weight in the regression models. However in analysis limited to
preterm children, birth weight showed no significant association to Scond. Concerning
the group of preterms we mainly included very preterm born children. This might repre-
sent a selection bias towards children with higher frequency of respiratory sequelae. Age
distribution in term-born and preterm children was not equal with a greater proportion of
older children among the term-born. However, average age was similar and since results
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remained stable after adjustment for age, the influence seems negligible. Finally, although
present the effect size of gestational age on Scond was relatively weak. The rather small
sample size of the subgroups of our study has to be kept in mind when interpreting the
associations between perinatal factors and convection-dependent VI. Some of the ex-
tremely preterm born participants also had normal Scond values despite low gestational
age. Presumably, there are additional factors (e.g., genetic, epigenetic, environmental
exposures, etc.) that may influence the susceptibility of the immature lung and determine
the long-term outcome of pulmonary injury.
In conclusion, our study provides first evidence for functionally normal alveolar compart-
ment in former preterm children at school age, but impaired ventilation inhomogeneity of
conducting airways a pattern supporting a prematurity-related dysanaptic lung growth.
Future studies need to elaborate the exact relationship between peripheral lung func-
tion and the underlying structural deficit, and thus help to advance prophylactic and
therapeutic strategies in prematurely-born infants.
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Scientific knowledge on the subject
Premature birth disturbs early lung growth, and phenotypes of respiratory diseases in
preterm children and adults are likely to differ from those in term-born individuals. Dur-
ing childhood, tracking of lung function parameters was shown for larger airways, and
several studies have suggested potential for catch-up growth after prematurity, but lon-
gitudinal data on lung volumes is lacking.
What this study adds to the field
From infancy to early childhood, we observed very weak tracking of functional residual ca-
pacity in preterm children. Maturity at birth was negatively associated with lung volume
increase, which might be explained by catch-up growth of lung parenchyma in children
born with immature lungs. In comparison to term-born children, lung volume relative to
body length and trapped gas were higher in preterm children at follow-up, which leads
us to conclude that compensatory lung growth after prematurity might exceed normal
growth.
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6.1 ABSTRACT
Rationale & objectives
Prematurity disturbs alveolar growth, but data on lung volumes is sparse. We aimed
to assess functional residual capacity (FRC) and potential influencing factors in preterm
children from early infancy onwards.
Methods & measurements
FRC was measured in preterm children without sedation in infancy (visit 1) by multiple-
breath washout (MBW, FRCMBW V 1) using 4% sulphur hexafluoride, and at school age
(visit 2) by nitrogen MBW (FRCMBW V 2) and plethysmography (FRCpleth). We evalu-
ated the association of absolute FRC values at visits 1 and 2, and determinants of lung
growth, i.e. increase in standard deviation score (SDS), by linear regression analysis.
Main results
We analysed longitudinal FRC measurements in 80 children (32 females), mean (SD)
gestational age at birth and at visit 1 were 29 (3.0) and 45 (2.2) wks., mean (SD) age at
visit 2 was 8.7 (1.3) yrs. After adjustment for height and age at visit 2, and for immaturity
of the lungs, we found a very weak association between FRCMBW V 1 and FRCMBW V 2
(beta = 2.6 ml per ml, 95% CI 0.02 to 5.22, R2 55.7%), with the highest proportion of
variance explained by the variables for which we had adjusted. Younger gestational age
at birth predicted increase in SDS of FRCpleth (beta = -0.18 after adjustment, 95%CI
-0.27 to -0.08, p <0.001). Compared to term-born children, preterm children showed
higher SDS for FRCpleth, and more trapped gas at school age.
Conclusions
We observed pulmonary catch-up growth after prematurity in this population, with some
evidence pointing to excessive lung volume increase.
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6.2 INTRODUCTION
A better understanding of early lung development after preterm birth would allow for
the improvement of clinical strategies for both preterm [Islam et al., 2015] and term-
born children [Frey et al., 2006]. In preterm children, respiratory diseases beyond the
postnatal period, e.g. wheezing disorders in childhood [Greenough, 2013], or chronic
obstructive lung disease in adulthood (COPD) [Bush, 2008] are more likely to occur, and
disease phenotypes might differ from those in term-born children [Martin and Fanaroff,
2013]. It is well known that prematurity interrupts the growth of airways, alveoli, and
pulmonary vessels [Stocks et al., 2013], and sequelae later in life can occur even in chil-
dren without postnatal respiratory problems [Hoo et al., 2002b]. For clinicians, specific
strategies were recommended [Bolton et al., 2015]. Bronchopulmonary dysplasia (BPD)
in preterm new-borns, initially described by Northway et al. in 1967 [Northway et al.,
1967], is one of the immediate consequences. It was originally characterized by injury of
mucosal, alveolar and vascular tissues, and progressive disease stages with prominence
of fibroproliferation. Today, the improvement of perinatal management, e.g. antena-
tal steroids, more gentle ventilation, and artificial surfactant, has changed the clinical
picture of BPD. The so-called new BPD is characterized by fewer and larger alveoli,
and defined as needing oxygen supplementation at the postnatal age of 28 days, or the
corrected age of 36 weeks of gestation [Jobe and Bancalari, 2001]. BPD is inversely
associated with gestational age [Costeloe et al., 2012], and different categories of disease
severity have been described [Ehrenkranz et al., 2005]. While there is fairly significant
evidence in the literature on the impact of prematurity on the functional growth of the
airways, literature on the functional growth of the lung volume is lacking. We recently
demonstrated a weak tracking of lung volume from infancy to early school age in healthy
children [Schmidt et al., 2015a]. In former preterm infants, longitudinal studies regarding
airway function showed an association of expiratory flow in infancy and later childhood
in individuals after premature birth [Hoo et al., 2002b, Baraldi and Filippone, 2007] with
potential for catch-up growth [Narang et al., 2008]. Airways and lung parenchyma can
grow disproportionately [Green et al., 1974, Martin et al., 1988]. We hypothesized that
lung volume growth in early childhood may exhibit different characteristics compared to
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growth of larger airways. The aim of this study was to longitudinally measure lung vol-
ume growth from infancy to school age after prematurity, as previously described [Roiha
et al., 2007, Latzin et al., 2009b, Pramana et al., 2011, Proietti et al., 2014]. Taking
into account known concomitant factors derived from our previous study in term-born
children [Schmidt et al., 2015a], we aimed to determine whether there is lung volume
tracking and / or functional catch-up growth in preterm children.
6.3 METHODS
Study design and subjects
For this longitudinal observational study, children born <37 weeks of gestation were re-
cruited during postnatal hospitalization, as previously described [Latzin et al., 2009b, Pra-
mana et al., 2011, Proietti et al., 2014]. We measured lung volume, i.e. functional
residual capacity (FRC), and ventilation inhomogeneity, i.e. lung clearance index (LCI),
repeatedly in 107 children using validated multiple-breath washout (MBW) equipment
[Schmidt et al., 2015b, Singer et al., 2012a] and plethysmography [Criée et al., 2011]
(see online supplement, OLS). A study in 124 term-born children provided data for com-
parison [Schmidt et al., 2015a, Fuchs et al., 2012a] (see OLS).
The study was approved by the ethics committee of the Canton of Bern, Switzerland.
Informed consent was provided by parents or caregivers. At the second visit, the childs
assent was obtained in addition.
Lung function measurements, exposures and health
At the corrected age of 1 month (visit 1), we measured infant lung function without
sedation in supine position. We performed tidal breathing tests, and MBW, using a com-
mercially available device (Exhalyzer D, Eco Medics AG, Duernten, Switzerland), and 4%
sulphur hexafluoride (SF6) [Latzin et al., 2007b]. Maximum SF6 concentration was de-
termined by end-inspiratory molar mass using an improved algorithm [Anagnostopoulou
et al., 2015].
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At early school age (visit 2), lung function was measured with the awake child sitting
upright by nitrogen MBW [Singer et al., 2012a] using the Exhalyzer D, and by spirom-
etry and plethysmography [Criée et al., 2011] using the JAEGER Master-Screen Body
(CareFusion, Wuerzburg, Germany).
FRC was measured in triplicates. The mean of high quality FRC measurements was
calculated per technique and visit, according to standards; ventilation inhomogeneity
was evaluated using the lung clearance index (LCI) [Frey et al., 2000a, Robinson et al.,
2013, Wanger et al., 2005]. See OLS for further details .
For definitions of exposures and health status see OLS.
Statistical Methods
Primary outcome was FRC measured by MBW at visit 2 (FRCMBW V 2). We tested the
association of FRC measured by MBW at visit 1 (FRCMBW v1) with FRCMBW V 2. Sec-
ondary outcome, allowing comparison with a term-born population, was FRC measured by
plethysmography at visit 2 (FRCpleth). For a calculation of relative lung volume increase,
gender-specific standard deviation scores (SDS) were generated. Published reference data
was available for anthropometric data [World Health Organization, 2006], plethysmogra-
phy [Rosenthal et al., 1993], and spirometry [Quanjer et al., 2012]. For lung function in
infancy, SDS were generated using reference data from our pediatric lung function labo-
ratory [Singer et al., 2012a, Fuchs et al., 2012a]. Relative FRC increase was calculated
as the difference between SDS at visit 2 and SDS at visit 1 (ΔSDS).
Hyperinflation at visit 2 was evaluated as (i) trapped gas, calculated as the difference
between FRCpleth and FRCMBW V 2, and (ii) residual volume per total lung capacity
(RVpTLC).
We tested for dysanapsis by searching for an association of SDS of FRC with expiratory
flow.
Associations of variables with the outcome of interest were tested using Pearson corre-
lation coefficient and / or linear regression analysis. After performance of univariable
regression, variables with a p-value <0.10 were sorted by physiological plausibility, and
variance explained (R2), and included stepwise in the multivariable model, accounting for
potential co-linearity and non-linear associations.
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We performed comparisons using paired or unpaired T-tests, or Chi-square tests, as ap-
propriate; a p-value <0.05 was considered significant.
The sample size in the current study is higher than in a longitudinal study on airway
function (n=18) [Filippone et al., 2003], but lower than in a study on lung volumes in
term-born children (n=124) [Schmidt et al., 2015a]. For tracking analysis, statistical
power was 86% to detect a correlation coefficient of 0.35 with a significance level of 0.05
(two-sided).
All analyses were performed in R 3.2.1 (http://www.r-project.org/), and STATA 11
(STATA Corporation, Texas, USA). See OLS for more details.
6.4 RESULTS
Subjects
We recruited 263 preterm children between 1999 and 2010, and performed lung function
measurements successfully in 236 children at visit 1 in early infancy. FRC data fulfilling
high quality criteria was available in 142 children at visit 1, and 211 families filled in
questionnaires regarding exposures and respiratory symptoms during the first year of life.
Until December 2014, 107 children attended visit 2 at early school age. Eighty (75%)
of them performed FRC measurements at both visits successfully, and were included in
this study (see figure 6.1). Their characteristics are shown in table 6.1, together with
characteristics of the healthy control group.
149




Early lung development 6 EXCESSIVE LUNG GROWTH AFTER PREMATURITY
151
Early lung development 6 EXCESSIVE LUNG GROWTH AFTER PREMATURITY
Figure 6.1
Participants
Children born <37 weeks of gestation were recruited between 1999 and 2010. Among
263 participants, 236 performed lung function measurements successfully at visit 1. High
quality measurements of functional residual capacity (FRC) were available in 142 chil-
dren at visit 1, and 211 families filled in questionnaires regarding the first year of life.
Until December 2014, 107 children eligible for visit 2 attended, and 80 (75%) of them
performed FRC measurements at both visits successfully.
Factors associated with lung volume at school age
Pearson correlation coefficient, and univariable regression analysis showed no associa-
tion of FRCMBW V 1 with FRCMBW V 2 at visit 2. A large number of variables showed
a positive association with FRCMBW V 2, including lower gestational age at birth, dura-
tion of postnatal intubation, days of oxygen supplementation, duration of invasive and
non-invasive ventilation, moderate or severe BPD (baseline group no or mild BPD), age
since term at visit 1, early weight gain, height and weight increase from visit 1 to visit
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2, anthropometric data at visit 2, age at visit 2, and any exposure to parental smoking
during the study period.
No association with FRCMBW V 2 was found for antenatal steroids, artificial surfactant,
maximum inspiratory pressure, duration of continuous positive airway pressure, chorioam-
nionitis, parental atopy or asthma, weight or length at visit 1, respiratory symptoms in
infancy or at follow-up, and male gender.
Many of the variables associated with FRCMBW V 2 exhibited co-linearity with the du-
ration of oxygen supplementation, a proxy of lung immaturity at birth. Thus, only the
variables height and age at visit 2, and duration of oxygen supplementation, were in-
cluded in the multivariable model. After adjustment for those variables, we found a
very weak association (beta= 2.6 ml per ml, 95% CI 0.02 to 5.22, R2 55.7%) between
FRCMBW V 1 and FRCMBW V 2, with the highest proportion of variance explained by an-
thropometric data at visit 2, and immaturity of the lungs at birth (see table 6.2 and OLS).
Table 6.2
Multivariable regression outcome FRCMBW V 2 in ml (n=71)
Factors associated with lung growth
In the univariable regression analysis, relative lung volume increase, i.e. ΔSDS, the dif-
ference between FRC SDS at visit 2 and visit 1, was positively associated with younger
gestational age at birth, longer duration of oxygen supplementation, severe lung disease,
lower SDS for weight and length at visit 1, younger age since term at visit 1, less early
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weight gain, lower BMI at visit 2, and with any instance ever, or within 12 months prior
to visit 2, of parent reported wheeze.
No association with ΔSDS was found for parental atopy, maximum peak inspiratory pres-
sure during neonatal ventilation, parental smoking, respiratory symptoms during infancy,
age or height at visit 2. Male gender was not associated with ΔSDS, as SDS were derived
separately for male and females.
Lower gestational age remained in the multivariable model predicting ΔSDS; after ad-
justment for early weight gain, age since term at visit 1, and BMI at visit 2, beta was
-0.18 (95%CI -0.27 to -0.08, p <0.001, see table 6.3 and OLS).
Table 6.3
Multivariable regression outcome relative lung volume increase ΔSDS (n=69)
Comparison with term-born children
We compared FRC SDS at both visits with data from 124 term-born children by unpaired
T-test, and found significantly lower SDS for FRCMBW V 1 (SDS term-born 0.0 vs SDS
preterm -0.6, 95%CI of difference -0.97 to -0.23, p=0.002), but higher SDS for FRCpleth
in the preterm group (SDS term-born -0.3 vs SDS preterm 0.6, 95%CI of difference 0.59
to 1.16, p<0.001) (see figure 6.2). The childrens age at visit 1 was comparable. At visit
2, preterm children were older than term-born children, which is why we used height-
specific SDS for FRCpleth. FRCpleth relative to height is displayed in figure 6.3.
Within the preterm group, we found elevated LCI values in 30% of preterm children at
visit 1, but only in 7% of preterm children at visit 2 (see figure 6.4). A paired t-test
showed evidence for a small but significant difference between LCI at visit 1 and 2 (6.9 at
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visit 1 vs. 7.2 at visit 2, 95%CI of true difference 0.05 to 0.53, p=0.02). Despite the low
percentage of elevated LCI values at visit 2 in preterm children, they showed significantly
higher LCI values in comparison to term-born children: mean LCI in term-born children
was 7.0, and in 71 preterm children 7.3 (95%CI of difference 0.01 to 0.48, p=0.04).
Comparison of SDS for FRCMBW V 2 with 22 term-born children showed no significant
difference between term-born and preterm children at visit 2 (see OLS).
No difference between term-born and preterm children was found for RVpTLC (see OLS).
Trapped gas in preterm children was significantly higher compared to term-born children
(97.4 ml in term-born children vs 232.0 ml in preterm children, 95%CI of difference 64.7
to 204.6 ml, p = <0.001, see figure 6.5).
Evaluation of dysanapsis showed no association of expiratory flow with FRC at either
visit in term-born children (n=120), but did show a significant association in preterm
children (n=68). Interestingly, this association in preterm children was positive at visit
1 (beta= 0.59, 95% CI 0.36 to 0.82, R2 25.3%), but negative at visit 2 (beta= -0.30,
95% CI -0.48 to -0.12, R2 12.6%; see OLS).
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Figure 6.2
FRC SDS over time in term-born and preterm children
In 124 term-born children (left pair of boxes), and in 64 preterm children (right pair
of boxes), Standard Deviation Scores (SDS) were generated for both study visits. For
visit 1, gender-specific SDS for FRC were generated using mean and SD of FRCMBW
of the term-born population. For visit 2, published gender- and height-specific reference
values for FRCpleth were used.[Rosenthal et al., 1993] Compared to term-born children,
preterm children showed significantly lower FRC SDS at visit 1 (SDS term-born 0.0 vs
SDS preterm -0.6, 95%CI of difference -0.97 to -0.23, p=0.002), and significantly higher
FRC SDS at visit 2 (SDS term-born -0.3 vs SDS preterm 0.6, 95%CI of difference 0.59
to 1.16, p<0.001)
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Figure 6.3
FRC relative to height (ml per cm) over time in term-born and preterm children
In 124 term-born children (left pair of boxes), and in 64 preterm children (right pair of
boxes), FRC per cm was calculated in order to compare lung volume according to body
size. Difference between groups remained statisticall significant even when adjusting
for male gender, height in cm at visit 2, height in SDS at visit 2 with and without
consideration of gestational age at birth (data not shown, see Online Supplement for
SDS of anthropometric data).
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Figure 6.4
LCI over time in preterm children
No tracking of LCI absolute values or LCI SDS was observed (n=71). LCI SDS were
derived using gender-specific data from term born children measured at our lung function
lab.
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Figure 6.5
Trapped gas in term-born and preterm children
Trapped gas, i.e. the difference between FRCpleth and FRCMBW V 2 per child, was cal-
culated for n=22 term-born and n=60 preterm children. Preterm children showed sig-
nificantly higher trapped gas than term born children for absolute values (97.4 vs 232.0
ml, 95% CI for true difference 64.7 to 204.6 ml, p <0.001), relative to weight (4.4 vs.
8.5 ml/kg body weight, 95%CI for true difference 1.2 to 7.1, p=0.007), and relative to
height (0.8 vs 1.8 ml/cm height, 95% CI for true difference 0.4 to 1.5, p=0.001)
159
Early lung development 6 EXCESSIVE LUNG GROWTH AFTER PREMATURITY
6.5 DISCUSSION
In this prospective observational study in preterm children, we found a very weak associ-
ation of FRC in early childhood with FRC in infancy. Maturity of the lungs at birth was
inversely associated with relative lung volume increase. The proportion of children with
elevated LCI decreased over time, and FRC and LCI were within normal range for the
majority of preterm children at follow-up. Comparisons with term-born children, however,
showed larger FRC, stronger FRC increase in relation to body length, and disproportion-
ate growth of large airways and lung parenchyma in preterm children. This additional
lung volume growth in preterm infants is likely the expression of a combination of catch-
up lung volume growth and hyperinflation, or gas trapping.
Strengths and limitations
To the best of our knowledge, this study is the first to present longitudinal FRC data in
preterm children, and one of the strengths was a relatively high number of participants,
especially when considering the complexity of measuring FRC. We performed infant MBW
without sedation, thus our results reflected the natural breathing pattern of children re-
covering from prematurity. The opportunity to compare results with data derived from
a term-born population increased the value of this analysis. Certainly, some limitations
need to be considered when interpreting our findings. Methodological differences be-
tween FRC measurements at visit 1 and 2 limited our longitudinal analyses. MBW using
SF6 as a tracer at visit 1 was not entirely comparable to MBW using nitrogen at visit
2. MBW and plethysmography were based on different concepts. It is well known that
different techniques and MBW tracers provide different results for FRC. Discrepancies
between FRCpleth and FRCMBW were most likely explained by trapped gas, i.e. gas in
non-ventilated areas of the lungs. Findings using either FRCpleth or FRCMBW at visit
2 were comparable, which underpinned their physiological validity. Our approach may
provide more detailed evidence of the nature of lung volume increase, such as hyperin-
flation and gas trapping. We challenged our results by comparing them to results when
SDS were used instead of absolute values. These sensitivity analyses supported our initial
findings.
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Statistical power would have been higher if more individuals had been included. However,
a very strong tracking would have been detected even in a population of this size.
Because of the availability of published reference data, we focused on group comparisons
using SDS from FRCpleth. However, comparisons based on SDS for FRCMBW V 2 pro-
vided complementary information. Age range at visit 1 was narrow, and SDS could be
calculated using data from a term-born group at our pediatric lung function laboratory.
At visit 2, age range was broader, and the participants were slightly older than the term-
born controls. Regarding FRCpleth SDS results, this small age difference was negligible,
as published reference values according to height were available. Regarding FRCMBW V 2,
we used data from our laboratory. Longitudinal results from nitrogen MBW in term-born
controls were available in 22 children only.
Loss to follow-up and a selection bias, which are common limitations of cohort stud-
ies, need to be taken into account. Families with less traumatic experiences during the
neonatal period were more likely to participate, especially for follow-up later in child-
hood, which limits the generalizability of the findings. The majority of parents reported
an overall good level of health of their child. Altogether, we were able to include a group
with heterogeneous clinical conditions after birth and later in childhood, but our findings
might have been more pronounced if attrition rates had been lower.
Comparison with previous findings
To our knowledge, this is the first study reporting lung volume growth in preterm infants.
Thus, comparability with previous findings is limited. Data on increasing lung volumes
from infancy onwards have only been published up to toddler age, and not beyond. Stud-
ies over longer periods reported lung function data from forced expiration, which mainly
reflects the growth of airways. Data regarding group comparisons in infancy is available.
A negative association of FRC with duration of respiratory assistance was described in
infancy, which fits with our finding of stronger lung volume increase in children born at a
younger gestational age, and with longer duration of oxygen supplementation. Hülskamp
et al. described a negative association of duration of oxygen supplementation with FRC
in infancy in a multicentre trial with 219 term-born and preterm infants [Hülskamp et al.,
2009]. It is not surprising that alterations in lung function in our study were not necessar-
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ily associated with disease severity after birth, as previous findings were heterogeneous.
One study in infancy showed FRC abnormalities in preterm infants with severe BPD [Hjal-
marson and Sandberg, 2005], others found reduced expiratory flow in the first month of
life even in healthy preterm infants [Friedrich et al., 2006].
Schulzke et al. measured FRC repeatedly in 58 preterm infants [Schulzke et al., 2010],
and described a negative association of duration of ventilation. Here, FRC increase in
infancy was positively associated with gestational age. A study comparing FRC between
preterm infants with (n=29) and without BPD (n=26) over approximately 2 years was
published by Schmalisch et al. Their main aim was to perform group comparisons over
time. FRC in infancy measured by plethysmography and SF6MBW was equal between
the groups when normalized to body weight [Schmalisch et al., 2012]. Our finding of a
negative association of FRC increase and gestational age, and of trapped gas at a later
period, suggested that catch-up growth happened beyond infancy.
Previous results from this ongoing study were published [Proietti et al., 2014, Riedel
et al., 2009, Yammine et al., 2015]. Riedel et al. described a comparison of electrical
impedance tomography (EIT) and MBW in infants, and by EIT found more ventilation
of the independent areas of the lungs in preterm children than in term-born controls
[Riedel et al., 2009]. Proietti et al. investigated whether infant lung function predicts
respiratory morbidity in the first year of life in preterm children [Proietti et al., 2014],
but no improvement of predictive value was found when infant lung function results were
added to established predictors. Interestingly, FRC was not associated with consecutive
respiratory symptoms in this analysis either.
Later in childhood, Yammine et al. [Yammine et al., 2015] compared parameters of
ventilation heterogeneity in 77 preterm children from this ongoing study to results from
46 term-born children of a similar age range. Indices of ventilation homogeneity at the
global and the acinar level were similar in term-born and preterm children. Scond was el-
evated in >50% of preterm participants, indicating ventilation inhomogeneity in the more
proximal, convection-dependent airways. Strongest predictor of having an elevated Scond
was lower gestational age, which again fits with our finding of the relevance of young
gestational age at birth. The finding of a significant difference of LCI between term-born
and preterm children in this current analysis needs to be interpreted with caution, as our
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comparison was performed with only 22 term-born children for which longitudinal LCI
data was available. Despite this weakness, the finding of a smaller percentage of preterm
children showing pathologic LCI values at visit 2 than at visit 1 can be interpreted as an
indicator of improvement of ventilation on the group level during recovery from prema-
turity.
Trapped gas is a typical finding in preterm infants [Greenough et al., 2000]. In adolescents
and adults after prematurity, evidence for elevated RVpTLC was found by Trachsel et al.
in a group of 20 individuals with severe BPD. Participants were born before lung protec-
tive ventilation and artificial surfactant were introduced [Trachsel et al., 2012]. Lum et
al. described elevated RVpTLC in 11 year-old children from the EPIcure study, in which
the children were born <26 weeks of gestation in 1995 [Fawke et al., 2010, Lum et al.,
2011]. In our participants, however, we found no evidence for elevated RVpTLC, which
might be explained by reduced postnatal damage due to improved ventilation strategies
compared to the first study, and by the broader range of gestational age at birth in our
population compared to the second study. However, the difference between FRCpleth
and FRCMBW V 2 at the same visit showed higher values in preterm children compared
to term-born controls, suggesting some intra-thoracic gas that does not communicate in
ventilation. Information on trapped gas at visit 1 was not available in our population, so
we could not exclude the possibility that it was already present in infancy.
There were only few studies investigating disproportionate growth of lungs and airways.
One study in healthy children and adolescents reported a weak association of vital ca-
pacity (VC) and expiratory flow when 50% of VC was expired [Hopper et al., 1991]. We
found no association in the healthy control group, but a change from a positive associa-
tion in infancy to a negative association later in childhood in the preterm group.
Interpretation and possible mechanisms
The weak tracking, and the higher increase of lung volume in children with less mature
lungs at birth, indicated catch-up growth in the investigated population. As alveolar
growth was shown even beyond early childhood [Narayanan et al., 2012], normal growth
of alveoli and vessels certainly contributed here. However, the complex interaction be-
tween alveolar growth, fibrosis, and emphysema is not understood. The negative impact
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of fibrosis on lung growth [Shi et al., 2009] may be highly non-linear. Fortunately, lung
volumes were within normal range at follow-up. However, compared to term-born chil-
dren, preterm children showed higher SDS for FRCpleth. This might, in part, be explained
by reduced body size after prematurity, as SDS for FRCpleth were height specific. Preterm
children had normal SDS for weight and height when using data from a preterm reference
population, but reduced SDS when compared to term-born children without consideration
of gestational age. Thus, the elevated FRC relative to body size could be explained by
reduced body size. Given that we found the difference between FRCpleth and FRCMBW
at the same visit to be higher in preterm children than in term-born controls, hyperin-
flation is also a likely contributor, and could cause excessive lung volume increase. We
can only hypothesize about potential mechanisms. As previous studies have described
hyperinflation in preterm infants [Greenough, 2013], it is likely that in our participants
some hyperinflation was already present infancy. It is possible that preterm children do
not achieve the same complex and fully functional lung structure compared to term-born
children. The ability to repair the altered lung structure after prematurity might be lim-
ited, and despite the presence of growth and repair, small airways might not be fully
restored. Over time, this could lead to increasing hyperinflation, and potentially explains
the higher incidence of COPD in preterm children later in adulthood.
We were surprised that some of the variables were not associated with either FRC or FRC
increase. Perinatal management, i.e. antenatal steroids or artificial surfactant, showed
no association with FRC in young childhood, possibly caused by non-random administra-
tion. Respiratory symptoms during infancy, or prior to follow-up, showed no association
with FRC either, which might be due to a high prevalence of respiratory symptoms in all
preterm children, regardless of lung disease severity after birth. Also, as symptoms were
reported by parents, their subjective perception of their childs lung and overall health
could have led them to report it as better than it actually was. Over time, the associ-
ation of airway function with lung volume changes from positive to negative in preterm
children. This could potentially be explained by the loss of physiological variability and
excessive increase of lung volume after prematurity.
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Clinical relevance and implications
Specific interventions for preterm children, or subgroups of them, would be highly desir-
able, but are not within reach. Previous studies have suggested to check for catch-up
growth in order to ensure that it occurs in all children affected by prematurity [Gree-
nough, 2013]. In our study, we were finally able to show catch-up growth of lung volume
in preterm children, which seemed to be exaggerated. In future studies, we would aim
to confirm and understand the mechanisms leading to this early hyperinflation. Such an
understanding could enable clinicians to both ensure catch-up growth takes place, and
the appropriate extent of said growth.
Conclusion
From infancy to early childhood, we observed very weak tracking of functional resid-
ual capacity in preterm children. Maturity at birth was negatively associated with lung
volume increase, which might be explained by catch-up growth of lung parenchyma be-
yond infancy. Compared to term-born children, relative lung volume and trapped gas at
follow-up were higher in preterm children; and compensatory lung growth after prematu-
rity might exceed normal growth. The change from a positive to a negative association
of lung volume with airway flow indicated a loss of physiological variability of breathing.
In conclusion, we observed catch-up growth of lung volume and gas trapping in this
group of preterm children, with some evidence pointing to excessive lung growth between
infancy and early childhood.
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6.6 Excessive increase in lung volume
during early development in infants recovering from prema-
turity
ONLINE SUPPLEMENT - DETAILS ON METHODS AND
RESULTS
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DETAILS ON METHODS
Study design and participants
Preterm children were recruited for an observational study during postnatal hospitaliza-
tion at Inselspital Bern, Bern, Switzerland; the study was previously described in detail
[Latzin et al., 2009a, Pramana et al., 2011, Proietti et al., 2014]. Briefly, inclusion criteria
were birth under 37 weeks of gestation, and the ability of the parents to speak one of
the major Swiss languages (German or French). Children with congenital diaphragmatic
hernia were excluded.
We measured lung volume and ventilation inhomogeneity in infancy and at early school
age, and generated a standard deviation score (SDS) for anthropometric data, functional
residual capacity (FRC), and expiratory flow. In a paired design, we tested whether FRC
in infancy was associated with FRC at early school age, and which biometric and clin-
ical factors were associated with FRC at early school age and with the change of FRC
SDS over time. A group of term-born children, i.e. born between 37 and 42 weeks of
gestation, included in a similar study, provided longitudinal lung function data for group
comparisons (n=124) [Fuchs et al., 2012a, Schmidt et al., 2015a].
Lung function measurements
All lung function measurements were performed by experienced operators using commer-
cially available equipment and according to standards [Frey et al., 2000a, Robinson et al.,
2013, Wanger et al., 2005, Miller et al., 2005].
We measured infant lung function at the corrected age of 44 weeks of gestation (visit
1) in unsedated sleep in supine position. We performed tidal-breath measurements and
multiple-breath washout (MBW) using validated equipment [Schmidt et al., 2015b], i.e.
the Exhalyzer D (Eco Medics AG, Duernten, Switzerland), and sulphur hexafluoride (SF6)
as an age-appropriate tracer [Latzin et al., 2007b]. Maximum tracer concentration during
washin and washout was determined by end-inspiratory molar mass using WBreath 3.28.0
[Anagnostopoulou et al., 2015].
At early school-age (visit 2), we measured lung function with the cooperative, awake
child in upright position. Children performed nitrogen MBW [Singer et al., 2012a] using
the Exhalyzer D and Spiroware 3.1.6 ext., and after that spirometry, and plethysmogra-
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phy [Criée et al., 2011] using the JAEGER Master-Screen Body (CareFusion, Wuerzburg,
Germany). For each visit and technique, FRC was measured in triplicates. For MBW, it
was calculated as cumulative expired volume (CEV) of tracer divided by the difference
between end-tidal tracer gas concentrations at start and end of MBW. For plethysmog-
raphy it was calculated according to the law of Boyle-Mariotte [Criée et al., 2011]. The
mean of high quality FRC measurements was calculated per technique and visit, accord-
ing to standards [Frey et al., 2000a, Robinson et al., 2013, Wanger et al., 2005, Miller
et al., 2005].
Mean lung clearance index (LCI) was calculated from high quality MBW measurements
as FRC over CEV until tracer was washed out to 1/40th of the initial concentration [Frey
et al., 2000a, Robinson et al., 2013, Wanger et al., 2005, Miller et al., 2005].
Health status and exposures
Gestational age at birth was defined as post-menstrual age at birth in weeks. Severity
of bronchopulmonary dysplasia (BPD) was defined according to the Jobe-Bancalari BPD
severity classification [Ehrenkranz et al., 2005]. The clinical risk index for babies (CRIB
score) was assessed [The international neonatal network, 1993]. Duration of mechanical
ventilation in days was defined as duration of invasive and non-invasive ventilation if
applicable.
Parental smoking was assessed at several points in time. We generated binary variables
for either maternal or paternal smoking (i) during pregnancy, (ii) during the first year of
life, or (iii) at early school age; paternal smoking was labelled as positive if the father, or
another person in the household, smoked.
Respiratory symptoms during the first year of life were assessed by questionnaire [Pra-
mana et al., 2011].
Parental asthma was defined as either parent reporting doctor-diagnosed asthma. Ma-
ternal or paternal atopic disease was defined as mother or father having asthma, atopic
dermatitis, or atopic rhinitis.
At the second visit, asthma of the child was defined as either doctor-diagnosed asthma
or current inhalation of bronchodilators and / or steroids. Wheeze was assessed based
on questions from the ISAAC questionnaire [Asher et al., 1995].
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Statistical Methods
Primary outcome was FRC at early school age. We tested for an association between
FRC in infancy and FRC at school age using the Pearson correlation coefficient and linear
regression analysis.
A standard deviation score (SDS) was generated for anthropometric data, FRC, and ex-
piratory flow. For weight, height, and body mass index (BMI) at both study visits, the
zanthro package was used in STATA 11. SDSs were specific for gender and gestational
age. [World Health Organization, 2006] In a post-hoc sensitivity analysis, SDSs were
generated without consideration of gestational age. Relative increase in body weight or
body length was defined as the difference of SDS at visit 2 and SDS at visit 1 (ΔSDS).
For FRC and mean expiratory flow at visit 1, SDSs were calculated based on gender-
specific mean and standard deviation (SD) within the term-born population (n=124):
SDS = (gender-specific mean within group individual value) / gender-specific SD within
group. For FRCpleth at visit 2, SDSs were calculated based on gender- and height-specific
reference values [Rosenthal et al., 1993].
For mean expiratory flow at visit 2, SDSs were calculated based on gender-, and age-
specific reference data published by the Global Lung Initiative using the software tool for
R [Quanjer et al., 2012]. FRC relative to body size was calculated as FRC / body weight
(ml/kg) and FRC / height (ml/cm). For FRCMBW at visit 2, gender- and age-specific
SDS were calculated from data in healthy children measured at our lung function labora-
tory. Ventilation inhomogeneity was evaluated using the mean lung clearance index (LCI)
from high quality MBW measurements [Frey et al., 2000a, Robinson et al., 2013, Wanger
et al., 2005, Miller et al., 2005]. Upper limit of normal for LCI was calculated from values
in term-born children measured at our pediatric lung function laboratory, it was 7.67 at
visit 1, and 8.06 at visit 2.
Trapped gas was calculated as ml difference between FRC from plethysmography and
MBW:
Trapped gas = FRCpleth – FRCMBW V 2.
For spirometric results, SDS were generated using gender- and age-specific reference data
[Quanjer et al., 2012].
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We performed linear regression analysis. After univariable linear regression, variables as-
sociated with the outcome of interest were included stepwise in the multivariable model.
For multivariable regression analysis, reasons for exclusion of a variable were co-linearity
with a previously included variable and / or increase of R2 of less than 10%. We tested for
non-linear associations by adding quadratic transformations of predictors to the model,
and excluded the quadratic term if the likelihood ratio test showed no model improve-
ment.
A group of term-born children included in an observational study provided longitudinal
lung volume data for group comparison (n=124 for comparison with FRCpleth, n=22 for
comparison with FRCMBW V 2) [Schmidt et al., 2015a].
Group comparisons were performed as follows: For continuous variables, we performed
visual control for equally distributed values, and then used the unpaired T-tests, for bi-
nary variables we used the Chi-square test. A p-value <0.05 was considered significant.
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Online Supplement Table 6.2a
Univariable regression analysis
Variables associated with outcome FRCMBW V 2 in ml
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Online Supplement Table 6.2b
Univariable regression analysis
Variables not associated with outcome FRCMBW V 2 in ml
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Online Supplement Table 6.3a
Univariable regression analysis
Variables associated with outcome ΔSDS from visit 1 to visit 2#
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Online Supplement Table 6.3b
Univariable regression analysis
Variables nnot associated with outcome ΔSDS from visit 1 to visit 2#
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Online Supplement Figure 6.1
RVpTLC in % in term born and preterm children
Residual volume per total lung capacity in term-born (n=124) and preterm children
(n=69) at early school-age (visit 2).
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Online Supplement Figure 6.2
LCI SDS over time in term-born and preterm children
Standard deviation score (SDS) for lung clearance index (LCI) over time in term-born
(n=22) and preterm children (n=67). LCI was measured by SF6 multiple-breath washout
in infancy (visit 1), and by nitrogen multiple-breath washout at early school-age (visit 2).
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Online Supplement Figure 6.3
Dysanapsis of lung volume and larger airways in preterm children
In infancy (visit 1), standard deviation score (SDS) for mean expiratory flow was posi-
tively associated with functional residual capacity (FRC) measured by SF6 multiple-breath
washout in preterm children (beta=0.59, 95% CI 0.36 to 0.82, p<0.001, R2 25.3%). In
the same group, at early school age (visit 2), SDS for mean expiratory flow was negatively
associated with SDS for FRC measured by plethysmography (beta=-0.30, 95% CI -0.48
to -0.12, p=0.002, R2 12.6%). In the term-born control group, mean expiratory flow and
FRC were not associated at either visit (n=124, data not shown).
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7 General discussion
This PhD thesis adds new information to the field of early lung development in term-
born and preterm children from infancy to early childhood. In the study presented in
chapter 2, we showed that our MBW equipment reliably measured lung volumes in models
with quasi-physiological conditions, corresponding to the lung sizes of infants and young
children. Using both this newly validated and other established equipment, we were able
to investigate several aspects of early lung development. Firstly, we investigated early
lung growth in term-born children early in childhood, which was presented in chapter
3. Here, we observed a weak tracking of lung volume throughout young childhood, and
no association of lung volume and function of larger airways. Secondly, we investigated
early lung development in preterm children (i) in infancy, (ii) at school age, (iii) and over
time, presented in chapters 4, 5, and 6. In infancy, we tested whether lung function
measurements could improve prediction of later respiratory symptoms when compared to
established predictive tools, but found no improvement. Thus, infant lung function did
not seem to be helpful for immediate clinical decision making. However, in this relatively
large population, we observed an altered breathing pattern in those preterm infants with
later wheeze, and this gave us reason to speculate on mechanisms for this early respiratory
pathophysiology. At early school age, we investigated ventilation homogeneity in preterm
children, and found differences in the peripheral lung regions compared to term-born
controls. Investigation of lung volumes over time detected excessive pulmonary catch-up
growth from infancy to early childhood in preterm children, and reduced physiological
variability of breathing pattern. Children born prematurely showed higher lung volume
increase when born at younger gestational age. To the best of our knowledge, these
are the first studies describing longitudinal FRC data over this long and early period in
term-born and preterm children.
180
Early lung development 7 GENERAL DISCUSSION
7.1 General strengths and limitations
Several strengths of the studies in this work are worth mentioning. The lung models we
used had quasi-physiological conditions, and our in-vitro study was the first to challenge
the equipment for MBWSF6 and MBWHe according to current consensus [Robinson et al.,
2013]. The studies on early lung growth in term-born and preterm children closed an im-
portant gap of knowledge, as data on lung volume over time during this long, early period
had not been available until now. In infants after prematurity, it was previously unknown
whether or not lung function at the corrected age of 44 weeks of gestation could be help-
ful for clinical decisions in an individual, and mechanisms of early pathophysiology were
not entirely understood. In school children born prematurely, our detailed comparison of
peripheral lung ventilation with term-born children of the same age and our investigation
of lung volume over time allowed new insights in early lung pathology of the affected
children. We added new pieces to the puzzle of early lung development, and answered
questions that will allow us to develop new strategies for better overall respiratory health.
The term-born and preterm children were unselected, which increases generalisability of
our findings. However, some families might have been more motivated to participate,
especially at the follow-up visit after several years. Families with a higher interest in the
respiratory health of their term-born child, or with less traumatising experiences in the
hospital after preterm delivery, might be slightly overrepresented. Also, exposures were
not assigned randomly. These were typical issues in observational studies which could
not be avoided. However, they needed to be taken into account when interpreting the
findings.
The lung function techniques we used were appropriate for the specific age groups. The
measurements were performed and analysed in a paediatric lung function laboratory in
a team with recognised expertise. We were able to include numerous participants in
our studies in spite of the complexity of the measurements, especially of measuring FRC
in infants and young children. Inclusion of high quality measurements only limited the
sample size.
Methodological differences between the measurement techniques could not be avoided,
as the most suitable setups and tracers were age-dependent. Also, vegetative state and
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body position of the children differed between the study visits. Our standard of MBW
analysis in infancy was recently improved [Anagnostopoulou et al., 2015]. MBW using
different tracers was previously shown to require specific reference data. This might have
hampered detection of associations of FRC over time. Physical principles of measuring
FRC by MBW and plethysmography differed as well, and the poor success rate of he-
lium MBW in term-born children at follow-up was a drawback. Despite our attempts
to improve success rate, we had to conclude that helium was not suitable for MBW in
the investigated population, and we now perform nitrogen MBW in all children at the
follow-up visit. The latter was easier to perform, test duration was shorter and success
rate was high. In the current study, longitudinal analyses of FRC in term-born children
was limited to FRCpleth as primary outcome, which had the disadvantage of using a dif-
ferent technical principle than FRCMBW measurement in infancy, but the advantage of
available height- and gender-specific reference values which could also be compared to
preterm children. At any visit, we used the equipment, tracers, and protocols for analyses
that were most promising when the study was initiated. During the process, we adapted
our procedures based on new knowledge.
The physiological breathing pattern in childhood was variable, and so was FRC, especially
as we performed infant lung function tests without sedation. This, combined with some
measurement error, probably made detection of associations more difficult than in studies
investigating measurements based on forced expiration with less variability. Still, in order
to investigate not only larger airways, but lung volumes and ventilation in smaller airways,
the tidal breathing lung function tests we performed were valuable tools.
Parameters of peripheral ventilation inhomogeneity, Scond and Sacin, were assumed to
represent the convection- and diffusion-convection-dependent lung zones respectively.
However, this was a model based interpretation [Verbanck et al., 2003], and proof of
association with specific lung morphology was not available.
When comparing findings in the term-born children of the BILD study with those in the
preterm population, a few differences between the study protocols and populations had
to be considered. Symptoms during the first year of life were assessed prospectively for
term-born infants, and retrospectively for preterm infants. Thus, a potential reporting
bias in the preterm population needed to be taken into account. This was improved for
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the follow-up visit, where questionnaires and interviews for assessment of symptoms were
identical in the two populations. At follow-up, success rate for FRC measurements de-
pended on cooperation, and preterm children might be limited in their ability to maintain
tight closure around a mouthpiece during measurements with consecutive lower rate of
successful trials. We encouraged and helped children as much as possible during measure-
ments, but preterm children with neurological impairment might be under-represented in
the group with successful FRC measurements. Age at follow-up was approximately 6
years for term-born children and 9 years for preterm-children. We aimed to overcome
this limitation by adjusting for age and body size, by using established reference values
whenever these were available, by comparing reference values with and without consid-
eration of gestational age and by challenging our findings in sensitivity analyses using
absolute values and values relative to body size.
Statistical power was limited by the sample size. Again, considering the complexity of our
measurements, sample size was considerably large. If tracking of FRC had been strong in
term-born and preterm children, statistical power in the current sample sizes would have
sufficed to detect that.
7.2 Comparison with previous findings and interpretation
Validation of MBW equipment
In the in-vitro lung model trials presented in chapter 2, we were able to show that our
equipment reliably measures lung volumes within 10% accuracy over FRC volumes be-
tween 80 and 300 ml with the infant setup and between 600 and 1,400 ml with the young
child setup. A validation study for an available N2MBW setup (Exhalyzer D, Eco Medics
AG) showed an error within 7% for the small model and within 5% for 98% of the runs
in the large lung model. The equipment had several similarities with our setups, e.g. the
use of an USFM, but N2 concentration was determined indirectly via O2 and CO2 sensors.
Also, CO2 application to the model differed in this study [Singer et al., 2012a]. Since for
infants, SF6 is currently the recommended tracer [Robinson et al., 2013], the setup we
investigated was the more appropriate. For children beyond infancy, both HeMBW and
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N2MBW would be suitable.
Lung growth in term-born children
The study on longitudinal lung volume data presented in chapter 3 showed a weak track-
ing of FRC in 124 unselected term-born children from infancy to early childhood. The
strongest predictors of FRC in early childhood were body size and age at the time of
FRC measurement. Male gender and maternal smoking during the first year of life were
positively associated with FRC. FRC in infancy alone explained 4% of the variance of
FRCpleth in early childhood, the multivariable model explained 22%. As this was the first
study on lung volumes over this long and early period, results can only be compared with
studies on lung volumes over shorter periods or with studies reporting airway function. A
study with a comparable study protocol, i.e. unselected birth cohorts with longitudinal
lung function measurements starting very early in childhood, showed a weak tracking of
airway function [Stern et al., 2007], with an explained variance of 9 to 14%. Spirometric
measurements in infants were performed with sedation, with lower physiological variabil-
ity than in our measurements without sedation. In preterm children, tracking of airway
function was shown [Filippone et al., 2003].
We observed that some investigators used the term tracking for group comparisons, and
we suggested the term should be used only when associations of individuals’ values over
time were evaluated, in order to allow comparability of studies.
Infant lung function in preterm children
In preterm infants, we observed no improvement of prediction of respiratory symptoms in
the first year of life when infant lung function was added to established clinical prediction
scores. Other investigators observed a weak predictive value of infants lung function pa-
rameters, e.g. of higher airway resistance in hospitalised preterm infants [Drysdale et al.,
2011], for prediction of symptoms in the first year of life.
We found an altered breathing pattern in infants who developed wheeze, with higher tidal
volume and lower respiratory rate. Previous studies in preterm infants showed increased
tidal volume [Putnam et al., 2005], and alterations in airway mechanics [van Putte-Katier
et al., 2012, Drysdale et al., 2011, Neufeld et al., 1992], and it is possible that thereby
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effective CO2 clearance was maintained despite a ventilation perfusion mismatch and a
rarefied acinar structure.
Ventilation in preterm children at school age
In former preterm children at early school age, ventilation on the overall and the aci-
nar level was normal, but function of more proximal conducting airways was impaired
in the majority of the investigated population. This confirms what was suggested pre-
viously, i.e. that alveolar growth continues after term and preterm birth [Narayanan
et al., 2012, Narayanan et al., 2013, Herring et al., 2014]. In a population of 11-year
old children born <26 weeks of gestation [Lum et al., 2011], the proportion of children
with inhomogeneous ventilation on a global level, i.e. elevated LCI, was higher than in
our study, which was most likely explained by the different range of gestational age at
birth. The finding of ventilation inhomogeneity on the conductive level, but not on the
more peripheral acinar level, was unexpected. We speculated that it was explained by
the timing of lung growth disruption: if the peripheral conducting airways were damaged
after they had already developed, while the alveolar regions developed later, this could
explain why Scond was elevated in the majority of preterm children, but Sacin was not.
Excessive lung growth after prematurity
In our longitudinal analysis of lung volume from infancy to early childhood in preterm
children, which was presented in chapter 5, we found only a very weak association of
the individuals’ FRC values over time. This was in contrast to strong tracking of airway
function that was previously described [Filippone et al., 2003]. Relative FRC increase
was negatively associated with gestational age, which we interpreted as catch-up growth
after preterm birth. When we compared the data in preterm children with a population of
term-born children (see chapter 2), we found some differences between the groups with
regards to ventilation heterogeneity, and hyperinflation. In the investigated population,
trapped gas was higher than in a group of term-born children. Even though we can-
not exclude that trapped gas was already present in infancy, our findings and what was
described by other investigators gave us reason to speculate that catch-up growth after
premature birth happened beyond infancy, and that it was overshooting. In the preterm
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population, FRC was within normal range at early school age. However, FRC SDS was
higher in preterm children compared to the term-born population. This might be ex-
plained in part by reduced body size in the preterm group, but the difference remained
significant even after adjustment. Because of that, and because of the higher values
regarding trapped gas, we interpreted our observations as excessive pulmonary catch-up
growth after premature birth.
7.3 Clinical and public health relevance
Our observations gave new insights into early lung development in term-born and preterm
children. Even though our findings do not have immediate consequences in clinical man-
agement, they were encouraging, and our understanding of lung growth in early childhood
was advanced. This new basic knowledge will facilitate the design of further studies and
it will be beneficial for communication with affected families.
Using validated MBW equipment, we were able to show the natural course of early
lung growth, with anthropometric values being the strongest predictors of lung volume
at follow-up. Tracking was weak, and measurements of lung volume and larger airway
function were not associated in term-born children. In preterm children, we observed
no improvement of prediction of respiratory morbidity by adding infant lung function to
established prediction tools, but we did note interesting alterations of breathing pattern
in children who developed wheeze in the first year of life. Thus, infant lung function in
preterm children did not seem to be advantageous for clinical decision making, but it was
beneficial for understanding early pathophysiology. At school age, differences in ventila-
tion homogeneity between term-born and preterm children were subtle, and this was an
encouraging observation. It confirmed previous observations of ongoing alveolar growth
during childhood. The finding of pulmonary catch-up growth after prematurity, which
we described in a longitudinal data set for the first time, was encouraging. We expected
to find fewer sequelae after prematurity compared to populations born in earlier periods.
However, recovery from interrupted lung growth seemed even better than expected.
The incidence of preterm birth will not drop in the future, and survival even after very
186
Early lung development 7 GENERAL DISCUSSION
premature birth will be improving, so clinicians in neonatology and paediatric respiratory
medicine will continue to see children suffering from pulmonary impairment after prema-
turity, and many of these patients will require respiratory treatment in adulthood. Our
goal would clearly be to ensure catch-up growth in these children, and to minimise early
hyperinflation. Due to non-random administration of potentially beneficial treatments we
were not able to identify specific strategies for the future. New studies will be necessary
to answer the open questions.
7.4 Outlook
In order to bring beneficial strategies within reach, the next scientific steps would be (a) to
confirm our findings and combine them with information on morphology or function, e.g.
by combining measurements of small airway function and hyperinflation or with functional
measurements like diffusion of carbon monoxide, or with modern imaging techniques like
magnetic resonance imaging (MRI). The latter can display lung tissue in increasing qual-
ity without exposing the children to radiation, and combined longitudinal investigations
of small airway function and structural lung growth would be of great interest in healthy
children as well as in those with chronic lung diseases. Histology might add valuable in-
formation, but acquisition of samples is invasive. Further scientific steps would be (b) to
continue follow-up of the investigated populations into adolescence and adulthood to see
whether hyperinflation increases in preterm children, and whether it predicts later respi-
ratory symptoms; (c) to observe the effect of potentially harmful substances, i.e. outdoor
air pollution and active smoking, and to compare susceptibility between term-born and
preterm-children; (d) to investigate gene-environment interactions, and (e) to compare
clinical management after preterm birth during childhood with regards to later lung vol-
ume as well as the function of larger and smaller airways, e.g. in a randomised controlled
trial (RCT). RCTs are certainly limited by ethical considerations, resources and number
of potential participants. To increase sample size, (f) collaborations for meta-analyses
are an interesting approach, which at the moment predominantly have an observational
design using classic lung function tests with a very broad availability. Last but not least,
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(g) an improvement of the already available new, non-invasive lung function tests would
help us to increase the quality of information that we can gain. At the same time, we
should aim for tests to be short and easy to perform with children.
Many of these steps are currently being undertaken in our group (see Appendix [Singer
et al., 2014b, Anagnostopoulou et al., 2015, Fuchs et al., 2015]), in collaborations (see
Appendix [Sonnenschein-van der Voort et al., 2014]), and by other research groups. In
the coming years this will increase our knowledge of potentially harmful exposures and
of best clinical management after preterm birth, and we will aim for the best possible
short-term and long-term outcomes of respiratory health in all children.
7.5 Conclusions
We can conclude from our in-vitro study that, in a lung model, the investigated setups
for multiple-breath washout were valid and reliable for measuring lung volumes in infancy
and early childhood.
Tracking of lung volume in term-born children early in childhood was weak, and lung
volume was not associated with function of larger airways. The weakness of tracking was
partially explained by the high physiological variability of functional residual capacity and
multiple influencing factors.
In preterm infants, lung function at the corrected age of 44 weeks of gestation did not
improve prediction of respiratory symptoms compared with standard clinical parameters.
Preterm infants with wheeze during infancy showed a different breathing pattern com-
pared to non-wheezers, possibly because of an adaptation to their altered lung structure.
In preterm children at school age, ventilation homogeneity measured by multiple-breath
washout differed from term-born children in the peripheral, conducting airways. Results
for ventilation on the overall and the acinar level showed no significant differences, which
suggested continued alveolar growth after preterm birth.
Tracking of lung volume in preterm children early in childhood was very weak. Stronger
increase of lung volume when born at younger gestational age suggested catch-up growth,
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while subtle differences to term born children regarding ventilation homogeneity and air
trapping pointed towards incomplete recovery from interrupted structural growth due to
prematurity.
Altogether, tracking was weak in both term-born and preterm children, which confirms
that early childhood is a window of vulnerability, but also of opportunity for lung de-
velopment. Lung volume in early childhood was not largely determined by lung volume
in infancy, and this stressed the importance of protection from potentially harmful sub-
stances throughout childhood. However, efforts to prolong intra-uterine development as
much as possible must still be regarded as beneficial: in our studies, respiratory health
and growth of peripheral lung structure beyond infancy did not seem to be determined
by harmful or preventive therapeutic interventions, but by prematurity per se.
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9 Appendix
Joining an internationally connected research group with broad expertise allowed me to
contribute to several studies and collaborations in addition to the focus of my thesis.
I worked in an interdisciplinary team, and this broadened my scientific experience. We
shared our experiences and knowledge in frequent team meetings and ensured mainte-
nance of the data set by mutual support. We constantly challenged our MBW protocols
and equipment and were able to improve those even further. Our collaborations gave
me insights into the work in a Genetic laboratory, and our contribution to meta analyses
showed me the potential of a well-coordinated, collective effort.
We investigated the associations of genetic variants with inflammatory markers in term-
born infants, tested improved protocols for measurement and analysis of infant lung
function, and contributed to two European meta analyses on asthma development. The
manuscripts and abstracts are shown in this appendix.
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Key messages 
 Genetic determinants at 6q12 and 11p14 are associated with higher postnatal eNO levels in 
healthy term-born infants while there were no associations on a genome-wide level with 
known genetic determinants of eNO in later life.  
 These genetic determinants are subsequently associated with less and less extensive 
respiratory symptoms during the first year of life in our study population.  
 Our findings imply potential differences in the relation between eNO metabolism and lung 
disease in early infancy in comparison to later childhood. 
 
Capsule Summary 
The identification of novel genetic determinants of infant eNO, at previously unknown loci 
6q12 and 11p14, may implicate that postnatal eNO metabolism in healthy infants prior to first 
viral infections and sensitization is related to mechanisms other than those associated with 
asthma, atopy or increased risk thereof later in life.  
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DEFINITION OF ABBREVIATIONS 
 
ANO3 Human anoctamin 3 gene locus 
BILD Basel/Bern Infant Lung Development (Cohort) 
bp base pair 
BPD Bronchopulmonary dysplasia 
cM CentiMorgan 
CEU Utah residents with ancestry from northern and western  
 Europe 
CTCF 11-zinc finger protein or CCCTC- binding factor 
DENND1B DENN/MADD domain containing 1B 
ECR Evolutionary conserved genomic region 
EGF(R) Epithelial growth factor (receptor) 
(e)NO  (Exhaled) nitric oxide 
ETS  Environmental tobacco smoke 
EYS Human eyes shut homolog gene locus 
GxE Gene-environment interaction 
GxG Gene-gene interaction 
GSDMB  Human gasdermin B gene locus 
GWAS Genome-wide association study 
HWE Hardy-Weinberg equilibrium 
IBD Identity-by-descent 
IRR Incidence risk ratio 
LD Linkage disequilibrium 
LUZP2 Human leucine zipper protein 2 gene locus
LYRM9 Human LYR motif containing 9 gene locus 
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MAF Minor allele frequency 
Mb Megabase 
MUC15 Human mucin 15 gene locus 
NOS Human nitric oxide synthase gene locus 
OLR Online repository 
OR Odds ratio 
PC(A) Principal component (analysis) 
pint Interaction p-value 
QC Quality control 
QQ Quantile-quantile plot  
QTL Quantitative trait locus 
rs Reference SNP cluster code (dbSNP) 
SD Standard deviation 
SNP Single-nucleotide polymorphism 
TFBS Transcription factors binding sites 
UCB Umbilical cord blood 
VEGF Vascular endothelial growth factor 
V’E Minute ventilation 
V’NO Nitric oxide output 
VT Tidal volume 
95% CI 95% confidence interval  
Fuchs and Gorlanova et al. 6 
 
ABSTRACT 
Background: Exhaled nitric oxide (eNO) is a biomarker of airway inflammation and seems 
to precede respiratory symptoms, such as asthma in childhood. Identifying genetic 
determinants of postnatal eNO may aid in unraveling the role of eNO in epithelial function or 
airway inflammation and disease.
Objective: To identify genetic determinants of early postnatal eNO and subsequent 
respiratory symptoms during the first year of life. 
Methods: Within a population-based birth cohort, eNO was measured in healthy term infants 
aged 5 weeks during quiet tidal breathing in unsedated sleep. We assessed associations of 
single-nucleotide polymorphisms with eNO in a genome-wide association study, and 
subsequent symptoms of lower respiratory tract infections during the first year of life; and 
asked if this was modified by prenatal and early-life environmental factors. 
Results: We identified so far unknown determinants of infant eNO: rs208515 (p=3.3 x 10-8) 
located at 6q12, explaining 10.3% of eNO variance, and furthermore rs1441519 (p=1.6 x 10-6) 
at 11p14. The 6q12 locus was inversely associated with subsequent respiratory symptoms 
(p<0.05) and time to recovery after first respiratory symptoms during the first year of life 
(p<0.05). 
Conclusion: The identification of novel genetic determinants of infant eNO may implicate 
that postnatal eNO metabolism in healthy infants prior to first viral infections and 
sensitization is related to mechanisms other than those associated with asthma, atopy or 
increased risk thereof later in life.   
Fuchs and Gorlanova et al. 7 
 
INTRODUCTION
Exhaled nitric oxide (eNO) is an important biomarker of airway inflammation. Low levels of 
outdoor air pollution and environmental tobacco smoke (ETS) affect eNO levels in 
newborns.(1, 2) Moreover, eNO seems to also be an early marker for future respiratory 
morbidity in infants(3) and to precede transient early but not persistent wheeze in infants,(4) 
and may thus help to differentiate early forms of infant wheeze, at least in individuals at risk. 
Later, eNO serves as an established indicator for allergic airway inflammation, aiding in 
discriminating childhood wheeze and asthma phenotypes(5-7) and in identifying exacerbation 
risk or asthma control.(8, 9)  
Interestingly, respiratory epithelial-derived NO is also important for cell signaling. There is an 
emerging role of NO in airway development and pulmonary angiogenesis both in rodent 
models(10, 11) and for premature children at risk for bronchopulmonary dysplasia (BPD).(12, 
13) In the context of lung epithelial-mesenchymal crosstalk,(14) NO has been shown to 
modulate recovery from lung injury and to attenuate transition of epithelial cells to 
myofibroblasts.(15) In rodents, this has important implications for epithelial function, 
structural maintenance, and lung remodelling in the postnatal phase.(16) In humans however, 
the role of postnatal eNO as a marker of epithelial function or for future respiratory morbidity 
irrespectively of underlying risk remains unclear. Thus, before it may be used as a marker for 
“FeNOtyping”,(6) it is important to better understand putative genetic determinants of 
postnatal eNO. 
Several lung cell types are able to produce NO from L-arginine through the action of nitric 
oxide synthase isoforms (NOSs).(17, 18) Previous work in infants at risk of atopy(19) and 
following a candidate-gene approach in older children(20-23) has suggested that variants in 
genes such as DENN/MADD domain containing 1B (DENND1B) and NOS2 may affect eNO 
levels. Only recently, a large genome-wide association study (GWAS) in individuals not at 
increased risk for atopy or asthma identified the loci LYR motif containing 9 (LYRM9), NOS2, 
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and one near gasdermin B (GSDMB) at 17q21 to be associated with eNO.(24) All these 
analyses have been performed in older children where eNO levels may also be affected by a 
number of other factors, e.g. concomitant disease and environmental effects. Here, we present 
a GWAS in a unique, unselected population-based cohort of term-born infants not at 
increased risk of atopy or asthma, the Basel/Bern Infant Lung Development (BILD) 
cohort.(25) There, eNO levels were measured shortly after birth in order to determine early 
genetic effects which may influence eNO levels and may precede disease development from 
early on.  
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METHODS
A more detailed description of the study population and methods is provided in the online 
repository (OLR). 
Study population, study participants 
All data were collected in the ongoing prospective BILD birth cohort of unselected, healthy 
neonates.(25) The study was approved by all involved Ethics Committees. All caregivers 
provided written informed consent for this study.  
 
Measurements and quality control of tidal breathing and nitric oxide 
Tidal breathing and mixed eNO were measured at five weeks of age as described 
previously.(25, 26) Outcome parameters were tidal volume (VT), minute ventilation (V’E=VT 
x respiratory rate), eNO, and NO output (V’NO=eNO concentration x expiratory flow).(26) 
 
Measurement of respiratory symptoms and time to recovery from first respiratory infection 
during the first year of life 
Respiratory symptom data was collected by weekly telephone interviews.(25) Respiratory 
symptoms were defined as ‘cough, wheezing, difficulty breathing and reduced activity during 
night and day’. Weeks with symptoms were defined as total number of weeks with respiratory 
symptoms. Time to recovery was defined as total number of weeks that the infant suffered 
from first respiratory symptoms during the first 6 and 12 months of life.  
 
Genotyping, genetic data quality control 
Whole-genome genotyping (Illumina HumanOmniExpress Bead Chips, Illumina Inc., San 
Diego, USA) was performed in two separate batches in all n=425 study participants (in 2011 
for n=329 and in 2013 for additional n=96 children).We checked for a batch effect due to two 
genotyping time-points. See Figure 1 for details on post-hoc exclusion of individuals and 
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quality control (QC) of eNO measurements and genotyping data. Principal component 
analysis (PCA) was performed in order to obtain eigenvectors as covariates for later 
association tests. The first principal component (PC1) was subsequently included for 
adjustment. 
 
Statistical analyses and association testing 
Analyses were restricted to additive models. No transformation was necessary for eNO or 
V’NO values. Associations between SNPs and eNO or V’NO were analyzed by adjusted 
linear regression. The Bonferroni method was chosen to control for multiple testing.  
Associations between SNPs and number of weeks with respiratory symptoms and time to 
recovery were analyzed by adjusted Poisson and logistic regression. For the latter, a binary 
variable (resolution of symptoms < 2 week or  2 weeks) was defined. Results are expressed 
as incidence risk ratio (IRR) and odds ratio (OR), respectively. Gene-gene (GxG) and gene-
environment interaction (GxE) were assessed by ANOVA. The corresponding p-value was 
labeled pint. A p-value <0.05 was considered significant.  
Association computations were done in R version 3.0.2 (www.r-project.org) (27) using the 
GenABEL package (28) and Stata 12.1 (STATA Corporation, College Station, TX, USA) 
both final subset of all n=229 individuals that were left for subsequent analyses as well as for 
each genotyping batch from either 2011 or 2013, separately. Regional plots were generated by 
LocusZoom (http://csg.sph.umich.edu/locuszoom). Permutation analyses were performed by 
chromosome using PLINK version 1.07.(29) Linkage disequilibrium (LD) was evaluated by 
PLINK version 1.07(29) based on 1000 Genomes Project (CEU population) data.(30) 
Regional LD plots were generated in R 3.0.0. Base pair (bp) positions correspond to genome 
assembly GRCh37.p13 and gene annotations are according to the NCBI RefSeqGene Project 
(accessed March 24th 2015). 
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Post-hoc power estimation 
Post-hoc statistical power was estimated with the Genetic Power Calculator (31). With a 
sample size  of n=229, there was more than 90% power to detect a quantitative trait locus 
(QTL) explaining 10.3% of the trait (eNO) variance together with accurate eNO 
measurements shortly after birth and therefore little environmental influence thereon.  
 
In-silico functional analyses 
Several databases (see OLR) were used to check the relationship of target polymorphisms 
with published data on expression (eQTL) and methylation QTLs (mQTL). ECR Browser 
(http://ecrbrowser.dcode.org/) was used to check whether the target polymorphisms are 
located in evolutionary conserved genomic regions (ECRs). CCCTC- binding factor (CTCF) 
binding sites and chromatin topological domains were determined using data from 
CTCFBSDB 2.0 - (http://insulatordb.uthsc.edu/).(32) 
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RESULTS 
Between 1999 and 2013, the study enrolled 425 eligible infants, of whom n=353 presented for 
lung function measurements at the age of 5 weeks after gestation. After secondary exclusion, 
technically acceptable data were obtained from n=344 infants. As indicated in Figure 1, 
n=229 individuals with data for n=567,864 SNPs were then subjected to analyses. Table 1 
presents anthropometric and demographic characteristics and distribution of known and 
possible confounders among all study participants for whom we had complete datasets on 
eNO measurements and from genotyping after aforementioned QC. Values for eNO and 
V’NO were highly correlated (r=0.71, p<0.0001). We did not find any differences in baseline 
characteristics between infants for whom data were in- or generally or specifically excluded 
from subsequent analyses (data not shown). 
Calculated genomic inflation factors for eNO and V’NO were below 1.006, showing no 
evidence for population stratification. While we did not find any association of NOS gene loci 
with our outcomes, LYRM9 and GSDMB loci were related to eNO and V’NO with the same 
effect direction as previously published(24) however not reaching genome-wide significance 
(p=0.082 and p=0.034, respectively). After adjustment for confounders and correction for 
multiple testing, we identified polymorphisms significantly associated with eNO and V’NO. 
Two SNPs on 6q12 (reference SNP (rs) cluster codes rs208515 and rs208520), were in high 
LD (r2>0.8) and significantly associated with eNO and V’NO, respectively. The T-allele (risk 
allele) of rs208515 and the G-allele (risk allele) of rs208520 were associated with increased 
eNO values (explained variance 10,3% and 10,2%, respectively) as well as increased V’NO 
values (explained variance 9,9% and 9,9%, respectively). Two variants on 11p14 (rs12223678 
and rs1441519) were also in high LD (r2>0.8) and were indicative for associations with eNO 
and V’NO. Here, the T-alleles (risk alleles) of rs1441519 and rs12223678 were associated 
with lower eNO values (explained variance 7,9% and 7,3%, respectively) as well as with 
lower V’NO values (explained variance 9,0% and 8,7%, respectively). Detailed association 
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data for the total final subset of n=229 individuals are provided in OLR Tables E1A and B, 
and summary statistics of associated SNPs are listed in OLR Table E2. Figures E1A and B in 
the OLR display quantile-quantile (QQ) plots and Figures 2A and B Manhattan plots for eNO 
and V’NO. Figures E2A and B in the OLR as well as OLR Figures E3A and B display 
regional plots for eNO and V’NO, respectively. The above mentioned top SNPs were also 
robust with regard to effect direction and of comparable effect size albeit not significant for 
the smaller batch from 2013 when analyses were performed for each genotyping batch from 
2011 or 2013, separately (see OLR Tables E3A and B for associations with eNO). Moreover, 
they remained also significantly associated with measured outcomes when we performed 
additional permutation analyses. For the 6q12 top SNPs this was also the case after 
accounting for multiple testing within the permutation analysis, while for 11p14 hitsa trend 
was observed (see OLR Table E4 for eNO). 
In a previous study, no association was found between postnatal eNO levels and respiratory 
symptoms during the first year of life for the entire study population but for the subgroup of 
mothers smoking during pregnancy or who were atopic.(3) We therefore investigated wether 
the identified genetic determinants were also relevant for n=209/229 children with respiratory 
symptoms during the first year of life. Table E5A in the OLR displays details on duration of 
respiratory symptoms in weeks for the study population and across group levels. The T-allele 
of rs208515 (6q12) was negatively associated with the number of weeks with respiratory 
symptoms with an IRR of 0.80 (95%CI 0.68-0.95, p=0.009, see Figure 3). This was 
independent of symptom severity (data not shown) and remained significant also after 
adjusting for confounders (sex, having older siblings, nursery care, maternal atopy, maternal 
smoking during pregnancy, V’E, and eNO) with an adjusted IRR (aIRR) of 0.81 (95%CI 
0.69-0.95, p=0.011, see OLR Table E5B). The same association with comparable effect size 
and direction was found for rs208520. In contrast, we did not find any significant associations 
between 11p14 variants and the number of weeks with respiratory symptoms (see OLR Table 
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E5B for adjusted and Figure 4 for unadjusted results). Stratifying for maternal atopy or 
maternal smoking during pregnancy did neither modify the association between SNPs and 
eNO or V’NO, nor between SNPs and subsequent symptoms for either locus. Furthermore, 
association of SNPs with assessed outcomes was not dependent of each other, i.e. there was 
no GxG for variants at 6q12 or 11p14 identified to be associated with eNO and V’NO in 
infants (data not shown). 
Lastly, we analyzed wether the effect of identified genetic determinants was also relevant for 
the time to recovery from first respiratory infections. There was no effect of genetic 
determinants on the duration of first respiratory infection in the study population with 
symptoms across the first 12 months of life (n=207) in either univariable or adjusted models 
(data not shown). Constricting our analyses to children with symptoms during the first 6 
months of life (n=130) however, rs208515 or rs208520 were significantly associated with 
faster recovery (i.e. less than two weeks) in both univariable models (data not shown) and 
models adjusted for known and possible confounders (sex, age, having older siblings, nursery 
care, maternal atopy, maternal smoking during pregnancy, season, being breast-fed at time of 
first respiratory symptoms, V’E, and eNO) with an aOR=0.34, p=0.008 and an aOR of 0.24, 
p=0.002, respectively. 
As association signals on chromosome 6q12 (rs208515 and rs208520) and chromosome 
11p14 (rs12223678 and rs1441519) are located in non-coding regions, we applied in-silico 
and database analyses to search for putative causal SNPs in the respective regions driving the 
observed signals. The closest RefSeq genes identified on 6q12 were SLC25A51P1, EYS and 
LOC441155 located upstream of rs208515 (446kb, 529kb and 930kb distance respectively), 
whereas no gene was listed within 1,000kb downstream of rs208515 (see Figure 3A). On 
11p14, LUZP2 was the closest gene upstream of rs12223678 (812kb distance). The closest 
downstream genes of rs1441519 were ANO3, MUC15 and SLC5A12 (424kb, 651kb and 
759kb distance, respectively, see Figure 3B). Linkage disequilibrium analyses in at least 
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1,000kb surrounding the associated polymorphisms on 6q12 identified an LD r20.8 for 177 
SNPs for rs208515 and 88 SNPs for rs208520. Due to r2 of 0.82 between rs208515 and 
rs208520, an overlap in tagged SNPs exists, resulting in 201 unique SNPs in the 6q12 tagging 
block (OLR Tables 6A and B). None of the tagged SNPs is located in close vicinity to known 
genes in the 6q12 locus (closest SNP: rs1563929 located 203kb from SLC25A51P1). Analysis 
for 11p14 identified an LD of r2 0.96 between rs12223678 and rs1441519. Both SNPs are 
tagging for the identical set of SNPs at r20.8. (n=13 SNPs; OLR Tables 6C and D). None of 
these 13 SNPs is in close vicinity to genes on the 11p14 locus (closest SNPs: rs11028996 with 
802kb distance to upstream LUZP2 and rs1348169 with 424kb distance to downstream 
ANO3). 
All identified SNPs (n=214) were subjected to further evaluation, whether they locate within 
regulatory sequences such as enhancers/ super-enhancers and insulators, transcription factors 
binding sites (TFBS) or evolutionary conserved regions (ECRs) determined in the respective 
regions as depicted in Figure 5A and B. Indeed, we identified 5 associated SNPs on 
chromosome 6q12 in binding sites for the CCCTC-binding factor (CTCF), which is 
specifically allocated to insulator regions in humans and was shown to play an important 
developmental role (OLR Tables E7A and B).(33-35) Three variants (rs9453663, rs9453664, 
rs12200490) belong to a sequence that allows cell type-specific binding of CTCF in lung 
fibroblasts. Polymorphisms rs3899423 and rs4618506 locate in regions where CTCF binds in 
embryonic stem cells and lymphoblastoid cells, respectively. In-silico predictions suggested 
that all 13 SNPs at 11p14 are located in an area that is part of two cell type-specific (human 
embryonic stem cells and fetal lung myofibroblasts, IMR-90) chromatin structures called 
topologically associating domains.  
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DISCUSSION 
In this unselected birth cohort,(25) we found two new loci, 6q12 and 11p14, to be associated 
with NO levels, measured in healthy term-born infants shortly after birth. The 6q12 locus 
explains a significant proportion of variance at a reasonably high significance level. 
Furthermore, this locus is also inversely related with the number of weeks with respiratory 
symptoms and time to recovery after first respiratory symptoms during the first year of life 
and may thus be of functional relevance.  
The most significantly associated SNPs (rs208515 and rs208520) are located at 6q12 
downstream the EYS gene locus, a member of the human epithelial growth factor (EGF) 
homolog family. EGF and homologs regulate several signal cascades(36, 37) that participate 
in functions such as proliferation, differentiation, mitosis, cell survival, and apoptosis on the 
transcription level.(36) Additional downstream events encompass glucose metabolism and 
cell migration.(37) The second identified locus at 11p14 (rs12223678 and rs1441519) is 
situated in vicinity to the human ANO3/MUC15 gene locus. While ANO3 belongs to a gene 
family encoding calcium-activated chloride channels,(38) the MUC15 protein belongs to the 
mucin family, representing glycoproteins important as mucus constituents as part of the 
physical barrier of the airway epithelium.(38) Remarkably, it also shares structural motifs 
with the EGF receptor (EGFR) and has been shown to modulate EGFR-signaling after EGF 
stimulation.(39)  
However, our long-distance LD analyses revealed that no polymorphisms in LD with eNO-
associated SNPs are located in close vicinity to so far identified genes in the respective 
regions. Therefore, a direct impact of eNO-associated polymorphisms on gene function (e.g. 
amino acid sequence, splicing, promoter activity) in either of the two chromosomal loci could 
not be established. Unfortunately, existing eQLT datasets are of no use to study gene 
expression effects in early childhood and thus, further targeted experiments will be needed. 
Interestingly, the extensive intergenic regions, where identified SNPs are located, are 
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predicted to harbor regulatory regions. Five of the variants from associated tagging bins at 
6q12 are placed in insulator sequences, defined as binding sites for the major human insulator 
protein CTCF. ChipSeq database derived data revealed that CTCF binds in a cell type-specific 
manner, and more importantly, in cell types involved in embryotic development and 
potentially relevant to the course of airway inflammation (lung fibroblasts and lymphoblastoid 
cells).(33-35) Prediction analysis for the 11p14 variants indicates cell type-specific CTCF-
driven formation of topologically associating domains in embryonic stem cells and in fetal 
lung fibroblasts, potentially orchestrating 11p14 chromatin rearrangements and affecting 
genes involved in lung tissue development. Thus, allele-specific effects on chromatin 
insulator function in both 6q12 and 11p14 regions might contribute to the association signals 
that were observed. 
Chromatin insulators regulate the effects of enhancers and silencers on a gene promoter(40, 
41) and thus they might induce or suppress transcription activity. Moreover, insulator activity 
is mainly driven by DNA conformation and the global chromatin architecture mediated by 
CTCF,(33) which has been identified as a major regulator in the genome.(33, 34) CTCF 
establishes boundaries between topologically associating domains in a cell type-specific and 
developmental fashion.(34, 42) It is possible that 6q12 and 11p14 polymorphisms influence 
CTCF binding and activity and thus gene expression in larger areas in both regions. Recently 
it was reported that CTCF might play a role in lung diseases such as cystic fibrosis(43, 44) by 
modulating CFTR expression through insulator activity in the CFTR locus.(45) Whether and 
how 6q12 and 11p14 polymorphisms affect CFTR binding, insulator activity and gene 
expression in the region, remains to be shown.  
Importantly, we measured mixed eNO in our study, thus containing eNO of nasal and 
bronchial origin. There is no data supporting that there is a difference between strictly oral or 
nasal NO (nNO) in term infants.(26, 46) However, such differences could be demonstrated for 
premature infants very early in life and before any possible significant bacterial colonization 
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and pneumatisation of paranasal sinuses, with much higher levels for nNO, predominantly 
under iNOS influence,(17) than for bronchial eNO.(47, 48) The link to the already mentioned 
role of NO metabolism in cell signaling, VEGF-mediated airway development,(10-13) lung 
epithelial-mesenchymal crosstalk,(14) and epithelial function is striking. Similarly to a 
possible role for endogenous NO in premature lungs, one could speculate that in our study, 
given that these are healthy term infants for whom there is no data on a relevant share of nNO, 
elevated eNO as an expression of elevated bronchial epithelial-derived NO might confer a 
counter regulatory effect. This might happen in the context of EGF metabolism and epithelial 
function independently from underlying risk factors for subsequent respiratory morbidity. 
These are functional implications and have to be taken with caution, as we are currently 
lacking clear functional outcomes such as measurements of gene expression in our study. 
Moreover, further genes adjacent to the most significant SNPs at 6q12 and 11p14 may 
importantly also play their roles. 
Remarkably, we neither found associations with known genetic determinants of eNO levels in 
children at risk of developing atopy(19) nor in older children or adults on a genome-wide 
level.(20, 21, 23, 24, 49) Interestingly, the ANO3/MUC15 locus at 11p14 has recently been 
related to atopic eczema in adults ascertained through asthma(38) but the genetic signal in that 
study is independent from the signal found in our study. Earlier in this study, the role of infant 
eNO as a marker for later respiratory symptoms was evident for the subgroup of smoking or 
atopic mothers.(3) This was confirmed by others.(4) We investigated the potential 
discrepancy to current findings and found several differences. The population included by 
Latzin et al. was smaller and had higher exposure to ETS (14.0% in (3) vs. 8.7%) or air 
pollution.(3) Furthermore, siblings were strictly excluded in the current study. We reproduced 
the former findings for the smaller population used by Latzin et al.(3) We speculate, that 
discrepancies could be due to sample size differences or differences in environmental 
exposure. 
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This study is to the best of our knowledge the first effort so far to uncover genetic 
determinants of eNO levels, which were collected in healthy term infants shortly after 
birth(25) according to latest standards and already published as part of a set of normative data, 
including extensive QC during data collection, and subsequent analyses.(26) Despite being 
the first effort so far, we are limited by the number of healthy subjects very early in life 
included to generate sufficient statistical power to detect all variants with at least modest 
effects and especially with regard to possible replication in independent populations. To our 
knowledge no such cohort exists, and a decade was needed to build up the presented study. 
Still, the analyses within the two different batches may nevertheless serve as discovery and 
replication samples. Analysing both batches seperately, they display the same effects, with 
same effect direction and comparable effect sizes while showing different levels of 
significance given their unequal numbers of individuals. Moreover, with this GWAS we were 
able to reach genome-wide significant levels with a significant effect size even with the most 
conservative method to adjust for multiple testing and with significant results for the 
identified top SNPs also after permutation. Still, additional larger and especially longitudinal 
studies are needed to characterize functional implications, as well as further loci with only 
modest effects that remain to be identified for eNO values during later life. 
 
Conclusion 
We identified novel genetic determinants of postnatal eNO in healthy infants not at increased 
risk for atopy or asthma. One identified locus is 6q12, for which rs208515 explained up to 
13% of outcome variance with a high level of significance. In addition, suggestive association 
was detected for SNPs at chromosome 11p14. Given the association with respiratory 
symptoms, these results may provide new insight into possible biological mechanisms 
underlying eNO levels, their regulation, and their functional relevance within the spectrum of 
respiratory disease especially in young children. The identification of these variants may 
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implicate that postnatal eNO metabolism in healthy infants not at increased risk for atopy is 
rather related to epithelial function prior to first viral infections and postnatal sensitization.
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FIGURES 
Figure 1. Flowchart of excluded study participants due to general exclusion criteria or quality control 
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Figure 2, A and B. Manhattan plots displaying the associations of eNO (A) and V’NO values (B), final models 
A.
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B.
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Figure 3: Association of the 6q12 locus with eNO and respiratory symptoms during the 
first year of life across genotypes 
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Figure 4: Association of the 11p14 locus with eNO and respiratory symptoms during the 
first year of life across genotypes 
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Figure 5, A and B: Fine mapping of eNO association signals on chromosomes 6 and 11 
Fuchs and Gorlanova et al. 32 
 
FIGURE LEGENDS  
 
Figure 1. Flowchart of excluded study participants due to general exclusion criteria or 
quality control. 
See text for details. 
Abbreviations: (e)NO – (exhaled) nitric oxide, IBD – inheritance-by-descend, NREM – non 
rapid eye movement, SD – standard deviation, PCA – principal component analysis 
 
Figure 2, A and B. Manhattan plots displaying the associations of eNO (A) and V’NO 
values (B), final models. 
Each dot represents the p-value for the association of a SNP with the outcomes eNO and 
V’NO. For this, the –log10 of each SNP (y-axis) is plotted against the genomic position, i.e. 
chromosome (x-axis) adjusting for PC1 as well as known and possible confounders. These 
were study length, maternal smoking during pregnancy, maternal history of atopy, age at 
measurement, as well as V’E for eNO, and study weight, maternal smoking during pregnancy, 
maternal history of atopy, age at measurement, and V’E for V’NO in the final models for 
either outcome. The black lines display the genome-wide Bonferroni significance threshold 
p<8.8×10-8 (0.05/ 567,864). The light grey lines display the suggestive genome-wide 
significance level p <1×10-5. 
Abbreviations: eNO – exhaled nitric oxide, PC1 – principal component 1, SNP – single 
nucleotide polymorphism, V’E – minute ventilation, V’NO – NO output 
 
Figure 3: Association of the 6q12 locus with eNO and respiratory symptoms during the 
first year of life across genotypes 
Figures display the effect of rs208515 on means of eNO on the left (y-axis, eNO in ppb) and 
weeks with respiratory symptoms during the first year of life on the right (y-axis in weeks 
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with symptoms) and their respective 95% confidence interval across genotypes (from left to 
right: homozygous for non-risk allele, heterozygous, homozygous for risk allele). 
Abbreviation: (e)NO – (exhaled) nitric oxide, ppb – parts per billion. 
Figure 4: Association of the 11p14 locus with eNO and respiratory symptoms during the 
first year of life across genotypes 
Figures display the effect of rs1441519 on means of eNO on the left (y-axis, eNO in ppb) and 
weeks with respiratory symptoms during the first year of life on the right (y-axis in weeks 
with symptoms) and their respective 95% confidence interval across genotypes (from left to 
right: homozygous for non-risk allele, heterozygous, homozygous for risk allele).  
Abbreviation: (e)NO – (exhaled) nitric oxide, ppb – parts per billion. 
 
Figure 5, A and B: Fine mapping of eNO association signals on chromosomes 6 and 11. 
LD analysis identified that no polymorphisms in linkage with the identified target SNPs at 
6q12 (A: rs208515 and rs208520) and 11p14 (B: rs12223678 and rs1441519) are located in 
close vicinity to known genes (LD threshold r20.8). Database search identified that five 
tagged polymorphisms on chr.6 are located in CTCF binding sites (rs4618506, rs3899423, 
rs9453663, rs9453664, rs12200490; please note that only CTCF binding sites matching to 
analyzed SNPs are depicted). In-silico prediction proposed that the 11p14 locus contains cell 
type-specific chromatin structures called topologically associating domains, which encompass 
the LUZP2 and ANO3/MUC15 loci (domains are not specifically depicted due to their vast 
predicted extend of over 3,000kb in embryonic stem cells and human lung fetal 
myofibroblasts).The plots were prepared using R version 3.0.0. 
Abbreviations: ANO3 - Human anoctamin 3 gene locus, CTCF - 11-zinc finger protein or 
CCCTC- binding factor, EYS – Human eyes shut homolog gene locus, kb – kilo bases, LD – 
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linkage disequilibrium, LUZP2 – Human leucine zipper protein 2 gene locus, MUC15 - 
Human mucin 15 gene locus, rs - reference SNP cluster code. 
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TABLES 
Table 1: Main outcomes, as well as anthropometric and demographic characteristics for 
n=229 study participants with complete data on eNO measurements and GWAS 
Variable Mean (SD)  Median IQR Range 
eNO, ppb 14.1 (5.2) 13.9 11.0-17.2 1.8-32.9 
V’NO, nL/s 0.63 (0.23) 0.63 0.46-0.78 0.07-1.29 
Minute ventilation, ml 1401.0 (251.1) 1401.0 1232-1565 786-2221 
Anthropometric characteristics     
Gestational age, weeks 39.8 (1.14) 40.0 39.1-40.9 37.1-42.3 
Postnatal age at measurement, days 35.2 (4.65) 34 32-38 25-53 
Birth weight, kg 3.4 (0.42) 3.4 3.1-3.7 2.3-4.9 
Birth length, cm 49.6 (2.03) 49.6 48.0-51.0 45.0-57.0 
Study weight, kg 4.4 (0.52) 4.3 4.0-4.8 3.1-5.8 
Study length, cm 54.9 (2.11) 54.8 53.2-56.6 50.0-59.6 
 Number (%)    
Demographic and socioeconomic 
characteristics, distribution of known 
and possible confounders     
Male sex 115 (50.2%)    
Maternal asthma 27 (11.8%)    
Maternal atopy 79 (34.5%)    
Positive maternal skin prick test* 82 (37.8%)    
Maternal smoking during pregnancy 20 (8.7%)    
Paternal smoking during pregnancy 42 (18.4%)    
Parental smoking during pregnancy 46 (20.1%)    
Caesarean section 39 (17%)    
* data available for n=217 mothers only 
Abbreviations: eNO – exhaled nitric oxide, GWAS – genome-wide association study,  
IQR – interquartile range, SD – standard deviation, V’NO – nitric oxide output. 
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False Normal Lung Clearance Index in Infants With Cystic
Fibrosis Due to Software Algorithms
Pinelopi Anagnostopoulou, MD,1,2 Sophie Yammine, MD,1 Anne Schmidt, MD,1,3 Insa Korten, MD,1
Elisabeth Kieninger, MD, PhD,1,3 Ines Mack, MD,1,3 Daniel Trachsel, MD,3 Gaudenz Hafen, MD,4
Alexander Moeller, MD,5 Carmen Casaulta, MD,1 and Philipp Latzin, MD, PhD1,3*
Summary. Background: Lung clearance index (LCI), a marker of ventilation inhomogeneity, is
elevated early in childrenwith cystic fibrosis (CF). However, in infantswithCF, LCI values are found
to be normal, although structural lung abnormalities are often detectable. We hypothesized that
this discrepancy is due to inadequate algorithms of the available software package. Aim: Our aim
was to challenge the validity of these software algorithms. Methods:We comparedmultiple breath
washout (MBW) results of current software algorithms (automatic modus) to refined algorithms
(manual modus) in 17 asymptomatic infants with CF, and 24 matched healthy term-born infants.
Themain difference between these two analysis methods lies in the calculation of the molar mass
differences that the system uses to define the completion of the measurement. Results: In infants
with CF the refined manual modus revealed clearly elevated LCI above 9 in 8 out of 35
measurements (23%), all showing LCI values below 8.3 using the automatic modus (paired t-test
comparing the means, P<0.001). Healthy infants showed normal LCI values using both analysis
methods (n¼47, paired t-test, P¼0.79). The most relevant reason for false normal LCI values in
infants with CF using the automatic modus was the incorrect recognition of the end-of-test too
early during the washout. Conclusion: We recommend the use of the manual modus for the
analysis of MBW outcomes in infants in order to obtain more accurate results. This will allow
appropriate use of infant lung function results for clinical and scientific purposes. Pediatr
Pulmonol.  2015 Wiley Periodicals, Inc.
Key words: cystic fibrosis; infant pulmonary function; multiple breath washout;
ultrasonic flowmeter.
Funding source: Swiss Cystic Fibrosis Foundation (CFCH); Fondation Botnar; Swiss
National Foundation, Number: 324730_144280/1.
INTRODUCTION
Multiple breath washout (MBW) is an established lung
function test that measures ventilation inhomogeneity, a
marker for small airway function.1 The lung clearance
index (LCI), its main outcome parameter, seems to be a
sensitive marker of mild lung disease in children with
cystic fibrosis (CF).2–4 It has been shown to be elevated
earlier than conventional spirometry (FEV1) in children
with CF,3–5 and to be a useful tool for monitoring and
prediction of disease course.6,7 The technique requires
only passive cooperation and minimal coordination,
therefore the measurements are feasible from infancy
on.8,9
Recent studies using CT scans revealed structural
abnormalities and air trapping in the lung in a significant
proportion of infants with CF.10,11 Thus, onewould expect
longer washout times and elevated LCI values, similar to
older patients with CF.2 However, several working groups
that performed MBW measurements in infants with CF
have reported LCI values within the normal range.12–14
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We hypothesized that this discrepancy is due to the
current software algorithms, as they are inadequate to
obtain accurate LCI values in infants. To test this
hypothesis, we assessed the validity of results obtained
from the automatic analysis in the available software. We
compared results from multiple breath washout (MBW)
measurements analyzed using the current software
algorithms (“automatic modus”) with those analyzed
using refined software algorithms (“manual modus”). We




For our methodological study we included MBW
measurements of 17 infants with CF diagnosed by
newborn screening15 and 24 healthy term-born infants
recruited from the Bern Infant LungDevelopment (BILD)
cohort.16 The study protocol was approved by local ethics
committees, and parents gave written consent.
MBW Measurements
MBWmeasurements were performed in infants during
natural sleep, in accordance with current ERS/ATS
standards.1 Flow, volume, and molar mass (MM) were
measured by an ultrasonic flowmeter (Exhalyzer D, Eco
Medics AG, Duernten, Switzerland). Main stream MM
was used for indirect measurement of tracer gas
concentration. We used 4% sulfur hexafluoride (SF6) as
the tracer gas, as previously described.17 A detailed
description of the ultrasonic flowmeter and the MM
measurements is available in the on-line supplement
(OLS).
Measurements were analyzed using software provided
by the manufacturer (WBreath Version 3.28.0.0, ndd
Medizintechnik AG, Zuerich, Switzerland). Body tem-
perature pressure saturation (BTPS), and flow baseline
corrections were applied to the volume signal, and MM
temperature simulation and MM step response correction
to the MM signal.17
We selected one to three high-quality measurements
per subject based on visual quality control and the
following criteria: no leaks, no sighs, no irregularities in
breathing pattern and complete washin and washout as
identifiable by visual control of original traces.
Calculation of MM Step
The MM signal acquired through the ultrasonic
flowhead is influenced by differences in temperature,
airway pressure, and gas composition.18 The calibration
of the device and the temperature model simulation
correction17 are intended tominimize the effect of the two
first parameters. Hence, changes in MM signal should
reflect changes in gas composition. Indeed, theMMsignal
is increased during expiration, due to the presence of
carbon dioxide (CO2). The MM signal at the end of
expiration [end-expiratory molar mass (EEMM)] is a sum
signal of the actual concentration of the tracer gas and
CO2 at the end of expiration (see Fig. 1). At the end of a
complete washin or washout phase, SF6 is equally
distributed within the lungs or completely washed out
of the lungs, respectively, and the difference inMM signal
between inspiration and expiration reflects again the CO2
exchange. Therefore, in an ideal measurement where
washin and washout are complete, the change in EEMM
(EEMM-step) between end of washin and end of washout
is expected to be equal with the change in end-inspiratory
MM (EIMM-step) between end of washin and end of
washout. Inequality between these two values reflects an
insufficient SF6 washin or washout, given that breathing
pattern and CO2 expirogram remain stable
18,19 (see
further details in the OLS).
Fig. 1.Originalmolarmass tracing curve of a SF6-MBWfroman infantwithCF. The enlargedparts
at the end ofwashin and the end of thewashout show the end-expiratorymolarmass (EEMM) and
end-inspiratory molar mass (EIMM). The difference of molar mass (MM) between the end of
washin and the end of washout is called MM-step; EEMM-step and EIMM-step, respectively.
2 Anagnostopoulou et al.
Pediatric Pulmonology
Calculation of FRC and LCI
The software calculates functional residual capacity
(FRC) and LCI at 2.5% of the initially defined 100% step
in gas concentration. The current automatic modus of
analysis uses the EEMM-step to define this initial 100%
step. In the manual modus, we used the EIMM-step
instead to define this step (Fig. 1). In contrast to the
EEMM, the EIMM signal is determined during inspira-
tion, and reflects changes of the tracer gas only. Applying
the EIMM-step thus enables a more thorough evaluation
of whether the tracer gas was completely washed in and
out during the test without further influence by other gases
(see further details in the OLS).
Procedure of Using the EIMM-Step
We determined the EIMM-step of each measurement
by using the automaticmodus of analysis. The value of the
EIMM-step is shown in the results-box, under the name
“deltaEIMM”. To perform the refined manual modus of
analysis, we selected “FRC analysis” under the “Analy-
sis” option.We then unselected the automatic MMmodus
and included the EIMM value manually in the box “delta
MM [g/mol]”. We then repeated the analysis using this
manual modus. To assess differences, we first compared
the EEMM- and EIMM-steps from measurements of
healthy infants and infants with CF. Second, we compared
the primaryMBWoutcomes (FRC and LCI) derived from
the automatic modus with the ones obtained by the
manual modus, that is, when the EEMM-step was
replaced by the EIMM-step for each measurement.
Statistical Analysis
Data were analysed using GraphPad Prism version 5.00
for Windows (GraphPad Software, San Diego, CA). We
performed statistical analyses using Student’s paired and
unpaired t-test, and P< 0.05 was accepted to indicate
statistical significance. The upper limit of normal was
defined as 7.9 for LCI.20
RESULTS
We analyzed 35 measurements of 17 asymptomatic
infants with CF, at median (IQR) age of 7.0 (2.7) weeks,
and 47 measurements of 24 healthy term born infants at
5.1 (0.8) weeks. The clinical characteristics of the
subjects included in the study are reported in Table 1.
Using the manual modus, we found elevated LCI in 8
out of 35 measurements (23%) in infants with CF,
whereas all but one measurement were within the normal
range using the automatic modus (Fig. 2A, Table 2, and E-
Fig. 3A, paired t-test comparing the means, P< 0.001). In
contrast, both modes of analysis resulted in similar LCI
values in healthy infants (n¼ 47, Fig. 2A, Table 2, and E-
Fig. 3A, paired t-test, P¼ 0.79).
If the washout phase is complete, both EIMM- and
EEMM-steps are similar, as mentioned above. This was
the case in all measurements of healthy infants (Table 2,
paired t-test, P¼ 0.54). In infants with CF, however, the
EIMM- and EEMM-steps were significantly different
(Table 2, paired t-test, P< 0.001). The EIMM-step was
similar in healthy infants and infants with CF (Table 2,
unpaired t-test, P¼ 0.24), as this is based on the
concentration of the tracer gas only. The difference
between EIMM- and EEMM-step was positively corre-
lated to the tracer gas concentration at the end of washout
in the manual modus, confirming that similar EIMM- and
EEMM-steps indicate completion of the washout
(Fig. 3A). It was also associated with the differences in
LCI values (Fig. 3B and OLS E-Fig. 2).
Using the manual modus, we found higher FRC values
in infants with CF compared to the automatic modus
(Fig. 2B, Table 2, and E-Fig. 3B, paired t-test, P< 0.001).
In healthy infants FRC remained unchanged (Fig. 2B,
Table 2, and E-Fig. 3B, paired t-test, P¼ 0.78). The LCI
derives from the cumulative expiratory volume (CEV)
divided by the FRC.1 The comparison between automatic
and manual modus reveals a LCI increase that is
proportionally higher than the FRC increase. According
to the equation, this is thus attributed to the higher CEV.
TABLE 1—Demographic Characteristics of Study Subjects, Data Are Given in Median (IQR)
Healthy infants Infants with cystic fibrosis
Number, male/female 24 (10/14) 17 (8/9)
Age (wks) 5.1 (0.8) 7.0 (2.7)
Weight (kg) 4.6 (0.6) 4.4 (0.6)
Height (cm) 55.0 (2.6) 55.0 (4.1)
BMI 14.7 (1.9) 14.7 (2.6)
BMI, z-score 0.2 (1.0) 0.7 (2.1)
Respiratory rate (min1) 39.4 (8.8) 42.6 (7.2)
Tidal volume (ml) 33.3 (3.8) 33.5 (6.1)
Age in weeks (wks), weight in kg, height in cm, bodymass index (BMI), BMI z-score, respiratory rate inmin1 and tidal volume in ml are reported
for healthy infants (N¼ 24) and infants with CF (N¼ 17). The BMI z-scores are calculated according to the WHO child growth standards [Group
WMGRS. WHO Child Growth Standards based on length/height, weight and age. In: de Onis M, Garza, C., Onyango, A.W., Martorell, R., editor.
WHO Child Growth Standards. Acta Paediatrica, 2006;95:76-85 (Suppl 450)].
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Indeed, as shown in the LCI breath number (LCIBrNr),
the end of the test is determined much later in CF infants
using the manual modus (Table 2, paired t-test,
P¼ 0.0003, compared with the automatic modus). In
healthy infants, however, it remains unchanged (Table 2,
paired t-test, P¼ 0.95).
In order to examine the ability of the automatic modus
to detect an incomplete measurement in detail, we further
challenged the software by performing FRC and LCI
calculations at different cut-off points within the same
measurement (Fig. 4). Using the EEMM-step (i.e., the
automatic modus of the software), an incompletewashout
was not detected, even when an artificial end was set very
early during thewashout. The software provided false low
LCI values for all earlier ends. The manual modus
overcomes this weakness, as the EIMM-step enables
reliable detection of insufficient washout traces (Fig. 4).
Being uninfluenced by the breathing pattern, an additional
advantage of the EIMM-tracing is that it remains more
stable throughout the measurement compared with the
EEMM-tracing (Fig. 4 and OLS).
DISCUSSION
Summary
In this study we show that the current automatic modus
used for the analysis of MBW measurements in infants
can result in false normal LCI values. This happens
unnoticed to the user and thus makes this way of analysis
useless for clinical or research applications. We present
Fig. 2. Impact of the automatic andmanual analysismodusonMBWoutcomes. (A) LCI values and
(B) FRCvalues (inml) in 47measurements from24 healthy infants, and 35measurements from17
infants with CF calculated using the automatic (based on the EEMM-step) and manual modus
(based on the EIMM-step). P values obtained from paired t-test. The manual modus revealed 3
incomplete washouts, and for thesemeasurements the LCI (^) was calculated at an earlier time-
point (see OLS).
TABLE 2—Mean (SD) Values of MM-Step (g/mol), FRC (ml), FRC Difference (Calculated as FRCEIMM-FRCEEMM in ml), LCI, LCI
Difference (Calculated as LCIEIMM-LCIEEMM), LCI Intrasubject Variability (IV, for Infants With Two Measurements) and
Coefficient of Variation (CV, for Infants With 3 Measurements) in %, LCI Breath Number (LCI BrNr), and Test Duration
Between the Beginning of the Washin and the Time-Point Where the Washout Reaches the 2.5% of the Initial SF6
Concentration in Sec in 24 Healthy Infants (n¼47 Measurements) and 17 Infants With CF (n¼ 35 measurements) Using the
Automatic (EEMM) Modus and the Manual (EIMM) Modus
Healthy infants Infants with cystic fibrosis
Automatic EEMM Manual EIMM Automatic EEMM Manual EIMM
MM-step (g/mol) 5.52 (0.04) 5.52 (0.04) 5.48 (0.08) 5.54 (0.07)
FRC (ml) 103 (15) 103 (17) 111 (16) 125 (27)
FRC difference (ml) 0.3 (7.0) 13.3 (15.8)
LCI 6.7 (0.4) 6.7 (0.4) 6.9 (0.5) 7.7 (1.5)
LCI difference 0.01 (0.3) 0.8 (1.3)
LCI IV/CV (%) 6.1 (4.1)/2.9a 5.1 (2.8)/0.8a 5.5 (3.2)/3.1 (1.0) 5.3 (10.0)/7.8 (2.8)b
LCI BrNr 86 (11) 86 (11) 93 (19) 100 (24)
Test duration (sec) 121 (15) 134 (22)
aBased on one subject.
bBased on four subjects, including one outlier.
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Fig. 3. (A) End-washout tracergas concentrationanddifferencesbetweenEIMM- andEEMM-step.
An incomplete washout phase, detected by elevated end-washout tracer gar concentrations
using the manual modus, is associated with large differences between EIMM-step and EEMM-
step. Plot of the differences between the EIMM-step and the EEMM-step against the endwashout
tracer gas concentration (%) determined using themanualmodus inmeasurements fromhealthy
infants (n¼47) and infants with CF (n¼35). (B) Differences between EIMM- and EEMM-step and
differences in LCI values. Differences between EIMM- and EEMM-step are associated with
differences in LCI between themanual and the automatic modus. Plot of the differences between
themanual LCI (LCIEIMM) and the automatic LCI (LCIEEMM) against the differences between EIMM-
step and EEMM-step in 47 measurements from 24 healthy infants and 35 measurements from 17
infants with CF.
Fig. 4. Earlier stops ofwashoutwithin an originalmolarmass tracing curve of a SF6-MBWfroman
infant with CF. In order to challenge the current software, we artificially defined the end of
washout at different pointswithin the samemeasurement. Thesepoints are displayedusing lines
1, 2 and 3. For each of these points, molar mass difference [DMM (g/mol)], FRC (ml), LCI and End
Concentration [EndCon(%)] values are shown, using the automatic (EEMM) and the manual
(EIMM)modus.When EndCon is higher than 2.5%, LCI is not reached and thus reported as “0” by
the software.
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explanations for this fault and we further provide an
alternative method to analyse the MBW measurements
that leads tomore precise results. In some infants with CF,
the new manual modus reveals pathological LCI values
found to be normal with the automatic modus.
A more detailed analysis revealed that the automatic
modus recognizes the end-of-test criteria too early, thus
calculatingMBWoutcomes in incompletewashouts. This
was the main cause for false normal LCI values in CF
lungs with ventilation inhomogeneity. This was proven by
modelling artificially earlier ends during the washout
(Fig. 4). The manual modus, however, depends only on
the concentration of the inert gas and, thus, provides more
accurate information about the completion of the
measurement.
Interpretation
Our findings indicate that the higher the difference
between EEMM- and EIMM-step, the more incomplete is
the measurement (see OLS). As mentioned above, the
measurements were carefully selected using quality
criteria. The greatest difference between the EEMM-
and EIMM-step within our study corresponds to a SF6
concentration of 0.17%, which is not possible to see
visually, neither during the performance of the measure-
ment, nor during the analysis. The fact that this small SF6
concentration cannot be detected by the user online is a
clear disadvantage of this software package (see also
OLS). In infants with CF, where the potential underlying
pathology of the small airways will prolong washin and
washout times, these small differences in gas concentra-
tion can have a high impact on final LCI results.
Interestingly, the analysis using the manual modus did
not change MBW outcomes of the healthy infants. This
supports our hypothesis that the non-detection of an
incomplete washout was the most relevant reason for
artificially normal LCI values in infants with CF, rather
than a systematicmistake in the algorithm of the software.
The manual modus also changed the FRC values in
infants with CF. This is explained by the fact that theMM-
step affects the initial relative SF6 fraction on which the
calculation for gas volumes is based.18 Interestingly, the
effect on CEV was even larger than on FRC, otherwise
LCI values would have been stable. The finding of higher
FRC values in infants with CF in comparison to the
healthy infants is, however, not surprising. The ventilation
inhomogeneity found in CF lung disease is partially
provoked by air trapping and hyperinflation.10,13 Thus,
LCI but also FRC values are expected to be increased.
The MM-step divided by the MM of SF6 provides the
SF6 fraction.
18 Based on this step, the software algorithms
will then calculate the FRC and the LCI. The accuracy of
MM-step is, thus, of great importance for the MBW
outcomes. Of note, the software algorithm used in the
manual modus uses the EIMM-step to define the 100%
concentration of SF6 and from this uses the EEMM-step
to calculate the FRC and determine when 2.5% of the
initial 100% concentration is reached. The automatic
software algorithm, instead, uses the EEMM-step for
both. This leads to false calculations of values at earlier
stops (Fig. 4).
It is important to mention that the optimised algorithms
used by the software to correct for environmental
parameters (increased temperature and humidity) change
the MM signal only during expiration, thus affecting the
EEMMvalue.17 During inspiration, the air passes through
the flowmeter under constant temperature and humidity
conditions, so no changes have to be applied to the MM
signal. Thus, the optimised algorithms do not affect the
EIMM value.
Our study raises specific questions regarding the
completion of MBW measurements. For example, the
identification of a complete washin phase is a crucial
issue, as this determines the validity of the washout
outcomes. However, this issue is not examined so far, also
with regards to other SF6 systems.
4,21 Additionally, there
is no specific recommendation on the analysis approach of
incomplete washin measurements. Especially for infants
with ventilation inhomogeneity, where the washin time is
expected to be prolonged, a short washin will miss the
poorly ventilated airway zones, leading to false MBW
outcomes. We show that the manual modus can identify
incomplete washin periods but we cannot make any
recommendation upon the analysis of those. Further
examination towards this direction is needed, in order to
clarify how to deal with measurements with incomplete
washin.
In theory a steeper phase III slope, as shown in older
patients with CF,22 could also contribute to differences
between EEMM- and EIMM-steps in infants with CF.
However, we did not observe steep slope III phase in any
measurements of infants with CF, even in those with
elevated LCI. This might be partly due to the fact that the
side chamber of the mainstream ultrasonic flowmeter is
washed in and washed out during the measurement and
thus a formal SnIII analysis cannot be performed, or
simply reflect less steep phase III slopes in infants with
less pronounced lung disease compared to older patients
with CF. In any case, our findings cannot be attributed to
steeper phase III slopes in infants with CF.
Relevance
The device and the software package we used are
currently the only commercially available equipment for
MBW measurements in infants. Several working groups
have reported FRC and LCI outcomes in healthy infants
and infants with CF obtained with this meth-
od.9,12,13,20,23,24 Moreover, this equipment together with
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this software package have been used for the evaluation of
lung function in preterm infants,25–28 infants with
congenital diaphragmatic hernia29,30 and ventilated
infants and children.30–32 Therefore, our findings have
broad implications not only for ongoing and future
studies, but also for the interpretation of existing data.
Hall et al., e.g., report normal LCI values in infants with
CF despite air-trapping in chest CT.13 It is tempting to
speculate that this lack of association is due to the
inability of the automatic modus to detect pathological
LCI values.
Because of its high sensitivity, there is an increasing
interest of the research community on using LCI as a
primary outcome in clinical studies.6 The incorporation of
infant groups in those studies is of high priority, therefore
our analysis methodwill serve as a useful tool for ongoing
and future studies in infants with respiratory diseases,
using MBW measurements as outcome.33
Of note, these findings account only for the present
device and the ultrasonic flowmeter. It is beyond the
scope of this study to determine how sensitive other
measurement devices and software packages for SF6-
MBW, such as the mass spectrometer4,34,35 and the
Innocor photoacoustic gas analyser,21,36 are to detect
differences of such small concentrations. In fact, these
two devices measure directly changes in tracer gas
concentration4,21 while the ultrasonic flowmeter meas-
ures them indirectly, by measuring changes in MM.18
However, the detection of incomplete washout traces is
an issue that accounts for all MBW techniques,
independent of the methodological approach. Espe-
cially for infants, where the fast respiratory rate, the
low tidal volume as well as the proportionally
increased dead-space create a priori different con-
ditions on performing MBW measurements,17,37 we
recommend a closer look at the end-of-test criteria and,
if necessary, a critical reevaluation of the cut-off that
the software uses to define differences in tracer gas
concentrations.
CONCLUSION
Assessing ventilation distribution using the MBW
technique is an important tool for monitoring early lung
disease. SF6-MBW measurements in infants are widely
used in therapeutic trials34 and epidemiological surveil-
lance studies.11 We show that the method used to
determine the initial MM-step has a significant impact
on both FRC and LCI results. Therefore we strongly
recommend the refined manual modus using the EIMM-
step to overcome the potential underestimation of LCI.
Only the EIMM modus will allow an accurate determi-
nation of MBW outcomes in infancy. In infants with CF,
this represents an important window of opportunity for
interventions.33
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Ventilatory Response to Nitrogen Multiple-Breath
Washout in Infants
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Summary. Background: Nitrogen multiple-breath washout (N2MBW) using 100% oxygen (O2) has
regained interest to assess efficiency of tracer gas clearance in, for example, children with Cystic
Fibrosis (CF). However, the influence of hyperoxia on the infants’ respiratory control is unclear. We
assessed safety and impact on breathing pattern from hyperoxia, and if exposure to 40% O2 first
induces tolerance to subsequent 100%O2 for N2MBW.Methods:We prospectively enrolled 39 infants
aged 3–57 weeks: 15 infants with CF (8 sedated for testing) and 24 healthy controls. Infants were
consecutively allocated to the protocols comprising of 100% O2 or 40/100% O2 administered for 30
breaths. Lung functionwasmeasured using an ultrasonic flowmeter setup. Primary outcomewas tidal
volume (VT). Results: None of the infants experienced apnea, desaturation, or bradycardia. Both
protocols initially induced hypoventilation. VT temporarily declined in 33/39 infants across 10–25
breaths. Hypoventilation occurred independent of age, disease, and sedation. In the new 40/100%O2
protocol, VTreturned to baseline during 40%O2 and remained stable during 100%O2 exposure. End-
tidal carbon dioxidemonitored online did not change. Conclusion: The classical N2MBWprotocol with
100% O2 may change breathing patterns of the infants. The new protocol with 40% O2 induces
hyperoxia-tolerance and does not lead to changes in breathing patterns during later N2 washout using
100%O2. Both protocols are safe, the new protocol seems an attractive option for N2MBW in infants.
Pediatr Pulmonol 2014; 49:342–347.  2013 Wiley Periodicals, Inc.
Key words: cystic fibrosis; inert gases; lung function tests; respiratory physiology.
Funding source: none reported
BACKGROUND
Multiple-breath inert tracer gas washout (MBW) is an
easy and sensitive lung function test assessing efficiency
of inert tracer gas clearance across multiple tidal
breaths.1–4 In children with cystic fibrosis (CF), impaired
tracer gas clearance quantified by the lung clearance index
(LCI) correlates to other biomarkers of small airways
disease,5–8 and detects pulmonary function response upon
short-term interventions.9–11
To overcome the need for expensive inert tracer gases
such as sulfur hexafluoride, nitrogen (N2) MBW using
pure oxygen (O2) has regained interest and seems
attractive for MBW in infants. However, there is scanty
evidence as to whether 100% O2 for the purpose of MBW
is applicable in infants.12–14 A regular breathing pattern is
a prerequisite for reliable MBW testing. By unloading
peripheral chemoreceptors, hyperoxia may change tidal
volume (VT) if 100% O2 is used.
15 We hypothesized that
40%O2may induce “tolerance” of the infants’ respiratory
control to subsequent 100% O2 exposure N2MBW.
Breathing 40% O2 would allow later washout of the
lungs’ remaining N2 fraction using pure O2. In the current
study, we measured tidal breathing indices when infants
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were exposed to hyperoxia during the classical 1-step
N2MBWprotocol with a switch from ambient to 100%O2
gas, and the new 2-steps protocol introducing an
intermediate 40% O2 step, that is, 40/100% O2. Our
aim was to assess safety and impact of hyperoxia (40% or
100% O2) on breathing patterns in infants with CF and
healthy controls, and to compare tidal breathing param-
eters from both N2MBWprotocols. Primary outcomewas
change in VT upon 40% or 100% O2 exposure.
METHODS
We prospectively enrolled 40 infants (16 with CF) from
two ongoing studies, the Bern Infant Lung Development
(BILD) cohort and the Swiss CF Newborn Screening
Study.16–18 The following inclusion criteria applied: white
ethnicity, term delivery (37 weeks), and no known other
diseases likely to affect lung function. General exclusion
criteria were clinical signs of lower respiratory tract
infection. The population is described in Table 1. The
study was approved by the Ethics Committee of the
Canton of Bern, Bern, Switzerland. Parents provided
written informed consent for this study. Parents from one
child withdrew consent.
We consecutively allocated 23 infants (7 with CF of
which 4 were sedated) to protocol I and 16 (8 with CF
of which 4 were sedated) to protocol II. The sequence
of tidal breathing measurements in protocol I was (i) 1
baseline test during ambient air exposure (21% O2) and
(ii) 1 test during breathing 100% O2. Protocol II implied
(i) 1 baseline test during ambient air exposure, (ii) 1 test
during breathing 40% O2, and (iii) 1 test during breathing
100% O2. Hyperoxia was administered for 30 breaths
which reflect approximately twice the cumulative expired
volume (CEV) of average N2MBW in infants.
12 Oxygen
saturation, heart rate, and the exhaled carbon dioxide
(CO2) fraction were monitored online.
Lung function was measured in infants in supine
position with the head midline via an infant mask (size 1;
Homedica AG, Huenenberg, Switzerland), according to
the ERS/ATS standards of infant lung function testing.19–
21 Thirty-one young infants, age range 3–13weeks, 7 with
CF, were studied during behaviorally defined natural
sleep. Measurements followed regular feeding of the
infants, usually resulting in quiet (non-rapid eye
movement) sleep in this age group. Eight older infants
with CF aged 13–14 months were studied during chloral–
hydrate sedation. Flow was measured using a mainstream
ultrasonic flow meter (Exhalyzer D; Eco Medics AG,
Duernten, Switzerland).17 Data were used if no apparent
volume drift was present, defined as a change exceeding
2 ml s1. Tidal breathing indices derived from tidal flow
were measured from all breaths. Main outcome was VT
which directly affects end-expiratory lung volume, the
functional residual capacity (FRC). Secondary outcomes
were respiratory rate (RR), minute ventilation (VE), mean
tidal expiratory flow (MTEF), and end-tidal CO2
monitored online. Tidal breathing indices within children
were compared by paired t-test. P-values < 0.05 were
considered significant (STATA 11; College Station).
Variability of VT was estimated by the coefficient of
variation (CV ¼ SD/mean %) within each test and per
child.
RESULTS
Thirty-eight infants completed the study according to
protocol (Table 1). None of the infants experienced apnea,
desaturation (92% O2), bradycardia (<60 min1) or
change in end-tidal CO2 levels. One non-sedated infant
woke up during 100% O2 exposure (protocol II). In total,
VT, RR, VE, and MTEF were measured in 4,063 breaths
from 132 tests.
In both protocols, initial hyperoxia (40% or 100% O2)
induced hypoventilation. In 33/39 infants, VT declined
after 2–4 breaths, remained low during 10–25 breaths, and
then returned to baseline (Fig. 1). Similarly VE andMTEF
but not RR decreased and increased again (Table 2). VT
decreased irrespective of disease, age, or sedation. We
stratified children according to disease, age, and sedation:
Mean (95% CI) VT decrease was 2.9 (1.4; 4.4) ml in the
24 controls, and 6.7 (2.9; 10.4) ml in the 15 infants with
CF; 3.0 (1.7; 4.2) ml in the 31 non-sedated (younger)
infants, and 9.7 (3.3; 16.2) ml in the eight sedated infants
(older, all with CF). Intra-individual variability of VT
increased during initial hyperoxia (Table 2). In both
protocols, mean (SD) CV rose from 8.8 (3.6)% at baseline
to 15.1 (7.3)%, P < 0.001, during initial hyperoxia.
Variability of VT increased irrespective of age, sedation,
or disease (P  0.001 for all).
The infants’ respiratory control apparently adapted to
hyperoxia (Figs. 1 and 2). Here, we report ventilatory
TABLE 1—Anthropometric Characteristics of the Study
Population (n ¼ 39)
Younger infants Older infants
N 31 (7 with CF) 8 (8 with CF)
Protocol I/II 19/12 4/4
Males/females 16/15 3/5
Age 5 (5–6) weeks 13 (13–14) months
Weight 4,150 (3,600–4,960) g 9.3 (8.7–9.5) kg
Height 55 (52–58) cm 77 (73–78) cm
Anthropometric data from the 24 healthy infants and 15 infants with CF.
Numeric data are described as median and interquartile range. Protocol
I ¼ classical 1-step nitrogen multiple-breath washout protocol using
100% oxygen; Protocol II ¼ new 2-steps nitrogen multiple-breath
washout protocol using 40–100% oxygen. Lung function wasmeasured
during natural quiet sleep in younger infants and during sedation in
older infants.
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dynamics from infants in protocol (II). After initial VT
decrease during 40% O2, VT returned to baseline during
100% O2 exposure. Mean (SD) baseline VT was 51.4
(29.2) ml, VT during 40% O2 exposure was 46.4 (26.8) ml,
P ¼ 0.007 and 51.5 (29.2) ml, P > 0.9 during 100% O2
exposure. Similarly VE and MTEF returned to baseline
while RR remained unchanged. Similarly end-tidal CO2
levels monitored online during hyperoxia remained stable.
VT variability remained slightly elevated (Table 2).
DISCUSSION
Summary
This is the first study to report on a new infant N2MBW
protocol inducing tolerance to hyperoxia. Infant N2MBW
protocols using 100% O2 or both 40% and 100% O2
applied sequentially are safe. Both protocols initially lead
to hypoventilation and increased variability of VT. These
VT dynamics were apparently independent of age,
disease, and natural or induced sleep in infants younger
than 14 months. Of importance, the infants’ hypoventi-
lation is temporary. The new protocol comprising 40%
O2 exposure prior to N2MBW using 100% O2 induces
tolerance to hyperoxia. Breathing 40% O2 allows later
washout of the lungs’ remaining N2 fraction using pure
O2. The new protocol seems applicable for future
N2MBW studies in healthy infants and infants with CF.
Physiological Aspects of Nitrogen Multiple-Breath
Washout in Infants
The principle of N2MBW is based on lung inherent N2
washout via breathing pure O2. It appears that temporary
Fig. 1. Tidal breathingpattern during the classical andnewnitrogenMBWprotocol. The course of
tidal volumes (VT) from 39 infants (16 with CF of which 8 were sedated) across both protocols
illustrates transient hypoventilation induced by hyperoxia (40% or 100% O2). The bars give
median and inter-quartile ranges of VT. VT slowly returns to baseline during both 100% O2
(protocol I: 23 infants, 4 sedated; upper panel) and 40% O2 exposure (protocol II: 16 infants, 4
sedated; lower panel) and remains stable during subsequent 100% O2 exposure in protocol II.
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hyperoxia does not influence respiratory control in
children older than 4 years,22 but may trigger the infants’
peripheral chemoreceptors which then activate the
brainstem respiratory pattern generator network.15 Hy-
peroxia may also induce temporary vasoconstriction of
cerebral circulation, an effect that theoretically could
have contributed to the observed change in ventilation by
the induced local increase in tissue CO2. Alternative
pathways mediated by systemic hypercapnia seem less
likely as end-tidal CO2 levels monitored throughout the
studies remained stable. During hyperoxia, the respiratory
control adapted. Administration of 40% O2 induced
tolerance to hyperoxia leading to normal but slightlymore
variable VT during 100% O2 exposure. Of note, breathing
pattern changed in some but not all infants (Fig. 2).
Respiratory responses were heterogeneous and apparent-
ly independent of age, disease, and sedation.
Methodological Aspects of Nitrogen
Multiple-Breath Washout in Infants
Previous MBW techniques based on sulfur hexafluor-
ide or helium are safe and have been frequently used in
children. However, sulfur hexafluoride is a potent
greenhouse gas and not available in many countries.1
Helium is highly volatile which increases the risk of gas
TABLE 2— Impact of the Classical and New Nitrogen MBW Protocol on Tidal Breathing
Baseline Protocol I Protocol II
Ambient air 100% O2 40% O2 100% O2








VT (ml) 44.7 [23.4–121.0] 3.9 (6.1; 1.7)# 4.9 (8.0; 1.9)# 0.1 (2.2; 2.4)
CVVT (%) 8.8 [4.3–23.1] 8.7 (5.9; 11.5)
# 2.2 (0.8; 5.1) 2.1 (0.8; 5.1)




177 (246; 108)# 141 (251; 31)## 9 (102; 119)
MTEF (ml s1) 46.1
[27.1–80.5]
6.5 (8.9; 4.0)# 3.4 (7.1; 0.3) 0.9 (2.7; 4.5)
Tidal breathing indices from baseline are given as mean [range], and as mean difference (95% confidence intervals) between (…) baseline and
later tests. One infant woke up during breathing 100% O2. VT, tidal volume, CVVT, intra-subject coefficient of variation from tidal volume; RR,




Fig. 2. Impact of the classical and new nitrogenMBWprotocol on tidal volumes. Mean tidal volumes during nitrogenmultiple-breath
washout (N2MBW) in 23 healthy infants (closed circles) and 16 infants with CF (hollow circles) of which 8 were sedated. In the
classical 1-step protocol, infants were exposed to ambient air and 100% oxygen (O2). In the new 2-steps protocol, infants were
exposed to ambient air, 40% O2, and 100% O2. Classical protocol on the left panel: 23 infants, 4 sedated; new protocol on the right
panel: 16 infants, 4 sedated.
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leakage during infant MBW. N2MBW has regained
interest for lung function testing in infants and young
children as N2MBW seems appropriate for widespread
use. N2MBW setups are available and O2 supply is easily
accessible. Modern N2MBW setups provide online
tracing of expired N2 and flow-volume loops.
22,23 These
technical features are also recommended by the new ERS/
ATS consensus statement on inert gas washout testing1
and could make the new N2MBW protocol attractive for
early CF lung disease assessment.12,22,24,25 Previous
studies12,13 reported initial hypoventilation during classi-
cal N2MBW (100% O2) in healthy infants and infants
with CF, bronchopulmonary dysplasia, or wheezy
bronchitis. However analysis of the breathing pattern
was presumably done post hoc as online VT control in
previous N2MBW setups was not available.
Strengths and Limitations of the Study
The ventilatory response to hyperoxia was similar in
older sedated sleeping CF infants and younger non-
sedated sleeping CF infants. However, carotid chemore-
ceptor and ventilatory response to hypoxia are known to
undergo significant changes early in life. Due to ethical
considerations, we did not sedate younger infants as
MBW success rate is excellent without sedation in this
age group.26 We acknowledge that consecutive allocation
hampered the assessment of the magnitude of the
ventilatory chemoreflex and possible interactions be-
tween ventilatory response and age and sedation.
Allocation ensured equal distribution of healthy and
diseased infants and older infants requiring sedation in
both protocols.
The current N2MBW setup is accurate for measuring
infant lung volumes as recently shown in a plastic lung
model.23 Due to expected software adaptations for 40%
O2, we could not measure classical in vivo N2MBW
outcomes such as the LCI which may limit the
interpretation of the current data. However, because
of the complex dynamic respiratory control and the
likely change in FRC, changes in, for example, LCI
seem also likely (LCI ¼ CEV/FRC).13 Furthermore,
the observed initial depression of the first few breaths
when hyperoxia is administered is of importance. The
depression in ventilation affects our potential to derive
alternative indices of gas mixing efficiency based on
phase III slopes (Sacin and Scond). The latter
assumptions are supported by recent preliminary data
from school-aged children suggesting a significant
decrease in gas mixing efficiency upon change in
breathing pattern.27 The impact from both N2MBW
protocols on FRC and LCI in infants nevertheless
remains to be determined. Before this is done, MBW
tests using foreign inert tracer gases seem preferable in
infants.
CONCLUSION
Taken together, we provide new perspectives for future
N2MBW infant studies. Hyperoxia for the purpose of
pulmonary function testing is safe but influences
ventilatory control in infants. The new 40/100% O2
protocol comprising 40% O2 exposure prior to N2MBW
using 100% O2 may induce tolerance to hyperoxia. The
current technique requires adaption for gradual O2
administration in infants. We assume that continued
100% O2 exposure, for example for 60 breaths, would
similarly induce tolerance to hyperoxia but would not
allow subsequent N2MBW. The new 40/100% O2
protocol seems an attractive option for N2MBW in
infants.
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Background: Preterm birth, low birth weight, and infant catch-up growth seem asso-
ciated with an increased risk of respiratory diseases in later life, but individual studies
showed conflicting results. Objectives: We performed an individual participant data meta-
analysis for 147,252 children of 31 birth cohort studies to determine the associations of
birth and infant growth characteristics with the risks of preschool wheezing (1-4 years)
and school-age asthma (5-10 years).
Methods: First, we performed an adjusted 1-stage random effect meta-analysis to as-
sess the combined associations of gestational age, birth weight, and infant weight gain
with childhood asthma. Second, we performed an adjusted 2-stage random-effect meta-
analysis to assess the associations of preterm birth (gestational age <37 weeks) and low
birth weight (<2500 g) with childhood asthma outcomes.
Results: Younger gestational age at birth and higher infant weight gain were inde-
pendently associated with higher risks of preschool wheezing and school-age asthma (P
<.05). The inverse associations of birth weight with childhood asthma were explained
by gestational age at birth. Compared with term-born children with normal infant weight
gain, we observed the highest risks of school-age asthma in children born preterm with
high infant weight gain (odds ratio [OR], 4.47; 95%CI, 2.58-7.76). Preterm birth was
positively associated with an increased risk of preschool wheezing (pooled odds ratio
[pOR], 1.34; 95%CI, 1.25-1.43) and school-age asthma (pOR, 1.40; 95%CI, 1.18-1.67)
independent of birth weight.Weaker effect estimates were observed for the associations
of low birth weight adjusted for gestational age at birth with preschool wheezing (pOR,
1.10; 95%CI, 1.00-1.21) and school-age asthma (pOR, 1.13; 95%CI, 1.01-1.27).
Conclusion: Younger gestational age at birth and higher infant weight gain were as-
sociated with childhood asthma outcomes. The associations of lower birth weight with
childhood asthma were largely explained by gestational age at birth.
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Background Children born preterm or with a small-size-for-gestational-age are at in-
creased risk for childhood asthma.
Objective To assess the hypothesis that these associations are explained by reduced
airway patency.
Methods We used individual participant data of 24,938 children from 24 birth cohorts to
examine and meta-analyze the associations of gestational age, size-for-gestational-age,
and infant weight gain with childhood lung function and asthma (age range 3.9 19.1
years). Second, we explored whether these lung function outcomes mediated the associ-
ations of early growth characteristics with childhood asthma.
Results Children born with a younger gestational age had a lower FEV1 (forced expira-
tory volume in 1 second), FEV1/FVC (FEV1/forced vital capacity), and FEF75 (forced
expiratory volume after exhaling 75% of vital capacity), whereas those born with a smaller
size-for-gestational-age at birth had lower FEV1 but higher FEV1/FVC (p-values<0.05).
Greater infant weight gain was associated with higher FEV1, but lower FEV1/FVC and
FEF75 in childhood (p-values<0.05). All associations were present across the full range
and independent of other early life growth characteristics. Preterm birth, low birth weight
and greater infant weight gain were associated with an increased risk of childhood asthma
(pooled odds ratio (95%CI): 1.34 (1.15, 1.57), 1.32 (1.07, 1.62) and 1.27 (1.21, 1.34),
respectively). Mediation analyses suggested that FEV1, FEV1/FVC and FEF75 may ex-
plain 7 (2, 10) % to 45 (15, 81) % of the associations between early growth characteristics
and lung function.
Conclusions Younger gestational age, smaller size-for-gestational-age, and greater infant
weight gain were across the full ranges associated with childhood lung function. These
associations explain to a substantial extent the risk of childhood asthma.
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